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Abstract 
 
Vascular Endothelial Growth Factor (VEGF) has been shown to be an absolute 
requirement for ovarian follicle development. Although VEGF is commonly 
regarded primarily as an angiogenic factor, granulosa cells are a major site of VEGF 
synthesis in the follicle and they express VEGF receptors (VEGFR1 and VEGFR2). 
Further, the development of the dominant follicle is characterised by a substantial 
increase in granulosa cell expression of VEGF and its receptors. In spite of this, 
potential non-angiogenic effects of VEGF in these follicles have not been elucidated. 
The objective of the three studies described in this thesis was to use an in vitro 
bovine granulosa cell model to investigate the roles of VEGF during development of 
the dominant follicle. In addition, in light of evidence in other cell types, potential 
interactions between VEGF signalling and heterotrimeric protein signalling in these 
follicles were also investigated. 
 
In the first study, granulosa cells were obtained from healthy follicles with 
diameters of 4 to 8 mm (corresponding to just before the selection of a dominant 
follicle during a follicular wave) or 9 to 14 mm (encompassing all developmental 
stages of a dominant follicle) and exposed to a range of VEGF concentrations (1 to 
100 ng/ml) encompassing concentrations found naturally in bovine dominant 
follicles. VEGF at 1 ng/ml, but not at higher concentrations (P > 0.1), induced 
significant proliferation of bovine granulosa cells from 4 to 8 mm follicles (P = 
0.024) and increased the proliferative response of these cells to FSH (P = 0.045). 
VEGF also induced a dose-dependent increase in ERK1/2 activation by granulosa 
cells from 4 to 8 mm follicles (P < 0.03) but did not have any effect on expression of 
the steroidogenic enzyme, CYP11A1, by these cells (P > 0.1). VEGF, at a dose of 1 
ng/ml (P = 0.003), but not at higher doses (P > 0.1), induced an increase in COX-2 
expression by granulosa cells from 9 to 14 mm follicles. In addition, LH stimulation 
of both ERK phosphorylation (P < 0.05) and COX-2 expression (P < 0.05) in 
granulosa cells from 9 to 14 mm follicles were prevented (P > 0.1) by specific 
inhibition of VEGFR2, indicating that VEGF may mediate COX-2 responses to LH 
in these cells.  
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   The second study sought to examine the expression of heterotrimeric G-protein á 
subunits and PLCâ isoforms by real-time PCR and westen blotting in bovine 
granulosa cells throughout follicle development to identify specific molecular 
components of heterotrimeric G-protein pathways that may functionally interact with 
intracellular VEGF signals. Results showed that GNAS, GNA11 and GNAI2 were all 
expressed at significantly (P < 0.05) higher levels in granulosa cells of pre-ovulatory-
size follicles (10.0 to 13.9 mm) than in cells from smaller follicles (2.0 to 5.9 mm 
and 6.0 to 9.9 mm). In addition, all PLCB isoforms except PLCB2 were expressed in 
bovine granulosa cells with PLCB3 being more abundant than PLCB1 and -4.  Levels 
of PLCB3 in granulosa cells from pre-ovulatory-size follicles were much higher 
(>16-fold; P < 0.005) than in smaller follicles. Immunocytochemical analysis 
revealed that PLCB3 was located primarily in the cytoplasm, whereas PLCB1 was 
distributed primarily in the nucleus. These results identified Gs, Gq/11, Gi2 and 
PLCâ3 as candidates for cross-talk between VEGF and heterotrimeric G-protein 
signalling during the development of the dominant follicle. 
The potential involvement of these molecules on VEGF-induced responses in 
granulosa cells from 9-14 mm follicles was investigated in the third study by 
determining the effects of specific inhibitors of Gi (pertussis toxin, PTX) or Gq/11 
(YM-25489) or PLCB3 siRNAs on VEGF-induced p-ERK. Results showed a 2.3
fold mean increase in p-ERK in response to VEGF in the absence of G protein 
inhibitors (P < 0.0001) but a VEGF response that was completely or partially 
abolished, respectively,  in the presence of PTX (P > 0.8) or YM-25489 (1.6-fold 
mean increase relative to untreated controls; P = 0.039). LH induced a 1.6fold 
increase in p-ERK1/2 (P < 0.02) and this response was prevented by pre-incubation 
with PTX (P > 0.4) or YM-25489 (P > 0.5). In contrast, similar EGF-induced 
phosphorylation of ERK (about 5-fold relative to controls) occurred in the absence (P 
< 0.003) or presence of PTX (P < 0.003) or YM-25489 (P < 0.003).  Transfection of 
granulosa cells with 3 siRNAs targeting PLCB3 that had been previously validated 
by western blotting and immunocytochemistry had no effect (P = > 0.7) on 
phosphorylation of ERK in response to VEGF, LH or EGF in granulosa cells.  
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   In conclusion, taken together, these results suggest novel roles of VEGF in 
stimulating granulosa cell proliferation and expression of COX-2 in bovine dominant 
follicles and implicate VEGF in synergising and/or mediating the effects of 
gonadotrophins in these cells. In addition, these results indicate a requirement for 
Gi2 and Gq/11 in VEGF activation of ERK1/2 and induction of the above responses 
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1.1 Folliculogenesis 
 
   Development of a preovulatory follicle in mammalian species is the first milestone 
towards successful reproduction. The ovarian follicle plays a fundamental role in 
reproductive outcome and as such it is imperative that the mechanisms of follicle 
development are fully understood in order to improve and control reproductive 
function in animals and humans alike. The lack of availability of human ovarian 
tissue severely restricts research in the field of human reproduction, therefore other 
species are commonly used as models for the human (Reviewed by Campbell, Souza, 
Gong et al. 2003). Cattle have been proposed as physiologically relevant models for 
the study of the basic mechanisms of folliculogenesis (Malhi, Adams, & Singh 2005; 
Adams & Pierson 1995). The large size and relative ease by which follicles in cattle 
can be monitored, together with the similarities that have been demonstrated between 
follicle dynamics in the cow and human have offered justification for this model. 
 
1.1.1 Stages of follicle development 
 
   Folliculogenesis occurs within the cortex of the ovary, where follicles develop to 
increasingly higher levels of organisation through proliferation and differentiation of 
both the oocyte and associated follicular somatic cells. Folliculogenesis involves the 
sequential development of a pool of primordial follicles into primary, secondary and 
tertiary (Graafian or antral) follicles from which a preovulatory follicle may 
eventually arise (Figure 1.1, Table 1.1). 
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Figure 1.1. Follicle development in mammalian species. There is a fixed population of primordial 
follicles at birth, the majority of which are maintained in a resting state. Growth of some of these 
follicles is initiated at or shortly after birth and continues throughout reproductive life. Follicles 
develop through primary and secondary stages of development prior to the formation of an antral 
cavity. The majority of antral follicles undergo atresia. However under appropriate gonadotrophin 
stimulation, some antral follicles develop to the preovulatory stage. Eventually the pool of resting 
follicles becomes exhausted. Taken from (McGee & Hsueh 2000).  
 
1.1.1.1 Primordial Follicles 
 
   Primordial follicles form when primary oocytes become surrounded by a single 
layer of flattened pre-granulosa cells (Braw-Tal & Yossefi 1997). In rodents, 
formation of primordial follicles occurs in a synchronous manner during the first few 
days after birth. In contrast, formation of primordial follicles in domestic species and 
humans occurs during foetal life. Primordial follicles are thought to be initially 
maintained in a resting state. Resting follicles are likely to be under the influence of 
both local and systemic inhibitory factors and only when these inhibitory effects 
decline or stimulatory factors are released will follicle growth be initiated (McGee & 
Hsueh 2000). Cattle have a reserve of approximately 150,000 primordial follicles in 
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subsequently falls to approximately 3000 follicles by 15 to 20 years of age (Erickson 
1966), reviewed by (Webb, Gong, Law et al. 1992). Once a primordial follicle enters 
the pool of growing follicles (a process that occurs continuously throughout life), it 
will develop through distinct morphological stages until ovulation or until it 
degenerates by atresia, which is the fate of the majority (>99%) of follicles (Ireland 
1987).   
 
1.1.1.2 Primary and secondary follicles 
 
   Development through primary and secondary stages of follicle growth involves the 
progressive acquisition of several layers of cuboidal granulosa cells, see table 1.1. 
Secondary follicles enlarge and recruited stromal cells close to the basal lamina of 
the follicle differentiate to form the thecal layer (composed of theca interna and 
externa). In rodent follicles, the thecal layer is present as early as the late primary to 
early secondary stage (Fortune 2003); this is in contrast with bovine (Braw-Tal & 
Yossefi 1997), ovine (Lundy, Smith, O'Connell et al. 1999) and primates (Gougeon 
1996), in which the thecal layer can not be identified until the mid to late secondary 
stage.  
 
1.1.1.3 Antral (tertiary) Follicles 
 
   Bovine preantral follicles progress to the early antral stage upon reaching a 
diameter of 115-280µm (Gordon 2003), at which point they begin to form an antrum. 
The formation of the antrum results from the formation of small fluid filled cavities 
(lacunae) within the granulosa cell layer that eventually coalesce (Van Voorhis 
1999). Follicle development up to early antral stage is not dependent on 
gonadotrophic influences (Scaramuzzi, Adams, Baird et al. 1993) and represents a 
relatively slow stage of growth, for example it takes approximately 30 days for a 
bovine follicle to grow from 300 ìm to 5mm (Lussier, Matton, & Dufour 1987). 
Subsequent follicle growth up to a preovulatory diameter of 15 to 20 mm is rapid and 
occurs over the following 4 to 6 days (Evans & Canty 2004). Gonadotrophic support 
for continued follicle development becomes absolutely essential after the early antral 
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stage (after follicles reach 2mm in diameter in cattle) (Campbell, Scaramuzzi, & 
Webb 1995; Campbell, Souza, Gong et al. 2003). 
 
Progression through the antral stages of follicle development in large domestic 
species can easily be monitored in real-time by ultrasonography (Reviewed by 
Ginther 1995), therefore relatively much more is known about the physiology of 
these latter stages of follicle development compared to earlier stages.  
 
Table 1.1. Chacteristics of bovine follicle developmental stages.  
                  Taken from (Braw-Tal & Yossefi 1997). 
 
 
1.1.2 Follicle Waves 
 
   Antral follicles in the mammalian ovary were first described by Dutch anatomist, 
Reigner de Graff (1641-1673). De Graff demonstrated that there were a number of 
follicles present in the ovary at any one time; however, the relationships among these 
follicles remained elusive for over 300 years. In 1928 McNutt concluded that large 
follicles in non-pregnant cattle follow cyclical changes and normally grow to their 
largest size during the latter half of the 21 day cycle (McNutt 1928). Initially, 
investigators believed that follicular development was a continuous process that 
occurred independently of phases of the oestrous cycle but in 1960, Rajakoski 
proposed that cattle have two follicular waves during a single estrous cycle 
(Rajakoski 1960). For three decades, this suggestion was controversial as there were 
numerous studies that either supported (Pierson & Ginther 1987; Hackett & Hafs 


















Primordial  1 <10 
(flattened) 
<40 29.7 ± 0.3 - - 
Primary  1-1.5 10-40 
cuboidal 
40-80 31.1 ± 0.4 - - 
Small 
Secondary 
2-3 41-100 81-130 49.5 ± 2.4 - - 
Large 
Secondary 
4-6 101-250 131-250 68.6 ± 2.8 + + 
Small 
Antral  
>6 >250 250-500 92.9 ± 4.5 ++ ++ 
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1969; Ireland, Coulson, & Murphree 1979; Swanson, Hafs, & Morrow 1972) or 
refuted (Donaldson & Hansel 1968; Dufour, Whitmore, Ginther et al. 1972; Ireland 
& Roche 1983; Matton, Adelakoun, Couture et al. 1981; Priedkalns, Weber, & 
Zemjanis 1968; Spicer & Echternkamp 1986) that claim. It was not until the 
introduction of ultrasonography in veterinary science that the knowledge barrier was 
broken and progress towards the current understanding of follicular dynamics was 
initiated.  The first full description of bovine ovarian follicular dynamics throughout 
a complete oestrous cycle was done using ultrasonographic analysis (Sirois & 
Fortune 1988). Ultrasonography is a non-invasive tool used to monitor individual 
follicles on consecutive days in the same animal as they grow and regress, allowing 
patterns of follicle development to be determined with relative precision (Ginther, 
Knopf & Kastelic 1989). 
 
   The term follicle wave refers to the growth of follicles that emerge as a cohort and 
can be detected by standard ultrasonographic techniques, i.e., follicles ≥ 2 mm 
(Mihm & Austin 2002). Typically, 2 to 3 waves per oestrous cycle are observed in 
cattle (Reviewed in Adams, Jaiswal, Singh et al. 2008) but there is a propensity for 
specific breeds to display a characteristic number of waves. For example lactating 
Holstein cattle tend to have two follicle waves per cycle (Taylor & Rajamahendran 
1991; Townson, Tsang, Butler et al. 2002) whereas beef and dairy heifers tend to 
have 2 or 3 waves per cycle (Ginther, Knopf, & Kastelic 1989; Savio, Keenan, 
Boland et al. 1988; Sirois & Fortune 1988). Tropical Bos Indicus cattle have been 
observed to have as many as 4 waves per cycle (B, Baruselli, & Martnez 2003). 
 
   Approximately every 10 days during an oestrous cycle, a follicle wave emerges 
under stimulation by a preceding surge in circulating FSH concentrations (Adams, 
Matteri, Kastelic et al. 1992; Ginther, Beg, Gastal et al. 2005; Sunderland, Crowe, 
Boland et al. 1994). Each follicular wave is characterised by the synchronous growth 
of a group (cohort) of follicles. Recruitment of follicles into the cohort occurs during 
a window of time of 2 days in cattle (Driancourt 2001). The number of follicles 
recruited into the cohort differs between species, but ranges from 5 to 10 in cattle 
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(Lussier, Matton & Dufour 1987). Initially all follicles in a cohort enter a common 














Figure 1.2. Schematic depiction of diameter profiles of the dominant and largest subordinate follicles 
of a wave in cattle and women. Adapted from (Ginther, Beg, Bergfelt et al. 2001). 
 
   By the end of the common growth phase only the largest (future dominant) follicle 
is able to maintain its growth rate, whilst the remaining (subordinate) follicles slow 
down or cease their growth before starting to regress (Reviewed by Ginther, Bergfelt, 
Beg et al. 2001a). The two largest follicles of a wave begin to deviate in diameter 
when the largest follicle reaches a diameter of 8.5 mm in cattle (Ginther, Beg, 
Donadeu et al. 2003). The selected follicle will either ovulate (dominant ovulatory 
follicle) or become atretic (dominant non-ovulatory follicle) depending on whether it 
develops in the presence (follicular phase) or absence (luteal phase) of high 
progesterone levels in circulation (Reviewed by Bao & Garverick 1998; Kastelic, 
Knopf, & Ginther 1990).  
 
   The future dominant (normally the largest) follicle has been shown to emerge 6-10 
hours before the largest future subordinate follicle (Ginther, Kot, Kulick et al. 1997a; 
Kulick, Kot, Wiltbank et al. 1999). This provides the future dominant follicle with a 
size advantage of about 0.5 mm relative to the second largest follicle (future largest 
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phase, all follicles are capable of becoming dominant as has been shown using 
ablation experiments. For example, when the largest follicle was ablated at the end of 
the common growth phase in both heifers and mares, the second largest follicle was 
capable of becoming dominant (Ginther, Beg, Donadeu et al 2003). Similarly a study 
in cattle found that when one, two or three of the largest follicles were ablated at the 
end of the common growth phase, of the remaining follicles the first to reach a 
diameter of 7mm became dominant (Ginther, Bergfelt, Beg, & Kot 2001a). Despite 
the largest follicle having obvious morphological dominance as indicated by its 
significantly larger size compared to others in the cohort during deviation, it remains 
difficult to pin-point the exact time that follicle selection begins because prior to 
diameter deviation distinct intrafollicular biochemical events occur that may prepare 
the largest follicle to become dominant (biochemical dominance) (Fortune, Rivera, & 
Yang 2004).  
 
1.1.3 Regulation of follicle selection and development of the dominant   
            Follicle 
 
   Follicle selection and the subsequent development of the dominant follicle to 
preovulatory stage has been extensively studied, particularly in large monovulatory 
species such as the cow and mare (Reviewed by Ginther 2000). Both systemic and 
local regulatory mechanisms have been shown to control this process. 
 
1.1.3.1 Systemic regulatory mechanisms 
 
Follicle Stimulating Hormone (FSH). A two-way coupling between FSH 
concentrations and the follicles of a wave has been shown whereby FSH stimulates 
follicle growth whilst the growing follicles exert an inhibitory effect on the 
concentrations of the FSH surge (Figure 1.3) (Ginther, Bergfelt, Kulick et al. 1999; 
Ginther, Bergfelt, Kulick et al. 2000b). Follicular requirements for FSH have been 
demonstrated in functional studies, whereby inhibition of FSH resulted in an 
inhibition of follicle emergence. This effect could be prevented by administration of 
exogenous FSH (Reviewed in Mihm & Bleach 2003). The concentrations of the FSH 
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surge begin to decline when the largest follicle reaches 4 mm and this is due to the 
FSH-suppressing activities of inhibin secreted by all growing follicles (Bleach, 
Glencross, Feist et al. 2001; Gibbons, Wiltbank, & Ginther 1997; Mihm, Good, 
Ireland et al. 1997; Sunderland, Knight, Boland et al. 1996). The role of inhibin-A in 
the feedback regulation of FSH concentration has been shown in a number of studies 
in which immunoneutralisation of inhibin-A resulted in significantly increased levels 
of plasma FSH (Glencross, Bleach, McLeod et al. 1992; Kaneko, Nakanishi, Akagi 
et al. 1995; Kaneko, Taya, Watanabe et al. 1997). Further support was provided by 
studies in heifers whereby administration of inhibin resulted in a significant 
reduction in plasma FSH levels (Beard, Castillo, McLeod et al. 1990; Beard, Savva, 
Glencross et al. 1989; Turzillo & Fortune 1993).  
Just before the beginning of deviation, the future dominant follicle begins to produce 
increased oestradiol concentrations and both inhibin and oestradiol contribute to the 
continuous suppression of FSH throughout the development of the dominant follicle 
(Ginther, Bergfelt, Kulick et al. 2000a). It has been concluded  that the combined 
effects of follicular inhibin and oestradiol at the beginning of deviation drive the 
decline in FSH concentration to levels below the requirement of the smaller follicles 
thus preventing their continued growth (Figure 1.3) (Ginther, Bergfelt, Kulick, et al. 
2000a). The largest follicle, however, acquires the ability to more efficiently utilise 
the reduced concentrations of FSH at the beginning of deviation so it can continue 
growing (Ginther 2000; Ginther, Beg, Bergfelt et al 2001), as described below.  The 
decline in FSH concentration has been shown to be critical for the selection of the 
dominant follicle in functional studies that involved artificial manipulation of FSH 
concentrations in cattle and this forms the basis for treatments to induce 
superovulation in domestic species (Adams, Kot, Smith et al. 1993; Hampton, Bader, 
























Figure 1.3. FSH-Follicle relationship during a follicular wave in bovine. Amended from (Ginther, 
Beg, Bergfelt, et al. 2001). Initially all follicles of a wave utilise circulating FSH for growth and at the 
same time contribute to the FSH decline. At the beginning of deviation the dominant follicle becomes 
soley responsible for the continuous supression of FSH. At that time circulating FSH levels are 
sufficient to maintain growth of the largest (dominant) follicle but are too low to support smaller 
(subordinate) follicles. 
 
Luteinising Hormone (LH). A transition from FSH to LH-dependency by the 
dominant follicle has been proposed as a potential mechanism in the continued 
development of the dominant follicle (Reviewed in Mihm & Evans 2008). In cattle, 
there is a transient increase in intrafollicular LH concentrations 24-32 hours before 
the beginning of deviation which remain elevated until 24 hours post deviation 
(Ginther, Bergfelt, Kulick et al. 1998; Kulick, Kot, Wiltbank et al. 1999). In addition, 
experimental suppression of LH results in a failure of the dominant follicle to 
develop in both cows (Gong, Campbell, Bramley et al. 1996) and horses (Gastal, 
Bergfelt, Nogueira et al. 1999).  
 
     LH receptor expression is not detectable in granulosa cells of bovine follicles 
<8mm (Bao, Garverick, Smith et al. 1997). Beg et al (2001) found that there was a 
significant increase in LH receptor mRNA expression in the largest compared to 
second largest follicle 8 hours before the start of deviation when the diameter of the 
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largest follicle ranged from 8.0 to 8.4mm, see figure 1.4. (Beg, Bergfelt, Kot et al. 
2001). Similarly, a recent study by Luo et al (2005) reported that on a day equivalent 
to the beginning of deviation, LH receptor mRNA expression was 8.3 times greater 
in the dominant follicle than in the largest subordinate follicle (Luo, Gumen, & 
Wiltbank 2005). In support of these findings Mihm et al (2006) used microarrays to 
show that during the early growth phase of first-wave dominant follicles in cattle 
there was a marked increase in LH receptor mRNA in granulosa cells which was 
concomitant with a reduction in expression of FSH mRNA and other FSH-induced 
genes (Mihm, Baker, Ireland et al. 2006). Despite these results there is still some 
discrepancy on the proposed degree of involvement of LH receptor levels in the 
selection of the dominant follicle as some studies reported no differences in LH 
receptor expression levels between the largest and second largest follicles until after 
selection of the dominant follicle (Bodensteiner, Wiltbank, Bergfelt et al. 1996; 
Evans & Fortune 1997),  Regardless of this controversy, it is generally agreed that 






Figure 1.4. Granulosa LHR mRNA content of largest (Follicle 1) and second largest (Follicle 2) 
bovine follicles. Means with different letters (a, b) within a follicle are different (P < 0.05). An 
asterisk indicates the beginning of mean differences between follicles. Adapted from (Beg, Bergfelt, 
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Other endocrine regulators. Nutritional status in cattle is believed to have a 
significant effect on circulating growth hormone (GH) levels and dietary restriction 
has been shown to increase plasma concentrations of GH (Reviewed by Armstrong 
1996). Treatment of cattle with GH has been found to have a significant effect on 
follicle development (Gong, Bramley, & Webb 1993; Lucy 2003; Lucy, Bilby, Kirby 
et al. 1999). In cattle, the main effect of GH seems to be through an increase in 
circulating concentrations of insulin-like growth factor (IGF) (Gong, Baxter, 
Bramley et al. 1997) which have well-characterised effects on follicle development 
(see below). 
Both severe under-nutrition and obesity are associated with impaired folliculogenesis 
(Kendall, Gutierrez, Scaramuzzi et al. 2004). Leptin, a metabolic hormone that 
modulates feeding behaviour (Foster & Nagatani 1999) has been demonstrated to 
inhibit the synergistic relationship between gonadotrophins and insulin in cattle 
(Spicer 2001), therefore, leptin may affect the process of follicle selection indirectly 
by reducing the efficiency of steroidogenesis in developing follicles (Kendall, 
Gutierrez, Scaramuzzi et al. 2004).  
Several other substances have been reported to regulate follicle selection including 
prolactin (McNeilly, Glasier, Jonassen et al. 1982), insulin (Diskin, Mackey, Roche 
et al. 2003), and numerous neuropeptides (Diskin, Mackey, Roche et al. 2003). 
 
1.1.3.2 Local regulatory mechanisms 
 
   Many follicular growth factors and cytokines are thought to regulate selection of 
the dominant follicle. The following is a description of those factors for which roles 
in selection have been well-described.  
 
IGF system. The IGF system is composed of two IGF peptides (IGF-I and IGF-II), 
two IGF receptors (IGFR1 and IGFR2), six different and specific IGF binding 
proteins (IGFBP-1, -2, -3, -4,-5 and -6) and IGFBP proteases (kallikreins, cathepsins 
and matrix metalloproteinases (e.g.pregnancy-associated plasma protein-A, PAPP-A) 
(Reviewed by Spicer & Echternkamp 1995). The actions of IGFs are primarily 
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exerted through IGFR-1 which has a high degree of homology with the insulin 
receptor. The IGFR-2 has no known intrinsic signalling function but it is thought to 
act as a negative regulator of IGF activity by sequestration, endocytosis and 
degredation of IGF-II (Jones & Clemmons 1995). The IGF system is known to be 
involved in follicle development in mammalian (Reviewed by Mazerbourg, Bondy, 
Zhou et al. 2003) and non-mammalian (Armstrong & Hogg 1996) species.  
 
IGF-I and IGFII. IGFs act synergistically with gonadotrophins to stimulate 
proliferation, differentiation and steroidogenesis in follicular cells (Adashi, Resnick, 
Payne et al. 1997; Gutierrez, Campbell, & Webb 1997a; Hammond, Mondschein, 
Samaras et al. 1991; Monniaux, Monget, Besnard et al. 1997; Spicer, Alpizar, & 
Echternkamp 1993). IGFs induce these effects by increasing both the number of 
gonadotrophin receptors and the activity of gonadotrophin receptor second 
messenger signalling cascades (Reviewed by Adashi 1998).  
 
   The major source of circulating IGF-I is the liver.  Yuan et al (1998) detected both 
IGF-I and -II in bovine granulosa cells from dominant follicles using in situ 
hybridisation, where levels of IGF expression were greater in the dominant compared 
to subordinate follicles (Yuan, Bao, Garverick et al. 1998). Similarly Spicer et al 
(1995) reported the detection of both IGF-I and II in bovine granulosa and theca 
cells (Spicer & Echternkamp 1995). These results are in contrast with the findings of 
Armstrong et al (2000) and Perks et al (1999) who were unable to detect IGF-I in 
granulosa or theca cells but were able to detect IGF-II in theca but not granulosa cells 
(Armstrong, Gutierrez, Baxter et al. 2000; Perks, Peters, & Wathes 1999). Similarly 
Sudo et al (2007) found no mRNA encoding IGF-I in granulosa cells at all stages of 
development (Sudo, Shimizu, Kawashima et al. 2007) and it has ben reported that 
bovine granulosa cells did not produce IGF-I in serum-free culture (Gutierrez, 
Campbell, Armstrong et al. 1997a).  
 
   To date a number of studies have suggested a role for the IGF system in the 
selection of the dominant follicle in monovular species. Establishment of dominance 
is associated with higher concentrations of IGF-I but lower levels of IGFBPs in the 
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dominant follicle than subordinate follicles in cattle and horses (Beg, Bergfelt, Kot et 
al. 2002). Santiago et al (2005) found that bovine dominant follicles had an 8.1-fold 
higher concentration of free IGF compared to subordinate follicles (Santiago, Voge, 
Aad et al. 2005).  Intra-ovarian administration of IGF-I for 7 days directly into 
bovine ovaries resulted in an increase in the size of the largest but not the second 
largest follicle (Spicer, Alvarez, Prado et al. 2000). Some of the most convincing 
evidence of the involvement of IGF-I in follicle selection has come from in vivo 
studies using injection of IGF-I into individual follicles in mares and heifers. 
Injection of recombinant human IGF-I (rhIGF-I) directly into the second largest 
follicle of a wave at the expected beginning of deviation in mares resulted in the 
continuous growth of the injected follicle which became dominant and eventually 
ovulated (Ginther, Gastal, Gastal et al. 2004b). In contrast, injection of the future 
dominant follicle with IGFBP-3 resulted in a 90% reduction in free IGF-I levels and 
in the injected follicle becoming subordinate rather than dominant (Ginther, Gastal, 
Gastal et al. 2004a). Taken together these results indicate that IGF-I is a strong 
candidate for involvement in the process of follicle selection. 
 
IGFBPs and IGFBP Proteases. Six types of IGFBPs (1 to 6) and at least 51 different 
IGFBP isoforms have been identified in bovine follicular fluid (Nicholas, Scougall, 
Armstrong et al. 2002). IGFs have been observed by immunohistochemistry to co-
distribute with IGFBPs and thus IGFBPS may provide a mechanism for extra-
cellular storage of IGFs (Hill, Clemmons, Wilson et al. 1989). Changes in IGFBP 
concentrations have been recorded during follicle growth and development in cattle 
(de la Sota, Simmen, Diaz et al. 1996; Stewart, Spicer, Hamilton et al. 1996). These 
changes in binding protein levels occur through differential regulation of binding 
protein expression, alterations in protease activity or by selective uptake of binding 
proteins from circulation during follicle growth (Canty, Boland, Evans et al. 2006).   
 
   Follicle dominance is normally associated with decreased activity of low molecular 
weight binding proteins, IGFBP-4 and IGFBP-5 (Austin, Mihm, Evans et al. 2001) 
(Rivera & Fortune 2003a). PAPP-A is a 200kDa metalloprotease that has been 
shown to be an important regulator of IGF bioavailability through its proteolytic 
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activities on IGFBPs (Sudo, Shimizu, Kawashima et al. 2007). Work done in cattle 
by Rivera et al (2003) found that in the early dominant follicle, intrafollicular 
concentrations of PAPP-A and free-IGF-I increased, whilst levels of IGFBP-4 and 
IGFBP-5 were reduced (Rivera & Fortune 2003a). In another study by the same 
author it was demonstrated that PAPP-A accounted for all of the proteolytic activity 
against IGFBP-4 and made a significant contribution to the proteolytic activity 
against IGFBP-5 in follicular fluid from bovine pre-ovulatory follicles (Rivera & 
Fortune 2003b). There were no changes in IGFBP-4 gene expression throughout 
follicle development and therefore proteolysis of IGFBP-4 is considered to be the 
primary mechanism involved in the regulation of this binding protein (Canty, 
Boland, Evans et al 2006). 
 
 There are several reports of decreased levels of IGFBP-2 in follicles before or 
after they become dominant compared to subordinate or atretic follicles (Armstrong, 
Baxter, Gutierrez et al. 1998; Canty, Boland, Evans et al 2006; Nicholas, Scougall, 
Armstrong et al 2002; Roberts & Echternkamp 2003; Santiago, Voge, Aad et al 
2005; Schams, Berisha, Kosmann et al. 2002; Yuan, Bao, Garverick et al 1998). 
Follicular fluid levels of IGFBP-2 may be largely regulated at the transcriptional 
level (Canty, Boland, Evans et al 2006), however some regulation may be 
attributable to the protease activity of PAPP-A and other proteases (Monget, Fabre, 
Mulsant et al. 2002).  
 
   Levels of IGFBP-3 tended to remain constant throughout follicle development in 
most species and expression was observed mainly in the thecal layer of growing 
follicles (Canty, Boland, Evans et al 2006; Monget, Fabre, Mulsant et al. 2005). 
Canty et al (2006) suggested that most of the observed IGFBP-3 expression may 
originate from systemic circulation (Canty, Boland, Evans et al 2006).  
 
Oestradiol. In addition to its endocrine role of suppression of FSH levels during 
follicle deviation, follicular oestradiol has important paracrine roles in promoting the 
development of the dominant follicle. These roles are mediated through the 
mitogenic effects of oestradiol as well as through its effects on enhancing 
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gonadotrophin-induced responses in follicular cells such as expression of 
gonadotrophin receptors and steroidogenic enzymes (Reviewed by Britt & Findlay 
2002; Rosenfeld, Wagner, Roberts et al. 2001). It has also been demonstrated in 
sheep and pigs that oestradiol promotes IGF-I production (Spicer & Chamberlain 
2000). Oestradiol levels have been shown to increase differentially in the largest 
follicle compared to the second largest follicle at the beginning of diameter deviation 
in cattle and horses (Beg, Bergfelt, Kot et al. 2001a; Ginther, Beg, Kot et al. 2003; 
Ginther, Kot, Kulick et al. 1997b; Mihm, Austin, Good et al. 2000) and this increase 
is driven, at least in part, by the increase in IGF-I bioavailability in the largest follicle 
(Ginther, Bergfelt, Beg et al. 2004).   
 
Androgens and Progestins. There were no significant differences in follicular fluid 
concentrations of androgens among the three largest follicles in cattle prior to 
diameter deviation (Beg, Bergfelt, Kot et al 2002). Furthermore, concentrations of 
androgens did not change in the second largest follicle following ablation of the 
largest follicle just before the onset of deviation (Beg, Bergfelt, Kot et al 2002). 
Similar results were observed in the horse (Donadeu & Ginther 2002). These results 
led to the conclusion that androgens are not involved in the beginning of deviation. 
After the beginning of deviation, levels of androgens were observed to increase in 
dominant follicles and decrease in subordinate follicles of cattle (Beg, Bergfelt, Kot 
et al 2001b; Beg, Bergfelt, Kot, et al. 2002; Stewart, Spicer, Hamilton et al 1996). 
This was in contrast with the horse where androgens increased in subordinate but not 
dominant follicles after deviation (Donadeu & Ginther 2002). Although androgens 
are required as a substrate for FSH-dependent oestradiol synthesis and so function 
indirectly to stimulate follicle growth, they have also been shown to directly and 
indirectly promote follicle atresia (Reviewed by Walters, Allan, & Handelsman 
2008). Results regarding the involvement of progesterone in follicle selection are 
inconsistent. Some studies reported no changes in progesterone levels at the 
beginning of deviation (Evans & Fortune 1997; Mihm, Good, Ireland et al 1997), 
whereas others did observe an increase in progesterone in the largest compared to  
the second largest follicle at the expected beginning of deviation (Beg, Bergfelt, Kot 
et al 2001a; Ginther, Bergfelt, Beg et al. 2001b). Whatever its role during the early 
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development of the dominant follicle, progesterone is recognised to play a critical 
role in ovulation.  Mice that are deficient in progesterone receptor (PR) fail to 
ovulate (Robker, Russell, Espey et al. 2000). Until recently the function of 
progesterone in the ovulatory process was largely unknown. It has recently become 
clear that the LH surge together with the action of progesterone and its cognate 
receptor induces a disintegrin and metalloproteinase with thrombospondin motifs 
(ADAMTS)-1 gene expression (Robker, Russell, Espey et al. 2000) which is thought 
to cleave versican (anti-adhesive proteoglycan) in the expanded cumulus-oocyte-
complex (COC) thus allowing the COC to be released (Espey & Richards 2006). 
 
Inhibin, Activin, Follistatin. Inhibins and activins are dimeric glycoproteins that are 
members of the TGF-â superfamily. Different inhibin and activin forms result from 
combinations of á- and â- (âA and âB) subunits.  There are two known forms of 
inhibin, each composed of different â subunits: Inhibin A (á-âA) and Inhibin B (á-
âB) (Reviewed by Knight & Glister 2001; Phillips 2005). â subunit dimerisation 
results in 3 possible forms of activin: Activin A (âA-âA), Activin AB (âA-âB) and 
Activin B (âB-âB). Follistatin is a cysteine-rich monomeric glycoprotein that is 
structurally unrelated to activins and inhibins and that binds with high affinity to 
inhibin/activin â subunits. Follistatin binds to inhibins with much less affinity than to 
activins and seemingly without affecting inhibin activity. 
 
  In addition to the systemic FSH-suppressing effects of inhibin, a number of in 
vitro studies have demonstrated local-paracrine roles for granulosa cell-derived 
activin, inhibin and follistatin in follicle development throughout effects on 
gonadotrophin responsiveness, steroidogenesis, oocyte maturation, ovulation and CL 
function (Reviewed by Knight & Glister 2001). 
 
   Activin and inhibin are produced in large amounts by the growing dominant 
follicle, although this increased production only occurs after the beginning of 
deviation (Beg, Bergfelt, Kot et al 2002). One study demonstrated that following 
ablation of the largest follicle at the start of deviation, the concentration of activin A 
in the second largest follicle increased (Ginther, Beg, Bergfelt et al. 2002). In another 
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study, an increase in the activin/inhibin ratio was identified in bovine follicles as they 
increased in diameter from 3 to 6mm (Glister, Groome, & Knight 2006). During this 
increase in follicle size there was an increase in activin A by approximately 30-fold 
compared to only a 6-fold increase in inhibin A. The concentration of follistatin 
remained constant throughout this time. Given that follistatin binds activin A in a 
ratio of 2:1, follistatin concentration would exceed that of activin A until after 
follicles grew larger that 6mm (Glister, Groome, & Knight 2006), just before the 
beginning of follicle deviation. Taken together these results suggest an important role 
for activin in the beginning of deviation. 
 
1.1.4 Control of ovulation and follicle-to-luteal transition 
 
The ovulatory process is complex involving reactivation of oocyte meiosis, 
rupture of the apical follicle wall and, finally, oocyte release. Subsequent tissue 
remodelling and cell differentiation processes result in the formation of the corpus 
luteum (CL). For over a century it was believed that the process of ovulation was 
induced by increased follicular pressure, thought to be caused by the action of 
smooth muscle in the ovary (Asdell 1962). In 1963, however, it was demonstrated 
that intrafollicular pressure did not increase prior to ovulation (Blandau & Rumery 
1963; Espey & Lipner 1963). In addition the ovary was not found to have any 
functional muscle tissue (Espey 1978). The general consensus is now that ovulation 
is an acute inflammatory reaction that is induced by the ovulatory gonadotrophin 
surge (Reviewed by Espey & Richards 2006). A great deal of focus over the past few 
decades has been placed on the critical role of prostaglandins (classically known 
activators of inflammatory response) in the ovulatory process (Reviewed by 
(Murdoch, Hansen, & McPherson 1993; Olofsson & Leung 1996). Postaglandins are 
synthesised from arachidonic acid which is formed from cell membrane 
phospholipids. The rate limiting step in prostaglandin synthesis is believed to be 
controlled by the COX enzymes, of which there are two main isoforms. COX1 is a 
constitutive enzyme that is present in almost all mammalian tissues whereas COX2, 
described as an inducible form, is present at low/undetectable levels in most tissue 
types. As a consequence of the ovulatory LH surge, prostaglandin synthesis is 
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induced and COX2, which is expressed by granulosa and cumulus cells, is 
upregulated (Murdoch, Hansen, & McPherson 1993). A possible correlation between 
a peak in COX2 expression and duration of ovulation has been proposed (Duffy & 
Stouffer 2001; Richards 1997). Studies in the rat reported that the induction of COX2 
following hCG was rapid (within 2-4 hours) and this occurred 10 hours prior to 
ovulation (Sirois & Richards 1992). In the cow, the induction of COX2 was not as 
rapid and occurred approximately 18 hours after hCG treatment and approximately 
10 hours before follicle rupture (Sirois 1994). In the horse, COX2 induction was 
found to occur 30 hours after hCG treatment and once again the interval of time 
between COX2 induction and follicle rupture was 10 hours (Sirois & Dore 1997). 
These results supported the hypothesis that COX2 may be a molecular determinant 
that sets the alarm of the mammalian ovulatory clock (Richards 1997). 
 
  Recently, a great deal of effort has been made to identify the genes that in addition 
to COX2 are involved in ovulation. Candidate genes have been identified in mural 
and cumulus granulosa cells, theca cells and the oocyte itself. A comprehensive 
description of genes involved in ovulation can be found elsewhere (Espey & 
Richards 2006). 
 
1.2 Vascular Endothelial Growth Factor (VEGF) and its role in 
folliculogenesis 
 
1.2.1 Discovery  
 
  VEGF, initially named Vascular Permeability Factor (VPF), was first identified in 
the early 1980s as a secretory product of tumour cells that was observed to induce 
vascular leakage (Senger, Galli, Dvorak et al. 1983) leading to the hypothesis that 
VPF could mediate the permeability of blood vessels in tumour development. For a 
number of years after its discovery, VPF/VEGF remained undefined at the molecular 
level. Ferrara and associates (1989) reported the isolation of VEGF, a diffusible 
endothelial cell-specific mitogen from bovine pituitary follicular cell-conditioned 
medium (Ferrara & Henzel 1989). They demonstrated that VEGF was able to induce 
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proliferation of endothelial cells in addition to promoting endothelial cell migration 
and survival. Connolly and associates sequenced VPF and subsequently discovered 
that VPF and VEGF were in fact identical molecules (Connolly, Olander, Heuvelman 
et al. 1989). 
 
1.2.2 VEGF Family 
 
  VEGF is a member of the cysteine knot family of growth factors and is secreted as 
a dimer in which two VEGF monomers are linked together by two disulphide bridges 
(Potgens, Lubsen, van Altena et al. 1994). The VEGF family is structurally related to 
the Platelet-Derived Growth Factor (PDGF) family and includes several members 
including VEGF-A (usually referred to as VEGF), VEGF-B, VEGF-C, VEGF-D and 
Placental Growth Factor (PlGF) (reviewed in Tammela, Enholm, Alitalo et al. 2005). 
The role of VEGF-B is not yet fully understood, although high levels of expression 
have been observed in skeletal muscle, myocardium and brown fat which may link 
the actions of VEGF-B with high energy metabolism. VEGF-C and D have both 
been implicated in the growth of lymphatic vessels (lymphanogenisis). The main 
sites of expression of PlGF include the placenta, heart and lungs (Persico, Vincenti, 
& DiPalma 1999). Potential roles proposed for PlGF include the mediation of 
arteriogenesis (increased diameter of existing blood vessels) and formation of 
arteries from pre-existing arterioles (Tammela, Enholm, Alitalo et al. 2005). Other 
highly related proteins, VEGF-E and VEGF-F, have also been identified. VEGF-E is 
encoded by pox viruses of the Orf and psuedocowpox families (Meyer, Clauss, 
Lepple-Wienhues et al. 1999) and VEGF-F variants have been isolated from the 
venom of snakes (Takahashi, Hattori, Iwamatsu et al. 2004).  
 
The gene encoding VEGF-A (VEGF) is located on the short arm of chromosome 6 in 
the human (Zimmermann, Xiao, Bohlen et al. 2002), on chromosome 17 in the 
mouse (Gomez, Simon, Remohi et al. 2002) and chromosome 23 in the cow 
(http://www.ncbi.nlm.nih.gov). The human VEGF-A (VEGF) gene is made up of 
eight exons, separated by seven introns and alternative splicing of VEGF results in 
multiple isoforms (VEGF-121, 145, 148, 162, 165, 165b, 183, 189 and 206) that have unique 
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signalling and functional properties (see figure 1.5) (Yamazaki & Morita 2006). Each 
of these isoforms are named according to the number of amino acids in the mature 
protein sequence. In both murine and bovine species VEGF isoforms contain one less 
amino acid than in humans, thus the murine and bovine homologues of VEGF165   are 
VEGF164.  All VEGF isoforms identified so far contain exons 1 to 5 and different 
combinations of exons 6 to 8. Exons 6 and 7 encode two heparin binding sites which 
affect receptor binding and isoform solubility. Isoforms containing exon 6 (e.g. 
VEGF145, VEGF189, VEGF206) are tightly bound to the cell membrane, whereas 
isoforms that lack exon 6 (e.g. VEGF165) are diffusible (not membrane-bound). 
Isoforms that lack both exons 6 and 7 (e.g. VEGF121) are even more diffusible than 
those that only lack exon 6. VEGF165 is the physiologically most common isoform of 
VEGF (Cross, Dixelius, Matsumoto et al. 2003). 
 
 
Figure 1.5.  Different isoforms resulting from alternative splicing of the VEGF gene.  
Adapted from (Takahashi & Shibuya 2005). 
 
1.2.3 VEGF Receptors 
 
  VEGF can bind to a variety of receptors on the cell surface (see figure 1.6) 
including the receptor tyrosine kinases (RTKs), VEGFR1, VEGFR2 and VEGFR3, 











exon 1-5 exon 6 exon 7 exon 8 
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Fjallman, & Ballmer-Hofer 2006; Petrova, Makinen, & Alitalo 1999; Takahashi & 
Shibuya 2005) . RTKs are characterised by seven immunoglobulin (Ig) homology 
domains in the extracellular ligand-binding region, a single transmembrane domain, 
and an intracellular tyrosine kinase domain that is interrupted by a 65 to 97-long 
stretch of hydrophilic residues that make up a kinase-insert domain (Reviewed by 
van der, Hunter, & Lindberg 1994). This domain is important for substrate 
recognition. Neuropilin-1 (NRP-1) and Neuropilin-2 (NRP-2) were first described as 
receptors for type 3 Semaphorins, which have important roles in the control of 
axonal growth and angiogenesis (Neufeld, Cohen, Shraga et al. 2002). Subsequently 
it was found that the neuropilins also function as co-receptors for some forms of 
VEGF. NRP-1 binds to VEGF-A, VEGF-B and PIGF, whereas NRP-2 binds to  






Figure 1.6.  Members of the VEGF family and their putative cognate cell membrane receptors.Taken 
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1.2.3.1 VEGFR1  
 
  VEGFR1 (fms-like tyrosine kinase, Flt-1) was the first RTK to be identified as a 
VEGF receptor almost 20 years ago (Shibuya, Yamaguchi, Yamane et al. 1990). This 
180 kDa glycoprotein has a high affinity for VEGF, VEGF-B, PlGF, and TfsvVEGF 
(Trimeresurus flavoviridis snake venom VEGF). Immunoglobulin domain 2 of 
VEGFR1 is the major binding site for VEGF and PlGF (Takahashi & Shibuya 2005). 
VEGFR1 binds VEGF with at least 10-fold higher affinity than VEGFR2 (Terman, 
Dougher-Vermazen, Carrion et al. 1992). However, the tyrosine kinase activity of 
this receptor is relatively weak compared to VEGFR2.  The biological function of 
VEGFR1 remains unclear. It has been proposed that VEGFR1 acts as a decoy 
receptor rather than as a signal transducer (Park, Chen, Winer et al. 1994). VEGFR1 
has been demonstrated to negatively regulate angiogenesis during early development, 
with targeted deletion of the VEGFR1 gene resulting in early embryonic death in the 
mouse (between days 8.5 and 9.5) due to overgrowth of endothelial cells (Fong, 
Rossant, Gertsenstein et al. 1995). Mice that express the extracellular region of 
VEGFR1 but lack the kinase domain develop normal vasculature and survive 
(Hiratsuka, Minowa, Kuno et al. 1998), thus indicating that the tyrosine kinase 
domain of VEGFR1 is not required for embryonic development. In contrast to the 
embryo, VEGFR1 has been found to enhance angiogenesis in a number of 
pathological conditions during postnatal life (Takahashi & Shibuya 2005), thus 
demonstrating that the actions of VEGFR1 can differ depending on the stage of 




  VEGFR2 (also known as KDR or Flk-1) is a 200 kDa glycoprotein that binds 
VEGF, VEGF-C and VEGF-D. Although VEGF has a lower affinity to VEGFR2 
than to VEGFR1, it has been shown that VEGFR2 is the primary receptor through 
which VEGF signalling occurs in endothelial cells (Gille, Kowalski, Li et al. 2001). 
In addition to endothelial cell types, VEGFR2 is expressed in numerous non-
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endothelial cell types such as neurons, osteoblasts, pancreatic cells, hematopoetic 
stem cells and ovarian cells (Tammela, Enholm, Alitalo et al. 2005). The key role of 
this receptor in development is demonstrated by a failure of Flk-1-null mice to 
develop blood islands and organised blood vessels. Such gene deletion causes 
embryonic death between days 8.5 and 9.5 (Shalaby, Rossant, Yamaguchi et al. 
1995) thus showing that VEGFR2 is an absolute requirement for vascular 
development. VEGFR2 is considered to be the major mediator of both physiological 
and pathological effects of VEGF. These include cell proliferation, survival, 
migration and permeability. Proliferation of endothelial cells is stimulated through 
the classical RTK-activated Extracellular Regulated Kinase (ERK) pathway as well 
as activation of PLCã-1 (Takahashi, Yamaguchi, Chida et al. 2001). VEGFR2 has 
been shown to promote survival of endothelial cells via the activation of PI-3 
kinase/Akt pathway (Reviewed by Cebe-Suarez, Zehnder-Fjallman, & Ballmer-




   VEGFR3 (also known as fms-like tyrosine kinase, Flt-4) has 6 rather than 7 Ig 
domains, as the fifth Ig domain is cleaved post-translationally. VEGFR3 binds 
VEGF-C and VEGF-D. This receptor is expressed on all endothelial cell types during 
development but becomes confined to lymphatic endothelial cells in the adult 
(Kaipainen, Korhonen, Mustonen et al. 1995). However, VEGFR3 is upregulated in 
the microvasculature of tumours and wounds. Recently, (Tammela, Zarkada, 
Wallgard et al. 2008) have shown that blocking VEGFR3 resulted in decreased 




  NRP-1 (mw, 130-140kDa) and NRP-2 (mw, 130 kDa) are transmembrane 
glycoproteins with short intracellular domains that can only signal in association with 
other receptor types. NRP-1 can associate with both VEGFR1 (Fuh, Garcia, & de 
Vos 2000) and VEGFR2 (Whitaker, Limberg, & Rosenbaum 2001). The formation 
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of a complex between NRP-1 and VEGFR2 enhances proliferation and migration 
induced by VEGF165  (Whitaker, Limberg, & Rosenbaum 2001). Targeted 
inactivation of NRP-1 in mice results in severe defects such as impairment of neural 
vascularisation and disorganised/insufficient development of vascular networks in 
the yolk sac (Kawasaki, Kitsukawa, Bekku et al. 1999). Following inactivation of 
NRP-2, there is either absence or severe reduction of small lymphatic vessels. 
However, arteries, veins and larger lymphatic vessels develop normally, thus 
suggesting that NRP-2 is selectively required for the formation of small lymphatic 
vessels and capillaries (Yuan, Moyon, Pardanaud et al. 2002). 
 
1.2.4 Roles of VEGF in Angiogenesis  
 
   The biological importance of VEGF has been shown through gene deletion studies, 
where the loss of even a single VEGF allele was demonstrated to be lethal between 
embryonic days 11 and 12 (Carmeliet, Ferreira, Breier et al. 1996; Ferrara, Carver-
Moore, Chen et al. 1996). Mutant embryos exhibited significant defects of the 
vasculature in many organs including the brain, heart, and spinal cord. These 
embryos also presented yolk sacs that contained a significantly reduced number of 
nucleated red blood cells within the blood islands. VEGF-/- embryos were observed to 
have a more severe phenotype than VEGF+/- (Carmeliet, Ferreira, Breier et al. 1996). 
Lethal mutations were also observed when VEGF was over-expressed (Feucht, 
Christ, & Wilting 1997; Flamme, von, Drexler et al. 1995). When VEGF was 
expressed in chicken embryos at a concentration 2-3 times greater than found 
physiologically there were lethal deleterious effects, a main effect being the 
prevention of normal development of the embryonic heart (Miquerol, Langille, & 
Nagy 2000). 
 
   The best defined role of VEGF is promotion of blood vessel formation both during 
normal and pathological states. Angiogenesis, the growth of blood vessels from pre-
existing vessels is dependant on the balance between stimulatory pro-angiogenic and 
inhibitory anti-angiogenic factors. The pro-angiogenic effects of VEGF result from 
stimulation of proliferation, survival and migration of endothelial cells (Leung, 
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Cachianes, Kuang et al. 1989; Senger, Ledbetter, Claffey et al. 1996; Spyridopoulos, 
Brogi, Kearney et al. 1997; Takahashi & Shibuya 2005). Increased angiogenesis is a 
hallmark of cancer and it has been well documented that VEGF stimulates the 
progression of various types of cancer through its pro-angiogenic properties 
(Reviewed in Harmey 2004). 
 
1.2.5 Non-Angiogenic roles of VEGF 
 
   In addition to its classical role as an endothelial cell-specific mitogen (Ferrara, 
Houck, Jakeman et al. 1992), VEGF (and its receptors) has been shown to have 
effects on a variety of non-endothelial cell types (Reviewed in Duffy, Bouchier-
Hayes, & Harmey 2004; Haigh, Ruiz de Almodovar, Schneider et al. 2007). These 
effects involve cell proliferation, survival, and migration. 
 
1.2.5.1 Proliferation and Survival 
 
   Cell proliferation is a key process during neural development and is also important 
for the regeneration of tissue following neural injury. VEGF has been shown to 
stimulate proliferation of a number of neural cell types including astrocytes 
(Silverman, Krum, Mani et al. 1999), schwann cells (Sondell, Lundborg, & Kanje 
1999a; Sondell, Lundborg, & Kanje 1999b), microglia (Forstreuter, Lucius, & 
Mentlein 2002), and cortical neurons (Jin, Zhu, Sun et al. 2002; Zhu, Jin, Mao et al. 
2003). 
 
   Another physiological process that requires intense proliferative activity is wound 
healing. In skin tissue, keratinocytes are considered to be the main site of VEGF 
production during cutaneous wound healing. Wilgus et al (2005) demonstrated that 
murine epidermal keratinocytes expressed VEGF and VEGFR1, and that VEGF was 
capable of stimulating proliferation in normal human epidermal keratinocytes 
(NHEKs) (Wilgus, Matthies, Radek et al. 2005). These proliferative effects were 
blocked following administration of anti-VEGFR1 antibodies. In addition, 
application of VEGFR1 antibodies directly to skin wounds resulted in reduced 
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number of keratinocyes at the wound edge and subsequently delayed re-
epithilisation. In support of these findings, the generation of a strain of mice in which 
keratinocytes did not express VEGF resulted in mice that had normal skin capillary 
systems however, when full thickness skin wounds were made, healing was delayed 
compared to control mice whose keratinocytes did express VEGF (Rossiter, Barresi, 
Pammer et al. 2004) thus indicating that VEGF is an important component of wound 
healing. 
 
   Myofibroblasts are important for the growth and repair of normal tissue and it is 
common to find myofibroblasts at sites of infarction (macroscopic area of necrotic 
tissue caused by loss of adequate blood supply). Myofibroblasts isolated from 
infarctions in rats have been shown to express VEGF, VEGFR1 and VEGFR2, 
suggesting an autocrine role for VEGF, whereby VEGF contributes to the repair of 
damaged tissue (Chintalgattu, Nair, & Katwa 2003). In addition VEGF has been 
shown to promote cellular proliferation and survival in heart tissues (reviewed in 
Zachary, Mathur, Yla-Herttuala et al. 2000). 
 
   Systemic administration of VEGF in mice resulted in VEGFR1 receptor activation 
and subsequent release of hepatocyte growth factor (HGF) which induced hepatocyte 
proliferation and increased liver sizes (LeCouter, Moritz, Li et al. 2003). In studies 
by Brockhorn et al (2007) VEGF was shown to stimulate proliferation of hepatocytes 
and subsequently regeneration of liver tissue following a partial (70%) hepatectomy 
(Bockhorn, Goralski, Prokofiev et al. 2007). VEGF was unable however to stimulate 
liver regeneration following a 90% hepatectomy (Bockhorn, Schollmann, Opitz et al. 
2007) thus indicating that although VEGF is able to stimulate hepatocyte 
proliferation following liver damage, the extent to which VEGF can assist with tissue 
regeneration depends on the amount of damage present. 
 
   VEGF is also expressed in human dental follicle cells (HDFC). VEGF was 
observed to stimulate HDFC proliferation and differentiation and to enhance HDFC 
survival (Chen, Qian, Wu et al. 2007). These results are in support of a role for 
VEGF in tooth eruption. 
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  The ability of VEGF to stimulate cell proliferation has also been described in 
relation to cancer. The first non-endothelial tumour cell type shown to express 
VEGFR2 was ovarian carcinoma cells (Boocock, Charnock-Jones, Sharkey et al. 
1995). Since then a wide variety of neoplasic cell types have been shown to express 
VEGF and its receptors (Herold-Mende, Steiner, Andl et al. 1999; Masood, Cai, 
Zheng et al. 2001; Stewart, Turley, Cook et al. 2003; Stitt, Simpson, Boocock et al. 
1998). For example, pancreatic tumour cells express elevated levels of VEGF and 
VEGF receptors compared to normal pancreatic cells (Itakura, Ishiwata, Shen et al. 
2000). Treatment of pancreatic cell lines (Dan-G and AsPc-1) with VEGF resulted in 
significant increase in cell proliferation (Von, Cramer, Hocker et al. 2000). These 
proliferative effects were abolished when cell lines were transfected with a retrovirus 
encoding a mutant non-functional form of VEGFR2 (Von, Cramer, Hocker et al. 
2000). These findings indicate that VEGF stimulates proliferation of human 
pancreatic cells through interaction with VEGFR2. Human malignant mesothelioma 
is a neoplasm that develops from the lung surface, peritoneum and testes (Strizzi, 
Catalano, Vianale et al. 2001). Mesothelioma cells have been shown to co-express 
VEGFR1 and VEGFR2. Exposure of these cells resulted in a dose-dependant 
increase in phosphorylation of both receptors in addition to increased cell 
proliferation, an effect that could be inhibited by administration of VEGFR-
neutralising antibodies (Strizzi, Catalano, Vianale et al. 2001).  
 
   In 2001, Oosthuyse et al reported that the presence of a mutation in the promoter 
region of the VEGF gene in transgenic mice resulted in the onset of neuron 
degeneration (Oosthuyse, Moons, Storkebaum et al. 2001). Since then, VEGF has 
been regarded as a trophic factor of cells of the central nervous system. VEGF is 
known to act directly on neural and glial cells to promote cell survival (Matsuzaki, 
Tamatani, Yamaguchi et al. 2001; Wick, Wick, Waltenberger et al. 2002; Jin, Mao, 
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   The largest avascular tissue in the body, the intervertebral disc (located between 
vertebral bodies) is composed of two tissue types, the nucleus pulposus (NP) and the 
annulus fibrosus (AF) (Fujita, Imai, Suzuki et al. 2008). Despite the lack of 
vasculature, the NP was shown to have high levels of expression of VEGF and 
VEGFR1. Fujita (2008) studied the role of VEGF in this tissue type and found that 
treatment of NP cells with a VEGF antagonist induced apoptosis, thus indicating that 
VEGF/VEGFR1 cascade has a survival function in NP cells (Fujita, Imai, Suzuki et 
al. 2008).  
 
   In addition to having an autocrine effect on proliferation of tumour cells, VEGF 
has also been shown to enhance tumour cell survival. Breast cancer is one example 
of a malignancy in which non-angiogenic VEGF signalling has been well 
documented (Bachelder, Crago, Chung et al. 2001; Chung, Bachelder, Lipscomb et 
al. 2002; Mercurio, Lipscomb, & Bachelder 2005; Pidgeon, Barr, Harmey et al. 
2001).  
 
1.2.5.2 Migration and motility 
 
   Similar to endothelial cells, VEGF can induce migration of non-endothelial cells. 
For example cancer cells acquire the ability to migrate and invade tissues as a 
mechanism of cancer progression. VEGF is able to induce migration of these cells 
via autocrine mechanisms (Mercurio, Lipscomb, & Bachelder 2005). NRP-1 was 
essential for invasion of breast cancer cells via CXCR4 (a chemokine receptor), 
which is regulated by VEGF (Bachelder, Crago, Chung et al. 2001). Another study 
by Bachelder and co-workers (2002) assessed the effects of VEGF inhibition (using 
antisense oligonucleotides) on the invasion and migration of cells from the MDA-
MB-231 breast cancer cell line through matrigel (Bachelder, Wendt, & Mercurio 
2002). Results showed that inhibition of VEGF resulted in a significant (65%) 
reduction in matrigel invasion. This effect was shown to be specifically caused by 
VEGF because re-administration of VEGF restored the migratory abilities of the 
breast cancer cells (Bachelder, Wendt, & Mercurio 2002).  
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   Further evidence that VEGF is involved in migratory mechanisms comes from 
studies with bone tissue. Bone repair is a multi-step process that involves migration 
in addition to proliferation, differentiation and activation of a variety of cell types 
(Street, Bao, deGuzman et al. 2002). VEGF and its receptors are important regulators 
of angiogenesis during bone formation (ossification). In addition to this angiogenic 
effects, there is also evidence that VEGF may have direct effects on bone-forming 
osteoblasts. Osteoblasts have been found to express both VEGFR1 and VEGFR2 
(Deckers, Karperien, van der et al. 2000) and to synthesise VEGF in culture (Wang, 
Yamazaki, Nohtomi et al. 1996). VEGF has been reported to bind to osteoblasts in 
culture and induce osteoblast migration and alkaline phosphatase activity (a 
biochemical indicator of bone turnover) (Midy & Plouet 1994). In contrast to bone 
formation by osteoblasts, bone resorption is carried out by osteoclasts. Bone 
resorption occurs in inflamed joints and is a main cause of arthritic joint disease. 
VEGF has been shown to act as a chemoattractant for osteoclasts (Engsig, Chen, Vu 
et al. 2000; Zelzer, McLean, Ng et al. 2002). 
 
   In the bovine oviduct, VEGF has been proposed to be involved in embryo 
transport. This was demonstrated in cultured bovine oviductal epithelial cells 
(BOEC) that were treated with VEGF (Wijayagunawardane, Kodithuwakku, 
Yamamoto et al. 2005). VEGF, alone or in synergy with LH, stimulated the 
production and release of substances regulating oviductal contractility, including 
Prostaglandin E2 (PGE2), Prostaglandin F2á (PGF2á) and Endothelin-1 (ET-1). 
Their results indicated that the ovulatory LH surge upregulates oviductal VEGF, 
which subsequently induces the releases the aforementioned substances stimulating 
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1.2.6 Roles of VEGF in Follicle Development 
 
1.2.6.1 VEGF expression during follicle development 
 
  In most species, there is a lack of VEGF expression in primordial follicles. 
Typically, VEGF only becomes detectable in granulosa and theca cells when follicle 
development reaches the secondary stage, concurrent with the development of 
follicle vasculature (Fraser 2006). In primates, there is generally a further increase in 
VEGF mRNA in granulosa cells of late secondary and tertiary follicles, resulting in 
higher VEGF levels than in the theca layer in those follicles (Fraser 2006). Close to 
the time of ovulation, VEGF expression in granulosa cells of the primate disappeared 
whereas VEGF expression in the theca increased (Wulff, Wiegand, Saunders et al. 
2001). This observation is in agreement with studies in the pig, where there was an 
increase in follicular fluid VEGF concentration during follicle growth followed by a 
decrease after hCG administration until VEGF became undetectable by 36 hours post 
hCG (Barboni, Turriani, Galeati et al. 2000). Similar patterns of expression were 
observed in the bovine, where VEGF expression increased with the growth of antral 
follicles (Greenaway, Connor, Pederson et al. 2004).  
 
1.2.6.2 Effects of VEGF on preantral follicles 
 
  VEGF has been proposed to stimulate the growth of preantral follicles in the rat 
ovary (Danforth, Arbogast, Ghosh et al. 2003). In that study, direct intraovarian 
injection of VEGF resulted (within 24 hours) in an approximately 75% increase in 
primary and secondary follicles in VEGF- compared to saline-treated rats. Several 
explanations for the VEGF-induced increase in number of preantral follicles were 
proposed; VEGF might stimulate vascular supply to these follicles which would 
subsequently increase the delivery of nutrients and growth factors to these follicles. 
Alternatively, VEGF may directly stimulate proliferation/survival pathways in 
follicular cells resulting in a large proportion of follicles being rescued from atresia. 
Similar results were reported by Yang and Fortune (2007) who found that treatment 
of cultured pieces of bovine foetal ovarian cortex with VEGF promoted the transition 
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from primary to secondary follicles (Yang & Fortune 2007). Regardless of whether 
the observed responses of preantral follicles to VEGF in these studies involved 
effects on endothelial cells, non-endothelial cells or both, these results indicate that 
VEGF is involved in early follicle growth 
 
1.2.6.3 Effects of VEGF on follicle selection and ovulation 
 
  Zimmerman et al (2001) showed that systemic treatment of rhesus monkeys with 
VEGF-neutralising antibodies during the late follicular phase resulted in delayed 
ovulation (Zimmermann, Xiao, Husami et al. 2001). The same authors carried out 
further investigations by administering VEGFR2 antibody early in the follicular 
phase. This resulted in arrested development in the cohort of growing follicles and 
subsequent lengthening of the follicular phase (Zimmermann, Xiao, Bohlen et al. 
2002). This group then went on to examine whether VEGF/VERFR-2 pathway was 
required for gonadotrophin-dependent follicle development. This was tested in 
hypophysectomised mice. (Zimmermann, Hartman, Kavic et al. 2003). In the 
presence of VEGFR2-neutralising antibodies, gonadotrophins were unable to 
stimulate follicle growth to the pre-ovulatory stage. It was therefore concluded that 
the interaction between VEGF and VEGFR2 is required for gonadotrophins to 
effectively stimulate follicle development (Zimmermann, Hartman, Kavic et al. 
2003). In another study, Hazzard et al (2002) demonstrated that VEGF is required for 
successful ovulation. This group carried out direct injections of soluble VEGFR1 
peptide into preovulatory follicles and this suppressed ovulation and luteinisation 
leading to reduced corpus luteum function (Hazzard, Xu, & Stouffer 2002). The role 
of VEGF throughout follicle development has also been evaluated by administration 
of VEGF Trap R1R2. This is a compound comprised of the extracellular VEGFR1 
and VEGFR2 domains fused with human Fc, the proteolytic fragment of an an 
antibody molecule that contains the two C-terminal domains of its two heavy chains. 
This trap is able to block responses to VEGF A, B and P1GF but not to VEGF C and 
D (Fraser 2006). When administered by subcutaneous injection in marmosets 
throughout the follicular phase, VEGF Trap R1R2 resulted in a ~80% decrease in 
endothelial cell area in secondary and tertiary follicles. Following inhibition of 
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VEGF, tertiary follicles developed but did not reach preovulatory size (>2mm) 
(Wulff, Wilson, Wiegand et al. 2002). The conclusions drawn from this study were 
that follicle development is dependant on the presence of normal thecal vasculature 
(Wulff, Wilson, Wiegand et al. 2002). VEGF trap was also found to affect corpus 
luteum function, whereby injection of the trap in the late follicular phase inhibited 
the rise in progesterone that is required for luteal function (Fraser, Wilson, Morris et 
al. 2005). 
 
  Given that VEGF inhibition prevents normal follicle growth, other studies have 
tested whether administration of VEGF may enhance follicle development. Shimizu 
and associates (2003) performed in vivo injection of VEGF gene fragments directly 
into the medulla of ovaries of pigs (Shimizu, Jiang, Iijima et al. 2003). VEGF was 
shown to be incorporated into granulosa cells following administration and 
concentrations of VEGF in follicular fluid in VEGF-treated ovaries were elevated in 
comparison with ovaries treated with saline. VEGF treatment resulted in a 2-fold 
increase in vascular density compared to control ovaries. This increase in vasculature 
was associated with a decrease in the number of atretic follicles in VEGF-treated 
ovaries. In addition, following injection of VEGF gene fragments, VEGFR1 mRNA 
was found to increase to a greater extent in theca cells than did VEGFR2, suggesting 
that perhaps VEGFR1 has a predominant role in thecal vasculature development 
(Shimizu, Jiang, Iijima et al 2003). More recently, a similar experiment in rats was 
carried out where VEGF gene fragments were injected into the ovaries of immature 
rats. Similar to observations in pigs, VEGF gene fragments resulted in increased 
development of thecal vasculature which subsequently led to stimulation of antral 
follicle development (Shimizu, Iijima, Miyabayashi et al. 2007). These results are in 
agreement with another study in rats, where intraperitoneal injection of VEGF in 
cycling rats stimulated follicle development and resulted in more oocytes being 
ovulated compared to untreated controls (Iijima, Jiang, Shimizu et al. 2005). Co-
treatment with an inhibitor of angiogenesis (TNP-470) completely inhibited the 
effects of VEGF on ovulation (Iijima, Jiang, Shimizu et al. 2005).  In another study, 
co-administration of VEGF gene fragments with GDF-9, a growth factor secreted by 
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the oocyte, did not augment the effects of VEGF administered alone (Shimizu, 
Iijima, Ogawa et al. 2008).  
 
   Studies in cattle and horses have considered the effects of VEGF specifically at the 
beginning of deviation during a follicular wave. In the horse, blood flow in the 
largest follicle was observed to increase relative to the second largest follicle 
approximately 1 to 2 days before the beginning of diameter deviation between the 
two follicles (Acosta, Gastal, Gastal et al. 2004; Gastal, Donadeu, Gastal et al. 1999). 
A study using coloured Doppler ultrasonography in cattle showed that detectable 
blood flow was not different between the largest and second largest follicles before 
the beginning of deviation (Acosta, Hayashi, Matsui et al. 2005). In contrast, after 
the beginning of deviation, blood flow was significantly increased in the dominant 
follicle (Acosta, Hayashi, Matsui, & Miyamoto 2005). These findings are in 
agreement with a study done in sheep which found that blood flow velocity was 
greater in the dominant follicle than in non-dominant follicles (Brown & Driancourt 
1989) These results suggest that blood may be delivered preferentially to the 
dominant follicle. As indicated above, follicular-fluid levels of VEGF increase 
during growth of antral follicles and are highest in dominant-size follicles 
(Greenaway, Connor, Pedersen et al. 2004). In horses, the concentration of VEGF in 
the largest follicle was found to be higher than in the second largest follicle 24 hours 
after the beginning of deviation (Ginther, Gastal, Gastal, & Beg 2004a). Another 
study by the same authors found that injection of rh-IGF-I into the second largest 
follicle in the mare induced an increase in the concentration of VEGF within 24 
hours (Ginther, Gastal, Gastal et al. 2004b).  
Taken together, the results provide strong evidence that a sufficient vascular supply 
is required for successful selection and maturation of dominant follicles and that 
VEGF treatment can significantly enhance the development of the thecal vascular 
supply and protect against follicular atresia. 
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1.2.6.4 Effects of VEGF on granulosa cell function 
 
  Considering the demonstrated non-angiogenic roles of VEGF in a variety of tissues, 
it is not known to what extent the responses of follicles to manipulation of VEGF 
levels are due to effects of VEGF on follicular cells other than endothelial cells. In 
that regard, granulosa cells represent the major source of follicular VEGF in a 
number of species (Grasselli, Basini, Bussolati et al. 2002; Greenaway, Connor, 
Pedersen et al. 2004; Kamat, Brown, Manseau et al. 1995). The fact that these cells 
express both VEGF and VEGF receptors may indicate potential paracrine/autocrine 
roles of VEGF in granulosa cells.  The following effects of VEGF on granulosa cell 
function have been described. 
 
Cell proliferation. Reports on the proliferative effects of VEGF on granulosa cells are 
conflicting. In their study, Greenaway and co-workers did not find any effect of 
VEGF treatment on bovine granulosa cell proliferation in follicles of any size 
(Greenaway, Connor, Pedersen et al. 2004). In contrast, Grasselli et al (2002) 
demonstrated that VEGF (0.026 to 1.3 nmol/l) dose-dependently stimulated 
proliferation of porcine granulosa cells from large (>6 mm) but not small (<3 mm) 
follicles (Grasselli, Basini, Bussolati et al. 2002), with doses of 0.26 to 0.52 nmol/l 
maximally stimulating proliferation.  
 
Cell survival. The first suggestion that VEGF may be involved in granulosa cell 
survival came from a study by Quintana et al (2001) who examined the relationship 
between VEGF production and apoptosis in cultures of human granulosa cells. This 
group found that VEGF concentrations in supernatants from cultures of granulosa 
cells from patients with decreased response to ovarian hyperstimulation were low 
whereas apoptosis in those cultures was high (Quintana, Kopcow, Marconi et al. 
2001). The opposite effect was observed when examining cultures of granulosa cells 
from patients with normal or enhanced response to ovarian hyperstimulation 
(Quintana, Kopcow, Marconi et al 2001). Consistent with these findings, Greenaway 
et al (2004) demonstrated that VEGF reduced the induction of active caspase-3, a 
mediator of apoptosis, by tumour necrosis factor á (TNFá) in cultures of bovine 
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granulosa cells (Greenaway, Connor, Pedersen et al. 2004).  The effects of VEGF 
were reversed by addition of a specific inhibitor of VEGFR2 (SU1498). These results 
indicated that VEGF and VEGFR2 interact in a coordinated manner to protect 
granulosa cells against apoptosis. The findings of this study are in agreement with 
those of Kosaka et al (2007) who found that VEGF and FSH had similar effects on 
bovine granulosa cell survival. They proposed that VEGF was capable of inhibiting 
apoptosis in granulosa cells possibly through effects on the Akt or ERK signalling 
pathways (Kosaka, Sudo, Miyamoto et al. 2007). Similarly, a study in rats involving 
inhibition of VEGF by in vivo administration of VEGFR1 peptide resulted in an 
increase in granulosa cell apoptosis due to an imbalance between antiapoptotic and 
proapoptotic signals (Abramovich, Parborell, & Tesone 2006). Consistent with this, 
treatment of rat granulosa cells with VEGF before cryopreservation has been shown 
to reduce the damage induced by the freeze-thaw process (Shin, Lee, Lee et al. 
2006), once again providing evidence that VEGF functions to protect against 
granulosa cell apoptosis.   
 
1.3. Signalling and crosstalk mechanisms of VEGF and heterotrimeric G-
protein pathways 
 
1.3.1 VEGFR Signalling 
 
   VEGFRs belong to the receptor tyrosine kinase (RTK) superfamily of cell surface 
receptors which have intrinsic protein tyrosine kinase activity. This involves the 
transfer of a phosphate molecule from a donor ATP molecule to the hydroxyl groups 
of tyrosine amino acids on target proteins (Hunter 1998). RTKs have been shown to 
be key regulators in normal cell processes, including proliferation, differentiation, 
survival, migration, progression through the cell cycle and metabolic activity 
(Schlessinger 2000) and in addition have been found to have a critical role in the 
development and progression of many types of cancers (Zwick, Bange, & Ullrich 
2001). Some 58 RTKs have been grouped in 20 subfamilies based on their kinase 
domain sequence (Robinson, Wu, & Lin 2000). 
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1.3.2 Activation of VEGF receptors 
 
  Binding of ligand to extracellular domains of RTKs induces changes in 
conformation leading to receptor dimerization. It has been demonstrated that VEGFR 
dimerization is critical for signal transduction (Fuh, Li, Crowley et al. 1998). 
Dimerisation of RTKs acts to stabilise interactions between adjacent cytoplasmic 
domains and to stimulate receptor tyrosine kinase activity, resulting in 
phosphorylation of specific tyrosine residues in the intracellular receptor domains 
(autophosphorylation) which are targets for (SH2) and phosphotyrosine binding 
(PTB) domain-containing proteins, including phospholipase Cã (PLCã), 
phosphoinositide 3 kinase (PI3K) and Src (Reviewed by Ullrich & Schlessinger 
1990; Zwick, Bange, & Ullrich 2001). Signalling pathways putatively mediating the 
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Figure 1.7.  Schematic diagram of the signalling pathways putatively mediating the effects of 
activation of VEGFR2 in endothelial cells. Adapted from (Cross, Dixelius, Matsumoto et al. 2003) 
and (Takahashi & Shibuya 2005). 
 
  In contrast to VEGFR2, the signalling ability of VEGFR1 remains controversial. 
VEGFR1 is considered to be a kinase-impaired RTK because it is poorly 
phosphorylated after ligand binding and its ability to phosphorylate RTK substrates 
is negligible. A recent study by Meyer et al (2006) has confirmed that this 
characteristic of VEGFR1 is due to a single amino acid substitution (Asp → Asn) in 
the activation loop that exists on the intracellular kinase domain of the receptor 
(Meyer, Mohammadi, & Rahimi 2006). These authors propose that the conserved 
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aspartic acid in RTKs favours transphosphorylation of this activation loop which is 
necessary for receptor activity. 
  
1.3.3 Activation of PLCã and ERK1/2 by VEGFR2  
 
 PLCã Pathway. PLCã is a substrate for most RTKs. To date, two mammalian PLCã 
isoforms have been identified, PLC-ã1 and PLCã-2 (Suh, Park, Manzoli et al. 2008). 
PLC-ã1 is the best characterised isoform and from here will be referred to as PLCã. 
All PLC isoforms share a catalytic domain composed of two regions of high 
homology (40-60%), X and Y. The region between X and Y contains Src homology 
domain 2 (SH2) and Src homology domain 3 (SH3) that are unique to PLCã 
(Reviewed by Rhee & Bae 1997). The presence of these domains aids the association 
of PLCã with other proteins, where SH2 recognises phosphotyrosine sequences and 
SH3 recognises proline-rich sequences (Carpenter & Ji 1999). Following VEGFR2 
activation, phosphorylation at Y1175 allows the binding, phosphorylation and 
subsequent activation of PLCã (Takahashi, Yamaguchi, Chida et al. 2001). PLC 
activation results in hydrolysis of membrane-bound phosphatidylinositol 4,5-
biphosphate (PIP2) into the second messengers, inositol 1, 4, 5-triphosphate (IP3) and 
diacylglycerol (DAG). IP3 rapidly diffuses through the cytoplasm to activate IP3 
receptors on the smooth endoplasmic reticulum membrane resulting in the opening of 
IP3-gated-calcium (Ca
2+) channels on the endoplasmic reticulum The increase in 
intracellular (Ca2+) results in activation of calcium-dependent kinases, such as 
calmodulin, and other membrane-bound, cytosolic and mitochondrial proteins 
(Reviewed by Balla 2006). After PLC-mediated PIP2 cleavage, DAG remains on the 
cell membrane where it can activate members of the protein kinase C (PKC) enzyme 
family (Nishizuka 1988) as well as a variety of non-PKC effectors (Yang & 
Kazanietz 2003). Many PKCs are calcium dependent and it is believed that the 
increase in Ca2+ concentration induced by IP3 causes PKC to translocate from the 
cytoplasm to the plasma membrane. PKC is anchored to the cell membrane via 
receptors for activated PKC (RACK) before it is activated by DAG, Ca2+ and 
phosphatidylserine. Both IP3- and DAG-induced signals eventually target a range of 
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transcription factors that are responsible for the effects of PLC activation on cell 
functions (Reviewed in Rebecchi & Pentyala 2000).   
 
MAPK Pathway. One of the putative targets of PLCã/PKC is the ERK1/2 signalling 
cascade.  This is a classical RTK-activated cascade that is involved in regulation of 
cell survival, proliferation, differentiation and motility (Reviewed in Rebecchi & 
Pentyala 2000). RTKs classically activate ERK1/2 through growth factor receptor-
bound protein 2 (Grb2) and guanine nucleotide exchange factor, Sos (son of 
sevenless) targeting of membrane-bound Ras (McCormick 1993) although the use of 
this mechanism by VEGFR2 is controversial. Recent studies have shown that VEGF 
can activate Ras through a pathway that requires PKC and sphingosine kinase 
(Meadows, Bryant, & Pumiglia 2001; Shu, Wu, Mosteller et al. 2002). Raf, a 
serine/threonine specific kinase, is subsequently phosphorylated and activates MEK 
protein kinases which in turn phosphorylate and activate the serine/threonine specific 
protein kinases, ERK 1 and 2. Activated ERK1/2 translocates to the nucleus where it 
phosphorylates target transcription factors to induce changes in gene expression.  
 
1.3.4 Heterotrimeric G-protein Signalling 
 
  Heterotrimeric G-proteins are involved in the transduction of signals from 
heptahelical transmembrane receptors, known as G-protein coupled receptors 
(GPCRs), the largest family of cell surface receptors with more than 1000 encoding 
genes that relay signals from a variety of ligands such as hormones, 
neurotransmitters, and chemokines in addition to autocrine and paracrine factors to 
regulate a wide range of cellular responses including sight, smell, neuronal activity 
and cell proliferation, survival and migration (Rens-Domiano & Hamm 1995).  
 
1.3.5 Heterotrimeric G-Protein subunits and classification  
 
   Heterotrimeric G-proteins are composed of three subunits, á subunit, with GTPase 
activity, and â and ã subunits that are usually found in the cell tightly associated as 
Gâã dimers (Morris & Malbon 1999). Different types of each subunit (21 different 
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Gá subunits, 6 Gâ subunits and 12 Gã subunits) have been described (Oldham & 
Hamm 2008). 
  A given type of Gá can trimerise with any of multiple combinations of Gâã and 
therefore G-protein families are classified according to the specific Gá subunit into 
Gs, Gq, Gi/o and G12/13 (see below).  However, the emerging importance of the 
Gâã complex have led to suggestions that the nomenclature should be revised 
(Morris & Malbon 1999).  
Gá subunits are 3952 kDa peptides with approximately 45-80% shared homology 
(Simon, Strathmann, & Gautam 1991). Each Gâ subunit has a molecular mass of 
approximately 350 kDa and each Gã is approximately 7-9 kDa in size. Gâ1-4 form a 
tight complex with Gã which can only be broken under denaturing conditions 
(Morris & Malbon 1999). The Gâ5 subunit is an exception as its association with Gã 
is considerable weaker than other Gâ subunits. There are is a large number of 
different Gâã complexes resulting from all possible subunit combinations. The roles 
of Gâã in cell signalling have been less well characterised than those of Gá subunits.  
The function of Gâã complexes was first thought to be restricted to facilitation of 
coupling of Gáâã trimers to activated GPCRs and inhibition of Gá activity through 
the intrinsic GTAPase activity of Gâã (McCudden, Hains, Kimple et al. 2005). 
However it is now clear that Gâã dimers themselves can activate a variety of 
downstream effectors that include PLCs (Rhee & Bae 1997), ACs (Sunahara, 
Dessauer, & Gilman 1996), ion channels (Schneider, Igelmund, & Hescheler 1997), 
PI3K (Vanhaesebroeck, Leevers, Panayotou et al. 1997; Zaballos, Garcia, & 
Santisteban 2008) and ERK (Lopez-Ilasaca 1998; Reusch, Schaefer, Plum et al. 
2001). 
 
Gás Class. This class contains two members, Gás and Gáolf, which activate the 
cAMP-producing enzyme, adenylyl cyclase (AC). Cyclic AMP activates Protein 
kinase A (PKA) as well as Exchange proteins directly activated by cAMP (EPAC) 
(Reviewed by Bos 2006). In addition to AC, Gás can also directly stimulate the Src 
family of tyrosine kinases (Ma, Huang, Ali et al. 2000). Gás subunits are substrates 
for ADP-ribosylation by cholera toxin, which prevents exchange of GTP for GDP 
thus maintaining the protein in the activated state (Kahn & Gilman 1984). 
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Gáq Class. The Gáq class includes Gá11 and Gáq which are ubiquitous in 
mammalian tissues. Other members of this class include Gá14, Gá15 and Gá16, the 
expression of which are limited to stromal, epithelial and hematopoietic cell types 
(Morris & Malbon 1999). Activating GPCRs do not appear to discriminate between 
Gá11 and Gáq (Wange, Smrcka, Sternweis et al. 1991). Members of the Gáq class 
can activate effectors including phospholipase Câ (PLCâ) (Dowal, Provitera, & 
Scarlata 2006), Rho-specific guanine nucleotide exchange factors (GEFs) (Rojas, 
Yohe, Gershburg et al. 2007) and Brutons tyrosine kinase (BTK) (Bence, Ma, 
Kozasa et al. 1997). Recently, a Gq/11-specific inhibitor has been developed (YM-
254890) which blocks the exchange of GDP for GTP by Gáq/11 (Takasaki, Saito, 
Taniguchi et al. 2004). 
 
Gái/o Class. The Gi class consists of Gái1, Gái2, Gái3, Gáo1, Gáo2, Gáz and Gát. 
Whereas Gái1-3 are ubiquitous, Gáo1-2 are specific to the brain and Gát is specific 
to the retina In contrast to Gás, Gái inhibits AC activity (Reviewed by Morris & 
Malbon 1999). Gái/o family members have also been found to activate the ERK 
signalling cascade via activation of c-Src/STAT-3 and RAP pathways (Weissman, 
Ma, Essex et al. 2004). Pertussis toxin (PTX) ATP-ribosylates the COOH-terminal 
cysteinyl residue of Gái/o, thus uncoupling the G protein from its activating receptor 
(Reviewed by Morris & Malbon 1999). All members of the Gái/o class with the 
exception of Gáz are sensitive to PTX. 
 
Gá12/13 Class. Gá12 and Gá13 are expressed ubiquitously and are often activated 
by receptors that also couple to Gq/11 (Dhanasekaran & Dermott 1996). Since 
specific molecular inhibitors of this class are not available relatively little is known 
about their function. Over-expression studies have shown that Gá12 and Gá13 can 
interact with a variety of effectors including Rho (Buhl, Johnson, Dhanasekaran et al. 
1995), BTK (Jiang, Ma, Wan et al. 1998) and HCLS1-associated protein X-1 (HAX-
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1.3.6 Heterotrimeric G-Protein Activation 
 
   In the inactive state, the GDP-bound Gá subunit and Gâã dimer are associated as a 
trimer in the inner face of the cell membrane. When an activated GPCR interacts 
with the G-protein trimer, the GDP on the Gá subunit is exchanged for GTP (figure 
1.8). This results in the dissociation of the Gá subunit from the Gâã complex. Both 
Gá and Gâã are released separately to stimulate a number of downstream effectors. 
G-protein signalling is terminated by the hydrolysis of GTP by GTPase activity 
intrinsic to the Gá subunit. The resultant GDP-bound Gá subunit subsequently re-
associates with Gâã dimer to re-establish a trimer ready to enter another activation 
cycle in the presence of an activated GPCR. More detailed reviews on the 
mechanism of G-protein activation can be found elsewhere (Cabrera-Vera, 
Vanhauwe, Thomas et al. 2003; Oldham & Hamm 2008; Wettschureck & 
Offermanns 2005). There are intracellular modulators of heterotrimeric G protein 
activity in addition to GPCRs. These modulators act to inhibit or promote the 
activated state of G proteins to ensure that their response to GPCR activation is 
limited in time and space. These modulators include heterotrimeric G protein 
effectors themselves. For example, all PLCâ isoforms stimulate the GTPase activity 
of the Gá subunit to accelerate the hydrolysis of GTP to GDP thus rendering the G 
protein inactive (Rebecchi & Pentyala 2000). A further level of control is provided 
by regulators of G-protein signalling (RGS), a protein family with more than thirty 
members that specifically interact with Gá subunits to enhance their Gá intrinsic 
GTPase activity (Reviewed by De, Zheng, Fischer et al. 2000; Hollinger & Hepler 
2002). There are also guanine nucleotide exchange factors (GEFs) that promote GDP 
to GTP exchange on Gá subunits to increase heterotrimeric G protein activity 
(Hagemann, Narzinski, & Baranski 2007). In addition, a variety of scaffolding 
proteins are known to interact with and provide spatial regulation of heterotrimeric G 
proteins (Reviewed in Andreeva, Kutuzov, & Voyno-Yasenetskaya 2007). 
Scaffolding proteins have been defined as proteins that associate with two or more 
partners to enhance the efficiency and/or specificity of cellular signalling pathways 
(Hall & Lefkowitz 2002). These proteins function as adaptors or scaffolds to 
selectively bridge the -N or -C terminal or other regions of RGS proteins to GPCRs, 
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G-proteins or effectors. Scaffolding proteins can strengthen, modify or convey 















Figure 1.8. Illustration of heterotrimeric G-protein activation at the plasma membrane. An activated 
GPCR acts as a guanine-nucleotide exchange factor to promote GDP for GTP exchange resulting in 
dissociation of Gá subunit from Gâã complex and subsequent activation of downstream effectors.  G-
protein signalling is terminated by hydrolysis of GTP resulting in re-association of GDP-bound Gá 
subunit with Gâã dimer. Taken from (Jones, Siderovski, & Hooks 2004) 
 
 
1.3.7 Heterotrimeric G-Protein activation of PLCâ 
 
   Four mammalian PLCâ isoforms have been identified (PLCâ1, PLCâ2, PLCâ3 and 
PLCâ4). The most widely expressed isoform is PLCâ-1, which has particularly high 
activity in certain areas of the brain (Reviewed by Rebecchi & Pentyala 2000). All 
isoforms are soluble in water but bind strongly to inner surface of the cell membrane 
with little specificity (Runnels, Jenco, Morris et al. 1996). Evidence also exists for a 
nuclear PLCâ system, which functions independently of the cell membrane system 
(Reviewed by Cocco, Martelli, Mazzotti et al. 2000). Nuclear expression is highest 
for PLCâ-1 followed by PLCâ-3, PLCâ-2 and PLCâ-4 (Cocco, Martelli, Mazzotti er 
al. 2000).  
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Figure 1.9. Both Gáq/11 and Gâã (putatively derived predominantly from Gi within many cells) can 
activate PLCâ isoforms. PLCâ. PLCâ catalyses the hydrolysis of PIP2 in the cell membrane to the 
second messengers, IP3 and DAG, which subsequently induce the release of intracellular calcium and 
the activation of PKC. RGSs act to down modulate the activity of Gá subunits. Taken from (Rebecchi 
& Pentyala 2000). 
 
   Both Gq/11 (through Gáq/11) and Gi (through Gâã) are recognised as putative 
activators of PLCâ isoforms (see figure 1.9). All Gá subunits of the Gq/11 family 
stimulate PLCâ but not PLCã or PLCä (Berridge 1993; Exton 1996; Rhee & Choi 
1992). However, PLCâs are differentially sensitive to Gáq subunits in a rank order of 
PLCâ1 > PLCâ3 > PLCâ2 (Rhee & Bae 1997). Furthermore, PLCâ4 isoform has 
been reported to be insensitive to Gáq/11 stimulation (Kim, Min, Ryu et al. 1998). 
However, experiments involving purified PLCâ1, PLCâ2 and PLCâ3 have 
demonstrated that there is little difference between the activation of PLCâ isoforms 
by purified members of the Gáq/11 family (Hepler, Kozasa, Smrcka et al. 1993; 
Kozasa, Hepler, Smrcka et al. 1993; Smrcka & Sternweis 1993), therefore the 
physiological role of Gáq/11 in activating different PLCâ subunits needs to be 
clarified. 
 
   In contrast to Gáq subunits, Gâã can activate all PLCâ isoforms. The sensitivity of 
PLCâ to Gâã dimers differs in a rank order of PLCâ3 > PLCâ2 > PLCâ1 > PLCâ4 
(Park, Jhon, Lee et al. 1993). Although it has not been possible to test every known 
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interchangeable when reconstituted with PLC in artificial vesicles (Boyer, Graber, 
Waldo et al. 1994) or when co-expressed in living cells (Watson, Katz, & Simon 
1994). In general, Gáq subunits are 50-100 fold more potent activators of PLCâ 
isoforms than Gâã subunits (Morris & Malbon 1999). PLCâ3 is an exception 
whereby Gáq and Gâã subunits have similar activating capacities on a stoichiometric 
basis (Rebecchi & Pentyala 2000). 
 
1.3.8 Cross-Talk between RTK and heterotrimeric G-protein pathways 
 
1.3.8.1 GPCR transactivation of RTKs 
 
   Transactivation of RTKs by GPCR ligands is a well-described phenomenon 
(Luttrell, Daaka, & Lefkowitz 1999; Shah & Catt 2004; Werry, Sexton, & 
Christopoulos 2005; Wetzker & Bohmer 2003). In the ovary, LH stimulation of 
granulosa cells activates the Epidermal Growth Factor (EGF) signalling system 
during the late periovulatory period (Reviewed by Conti, Hsieh, Park et al. 2006). 
Following LH/hCG stimulation, mRNA levels for EGF-like growth factors, 
epiregulin (EREG), amphiregulin (AREG) and betacellulin (BTC), increase both in 
vitro and in vivo (Espey & Richards 2002; Park, Su, Ariga et al. 2004; Sekiguchi, 
Mizutani, Yamada et al. 2004). These factors have been shown to induce oocyte 
maturation as efficiently as LH (Conti, Hsieh, Park, & Su 2006). It is believed that 
these factors exert their effects on the oocyte via the cumulus cells because denuded 
oocytes did not undergo maturation in the presence of these growth factors (Conti, 
Hsieh, Park, & Su 2006). In support of these findings, when EGFR inhibitor was 
injected directly into the ovarian bursa of the rat, there was a 50% decrease in 
ovulation and many follicles were observed to have trapped oocytes present in 
comparison with the contralateral ovary that was injected with a saline control. In 
addition, mice that are deficient in either amphiregulin or epiregulin display either 
delayed or reduced oocyte maturation (Hsieh, Lee, Panigone et al. 2007). The LH 
surge is believed to induce EGF-like growth factor shedding from the cell membrane 
through activation of matrix metalloproteinases (MMPs) (Park, Su, Ariga et al. 
2004). This was demonstrated by studies involving MMP inhibition which resulted 
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in blocked oocyte maturation (Ashkenazi, Cao, Motola et al. 2005). A recent study 
by Downs and Chen (2008) has demonstrated that the FSH receptor can also 
transactivate the EGF network (Downs & Chen 2008). These authors suggest that 
EGF-like peptides are released from cumulus cells in response to stimulation with 
FSH and that these factors have a role at the local level to regulate meiosis (Downs 
& Chen 2008).  
 
1.3.8.2 RTK activation of heterotrimeric G-protein pathways 
  
   Another mechanism of crosstalk between heterotrimeric G-proteins and RTKs is 
exemplified by the reported involvement of heterotrimeric G-proteins in RTK 
signalling. This has been demonstrated in a number of examples (Reviewed by Patel 
2004) as follows: 
 
EGFR. The activation of PLC by EGF in rat whole liver has been shown to involve 
Gi/o family members as demonstrated by the inability of EGF to increase 
intracellular Ca2+ in the presence of pertussis toxin (PTX) (Liang & Garrison 1991; 
Rashed & Patel 1991). Further support for a role of G-proteins in the activation of 
EGF was provided by Nair et al (1990) who showed that Gs activity in isolated rat 
hearts was involved in stimulation of the PLC pathway (Nair, Parikh, Milligan et al. 
1990). Interestingly, a short (13 amino acid) Gs-activating sequence has been 
identified in the cytoplasmic region of the EGF receptor (Sun, Chen, Poppleton et al. 
1997; Sun, Seyer, & Patel 1995). Further, an interaction between Gs and this 
activating region on EGF receptor has been reported necessary for efficient 
phosphorylation of this G-protein (Poppleton, Sun, Mullenix et al. 2000).  
 
Insulin receptor (IR). The first evidence that the insulin receptor was functionally 
coupled to heterotrimeric G-proteins was presented in the mid 1980s (Goren, 
Northup, & Hollenberg 1985). In that study Goren and associates demonstrated that 
the ability of insulin to inhibit lypolysis and glucose oxidation in rat adipocytes was 
blocked by exposure to Pertussis toxin. Consequently there were reports that showed 
that the insulin receptor couples to members of the Gái/o family (Ciaraldi & Maisel 
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1989; Krupinski, Rajaram, Lakonishok et al. 1988; Rothenberg & Kahn 1988). It was 
further elucidated that Gái2 was specifically involved in insulin-mediated signalling 
(Moxham & Malbon 1996; Song, Zheng, Malbon et al. 2001; Zheng, Guo, Wang et 
al. 1998). Furthermore, Gáq/11 was also demonstrated to associate with the insulin 
receptor and to be phosphorylated in the presence of insulin (Imamura, 
Vollenweider, Egawa et al. 1999). Additionally, Gáq/11 was found to stimulate 
insulin-mediated translocation of GLUT4, an insulin-regulated glucose transport 
molecule, to the cell membrane (Imamura, Vollenweider, Egawa et al. 1999). These 
results indicate that Gáq/11 has a role in glucose transport in cells. There have also 
been a number of reports to suggest that the actions of IGF are mediated by 
heterotrimeric G-proteins (Reviewed by Patel 2004). 
 
Platelet-Derived Growth Factor receptor (PDGFR). The PDGF-stimulated 
phosphorylation of ERK has been reported to involve Gâã subunits that are likely 
derived from Gi protein as this effect can be inhibited by pertussis toxin (Conway, 
Rakhit, Pyne et al. 1999). It has been shown in HEK cells that PDGFR and 
endothelial differentiation gene 1 (EDG1, a GPCR that is activated by sphingosine-1 
phosphate) form a tethered complex. This complex has been shown to provide a 
platform on which receptor crosstalk can occur to stimulate more efficient regulation 
of downstream pathways such as ERK activation (Alderton, Rakhit, Kong et al. 
2001).  
 
Fibroblast Growth Factor receptor (FGFR). Very little is known about the interaction 
of FGF with heterotrimeric G-proteins although one study demonstrated that upon 
FGF binding to FGFR, AC was stimulated whilst NADPH-dependent H2O2 
production was inhibited in adipose cell membranes (Krieger-Brauer, Medda, & 
Kather 2000). Krieger-Brauer et al (2000) confirmed that these effects were confined 
to the cell membrane and occurred without ATP, indicating that classical RTK 
activity of the FGFR was not required. The stimulatory effect of FGF on AC could 
be blocked by an Anti Gs peptide, thus showing that FGF could associate with Gs. 
G-protein activity was also required for inhibition of NADPH-dependent H2O2 
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synthesis as indicated by the ability of a Gâã-sequestering fragment to reverse this 
effect. 
 
   In addition to RTKs, G-proteins have been shown to associate with a variety of 
non-classical receptor types, for example, zona pellucida protein 3 (ZP3), a receptor 
that is involved in fertilisation. ZP3, contains O-linked oligosaccharide ligands which 
are responsible for binding to â-1,4 galactosyltransferase (GalTase) that is present on 
the sperm (Wassarman 1999). When sperm and egg meet, ZP3 and GalTase interact 
and Gi is subsequently activated which in turn initiates the acrosome reaction (Gong, 
Dubois, Miller et al. 1995). Other examples of non-GPCR family receptors 
functionally coupled to G-proteins include integrins, T cell receptors and natriuretic 
peptide receptors (Reviewed by Patel 2004). 
 
1.3.9 Crosstalk between VEGF Receptor and heterotrimeric G-protein    
pathways  
 
   Zeng and associates demonstrated that VEGFR2 but not VEGFR1 was involved in 
VEGF-induced endothelial cell proliferation and migration (Zeng, Dvorak, & 
Mukhopadhyay 2001a; Zeng, Zhao, & Mukhopadhyay 2002a). In fact, VEGFR1 had 
an inhibitory effect on endothelial cell proliferation (Zeng, Zhao, & Mukhopadhyay 
2002a). This down-regulation of endothelial cell proliferation occurred through the 
PI3K pathway as shown by a reversal on the inhibitory effect on proliferation by 
treatment with PI3K inhibitors (Zeng, Dvorak, & Mukhopadhyay 2001a). To identify 
whether heterotrimeric G-proteins were involved in VEGF-induced proliferation and 
migration, these authors first investigated whether the canonical G-Protein/PLCâ 
pathway was activated. It is generally accepted that stimulation of a VEGF-
responsive cell normally results in induction of PLCã phosphorylation within 5 
minutes, as observed by an intracellular rise in calcium (Ca2+) concentration (Zeng, 
Sanyal, & Mukhopadhyay 2001). However, Mukhopadhyay and associates (2004) 
found that following treatment of endothelial cells with VEGF there was an 
accelerated rise in intracellular Ca2+ after only 40 seconds, thus suggesting that 
phosphorylation of PLCã may not be responsible for the increased Ca2+ 
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concentration (Mukhopadhyay, Zeng, & Bhattacharya 2004). They proposed that the 
increased Ca2+ levels may be mediated instead by PLCâ. This was tested in a study 
that measured the catalytic activities of PLCâ isoforms following VEGF stimulation 
and found that PLCâ3 and not PLCã was activated by VEGF stimulation. The 
authors then tested the involvement of heterotrimeric G-proteins in the VEGF-
induced Ca2+ increases and found no effects of PTX on such response. Leading to the 
conclusion that Gái/Gáo were not involved. Using a Gá11 antagonist fusion peptide 
Mukhopadhyay et al (2004) found that the VEGF-stimulated increase in Ca2+ was 
instead predominantly mediated by the Gá11/PLCâ3 signalling pathway. This was 
further confirmed by inhibition of Gáq, which severely impaired PLCâ-3 activation 
(Reviewed by Mukhopadhyay, Zeng, & Bhattacharya 2004).  
 
   Further evidence for the involvement of G-proteins in VEGF signalling comes 
from studies in the zebrafish. It has been shown that targeted knockdown of the G 
protein GNG2 (Gã2) leads to a block in normal angiogenesis in the zebrafish embryo 
(Leung, Chen, Stauffer et al. 2006). Loss of GNG2 reduced the ability of VEGF to 
promote the angiogenic sprouting of blood vessels by disrupting VEGF induced 
phosphorylation of PLCã1 and serine/threonine kinase AKT was compromised 
(Leung, Chen, Stauffer et al. 2006). GNG2 was not necessary for VEGFR2 activation  
indicating that, in contrast to what had been previously reported for G11 by Zeng and 
associates (2003)  the involvement of GNG2 is not likely to occur at the level of the 
receptor, but downstream in the VEGFR signalling cascade (Leung, Chen, Stauffer et 
al 2006; Zeng, Zhao, Yang et al. 2003). Another recent study found that Gá13 is 
required for migration of fibroblast and endothelial cell types (Shan, Chen, Wang et 
al. 2006), Furthermore, mouse cells that were treated with Gá13 siRNA had reduced 
levels of VEGF-induced endothelial cell migration (Shan, Chen, Wang et al. 2006).  
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1.4   Overall Aims 
 
   From the afore-reviewed literature, it is clear that there is a paucity of information 
on the roles of VEGF in follicle development, particularly those roles involving non-
vascular follicle components. Based on above-presented information on other cell 
types, such roles, if confirmed, may very well involve critical interactions at the 
intracellular level with heterotrimeric G-protein pathways, most notably, 
gonadotrophin-activated pathways.   
 
   A better understanding of the roles of VEGF during follicle development will not 
only expand our knowledge on the basic mechanisms of follicle development but 
may also aid in the design of therapeutic approaches to better control reproductive 
cycles in animals and humans alike. 
Consequently, the aims of the work described in this thesis were: 
 
1. To investigate the roles of VEGF in granulosa cell function during the 
development of bovine dominant follicles 
2. To investigate the involvement of heterotrimeric G-protein pathways in such 
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2.1 Abstract. 
 
 The current study used an in vitro bovine granulosa cell model to investigate the 
roles of VEGF in specific granulosa cell functions during the development of 
dominant follicles. Granulosa cells were obtained from healthy follicles with 
diameters of 4 to 8 mm (corresponding to just before the selection of a dominant 
follicle during a follicular wave) or 9 to 14 mm (encompassing all developmental 
stages of a dominant follicle) and exposed to a range of VEGF concentrations (1 to 
100 ng/ml) encompassing concentrations found naturally in bovine dominant 
follicles. A concentration of VEGF of 1 ng/ml induced significant proliferation of 
bovine granulosa cells from 4 to 8 mm follicles (P = 0.024) and increased the 
proliferative response of these cells to FSH (P = 0.045), whereas higher doses of 
VEGF had no effect on proliferation (P > 0.1). None of the concentrations of VEGF, 
alone or in combination with FSH, had an effect on expression of the steroidogenic 
enzyme, CYP11A1, by these cells (P > 0.1). In contrast, VEGF induced a dose-
dependent increase in ERK1/2 activation by granulosa cells from 4 to 8 mm follicles 
(P < 0.03). Granulosa cells from 9 to 14 mm follicles responded to 1 ng/ml VEGF 
with an increase in COX-2  (P = 0.003) but higher doses had no effect (P > 0.1)  
Treatment with 1 ng/ml VEGF, however, abolished an LH-induced increase (P < 
0.0002) in COX-2 in these cells. In addition specific inhibition of VEGFR2 
prevented (P > 0.1) LH stimulation of both ERK phosphorylation and COX-2 
expression in granulosa cells from 9 to 14 mm follicles. These results suggest 
important roles of VEGF in granulosa cell function during the development of the 
dominant follicle. VEGF may act, at least partially, by mediating the effects of 
gonadotrophins on granulosa cells. 













   Follicle development in monovular species involves the synchronous growth of 
antral follicles as follicular waves. Within each wave, usually one follicle (dominant 
follicle) is selected to undergo pre-ovulatory maturation whereas the remaining 
follicles become subordinate and eventually undergo atresia. In cattle, follicle 
dominance is established when the largest follicle of a wave reaches about 8.5 mm 
and this follicles continues to grow to about 14 to 20 mm when it normally ovulates 
or begins regressing (Ginther, Beg, Donadeu et al. 2003). The control of follicle 
selection and the growth of the dominant follicle lies within complex interactions 
between systemic gonadotrophins and local growth factors. For example, the 
synergistic actions of IGF-I and FSH are critical in the selection of a single follicle 
from the cohort of a wave (Mihm & Evans 2008) whereas EGF plays a very 
important role in mediating some of the responses of the preovulatory follicle to the 
ovulatory LH surge (Conti, Hsieh, Park, & Su 2006). The role of many other 
follicular factors remains poorly understood. One such factor is VEGF.             
                                                                                                                                                                                                                                                                                                                                                
   Numerous studies have shown that VEGF and its receptors (VEGFR1 and 2) are 
expressed in granulosa cells (Greenaway, Connor, Pedersen et al. 2004; 
Ravindranath, Little-Ihrig, Phillips et al. 1992; Barboni, Turriani, Galeati et al. 2000; 
Shin, Lee, Ko et al. 2005; Watson & Al-Zi'abi 2002; Gordon, Mesiano, Zaloudek et 
al. 1996). Dynamic changes in the expression of VEGF and its receptors have been 
reported throughout follicle development in primates (Taylor, Hillier, & Fraser 2004; 
Kamat, Brown, Manseau et al. 1995; Otani, Minami, Yamoto et al. 1999), pigs 
(Barboni, Turriani, Galeati et al. 2000; Shimizu, Kawahara, Abe et al. 2003; Mattioli, 
Barboni, Turriani et al. 2001) and cattle (Greenaway, Connor, Pedersen, Coomber, 
LaMarre, & Petrik 2004; Yang & Fortune 2007), with a consistent increase in both 
VEGF production and expression of its receptors in dominant follicles.  
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   Studies in non-human primates have shown that intrafollicular or systemic 
injection of a VEGF antagonist results in significant impairment of ovulation and 
subsequent luteal function (Fraser, Wilson, Rudge et al. 2005; Hazzard, Xu, & 
Stouffer 2002). Further, Danforth et al (2003) showed that VEGF can stimulate pre-
antral follicle development in culture and Shimizu et al (2007) recently demonstrated 
that intraovarian injection of VEGF promoted follicle development to the 
preovulatory stage in gilts.  
 
   The mechanisms by which VEGF elicits those effects in follicles are not yet fully 
understood. While the role of VEGF is undoubtedly associated, at least in part, with 
the induction of an extensive vascular system in the follicle, limited studies using 
ruminant or porcine cells suggest that VEGF may modulate granulosa cell function 
directly by promoting survival (Greenaway, Connor, Pedersen et al. 2004; Kosaka, 
Sudo, Miyamoto et al. 2007) and/or proliferation (Grasselli, Basini, Bussolati et al. 
2002). VEGF has been shown to promote survival of a variety of other cell types 
including cells of the central nervous system (Sondell, Lundborg, & Kanje 1999a; 
Jin, Mao, & Greenberg 2000a; Jin, Mao, & Greenberg 2000b; Oosthuyse, Moons, 
Storkebaum et al. 2001), haematopoietic cells (Gerber, Malik, Solar et al. 2002) and 
tumour cells (Pidgeon, Barr, Harmey et al. 2001; Chung, Bachelder, Lipscomb et al. 
2002; Barr, Pidgeon, & O'Byrne 2006). In addition, VEGF can induce proliferation 
of non angiogenic cells during bone formation (Gerber, Vu, Ryan et al. 1999), 
hematopoiesis (Ferrara, Carver-Moore, Chen et al. 1996), wound healing (Wilgus, 
Matthies, Radek et al. 2005) and neural development (Sondell, Lundborg, & Kanje 
1999b; Zhu, Jin, Mao et al. 2003). 
 
   The observations that granulosa cells are a major site of VEGF synthesis within the 
follicle (Fraser & Wulff 2001) and that expression of both VEGF and its receptors 
increase in the dominant follicle (Ginther, Gastal, Gastal et al. 2004b) reaching their 
maximal levels in preovulatory follicles (Greenaway, Connor, Pedersen et al. 2004) 
suggest potentially important non-angiogenic roles of this growth factor during 
follicle selection and the development of the dominant follicle. The aim of this study 
was to investigate such role(s) of VEGF by examining its effects on proliferative, 
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steroidogenic (CYP11A1 expression) and ovulation-associated (COX-2 expression) 
responses of bovine granulosa cells in culture. Potential interactions between VEGF 
and gonadotrophins in these cells were also studied.  
 
2.3 Materials and Methods 
 
2.3.1 Collection and culture of granulosa cells. 
 
   Bovine ovaries were obtained from a local abattoir and transported to the 
laboratory at 38°C in Phosphate Buffered Saline (PBS) containing kanamycin 
(50 ìg/ml; Sigma, Dorset, UK). Upon arrival at the laboratory, ovaries were briefly 
trimmed free of extraneous tissues and rinsed in 70% alcohol before being added to 
pre-warmed McCoys 5a media containing penicillin/streptomycin (10000 
units/ml10mg/ml, Sigma, Dorset, UK). Follicles were dissected from ovarian stroma 
and their surface diameter was determined in 2 axes using a ruler. Follicles were 
were dissected from ovarian stroma and their diameter was measured with a ruler. 
Follicles were deemed healthy if they were well vascularised with transparent, 
amber-coloured follicular fluid without debris (Yang & Rajamahendran 2000). 
Follicles which were opaque/cloudy with little vasculature were considered atretic 
and were discarded. Granulosa cells were harvested by dissection of follicles into 
hemispheres within small Petri dishes containing McCoys 5a media and blunt-ended 
forceps were used to gently scrape follicle walls to release granulosa cells. Granulosa 
cells from 4 to 8 mm or 9 to 14 mm follicles (corresponding to diameters of follicles 
before and after the beginning of dominance, respectively) were pooled and the 
resulting cell suspensions were transferred to 15ml pre-warmed McCoys 5a culture 
media and centrifuged at 1500 rpm for 5 minutes. Red blood cell lysis was carried by 
adding 1 ml of lysis buffer (10mM KHCO3, 150mM NH4Cl, 0.1mM EDTA (tri 
sodium), pH = 8.0) to the granulosa cell pellets for 1 minute at room temperature. 
Cells were then washed and centrifuged at 1500 rpm for 5 minutes and finally either 
cultured or processed for polymerase chain reaction (PCR) analysis of VEGF 
receptor.  Cells were in all instances, cultured in a humidified atmosphere with 5% 
CO2 at 37
OC in 12- or 96- well plates (Nuclon, Nunc, Denmark) that had been pre-
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coated with Fibronectin (Sigma, Dorset UK). Cells were cultured under serum free 
conditions (Gutierrez, Campbell, & Webb 1997b) in  McCoys 5a with 0.02M 
HEPES, 3mM L-Glutamine, 0.1% BSA, 1ml/100ml Pen/Strep, and ITS (10ng/ml 
bovine insulin 2.5mg/L transferrin and 4µg/L sodium selenite). Cell numbers were 
determined using a haemocytometer and viability was assessed using trypan blue 
exclusion. Typical viability before plating ranged from 30 to 40%. In addition, 
during initial validation of the culture system, granulosa cell steroid secretion 
(oestradiol and progesterone) was measured and both the levels of steroid production 
and cell morphology were found to be similar to those described by Gutierrez et al 
1997 (Gutierrez, Campbell, & Webb 1997b). 
 
2.3.2 Proliferation Assay  
 
  Granulosa cells from 4 to 8 mm follicles were plated in 96-well plates at a density 
of 50 000 cells per well in a total volume of 100µl of media for 24 hours prior to 
addition of treatments. Treatments were prepared in sterile 96 well plates which were 
equilibrated for 1 hour in the incubator before addition to cells. During each 
experiment, the following treatments were applied in triplicate: recombinant human 
VEGF (R&D Systems Minneapolis, USA; 0, 1, 10, 100 ng/ml), FSH (National 
Hormone and Peptide Program; Torrance, California, USA; 10 ng/ml), FSH (10 
ng/ml) in combination with VEGF (1 ng/ml), LH (National Hormone and Peptide 
Program; Torrance, California, USA; 10 ng/ml). Following 72 hour incubation with 
treatments and a single wash with pre-warmed culture media, cell proliferation was 
measured using Celltiter 96 Aqueous One Solution Cell Proliferation Assay 
(Promega, Southampton, UK), according to manufactures instructions. This assay 
uses a MTS Tetrazolium compound that is bio-reduced by cells into a coloured 
formazan product that is soluble in culture medium. This bio-reduction takes place in 
metabolically active cells, thereby allowing comparative analysis of viable cell 
numbers. Changes in colour were measured using a Wallac 1420 Multilabel Counter 
(Wallac, Turku, Finland). To correct for background absorbance a triplicate set of 
control wells containing culture media only were included and their absorbance was 
subtracted from the absorbance values of all other samples. 
 




2.3.3 Western blotting analyses of p-ERK1/2 
 
   Granulosa cell populations from 4 to 8 mm and 9 to 14mm follicles were plated at 
a density of 500, 000 cells per well in 12-well plates and allowed to settle for 24 
hours. Cells were then starved in culture media without ITS for another 24 hours. 
After starvation cells were washed with the same media and incubated in duplicate 
wells for 20 minutes at 37OC with VEGF (0.1, 1, 10, 100 ng/ml), EGF (Sigma, 
Dorset UK, 100ng/ml), LH (National Hormone and Peptide Program; Torrance, 
California, USA; 100 ng/ml) or media alone. In some experiments, cells were 
incubated for one hour with a selective VEGFR2 inhibitor, ZM323881 (final 
concentration 50µM, Merk Chemicals Ltd., Nottingham, UK) prior to addition of 
treatments. After incubation with treatments all cells were washed twice with ice 
cold PBS and lysed with 70µl of RIPA buffer (150 mm NaCl, 50 mm Tris, 1 mm 
EDTA, 1% Nonidet P-40, 0.5% sodium deoxycholate, 0.1% sodium dodecyl 
sulphate, 1 mM Na3VO4, and 1 mM NaF, pH 7.4) by gentle rocking at 4OC for 45 
minutes. Lysates were centrifuged for 5 minutes at 13,000 rpm to remove nuclei and 
cell debris. Protein lysates were stored at -20OC until required for immunoblotting. 
 
   Protein lysates were assayed for protein content using the DC protein assay kit 
(Bio-Rad Laboratories Inc. Hercules, CA). Twenty micrograms of protein from each 
lysate were heat-denatured in buffer containing 12% SDS, 40% glycerol, 30% â-
mercaptoethanol, 300mM DTT, 120mM EDTA, 1mg/ml bromophenol blue, 375 mM 
TrisCl, pH 6.8 for 5 minutes at 100OC before being separated on a 12% SDS-
Polyacrylamide gel that was run at 150 volts for approximately 45 minutes (or until 
tracking dye neared bottom of plates). Prior to transfer, filter paper was soaked in 
transfer buffer (25nM Tris, 192mM glycine, 20% methanol) at 4OC and a PVDF 
membrane was activated in 100% methanol for 15 seconds and then placed into 
transfer buffer. After running SDS-PAGE, the gel was immediately equilibrated in 
transfer buffer for 10 minutes. Proteins were then transferred onto PDVF membranes 
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using the semi-dry blotting apparatus, Trans-Blot SD (Bio-Rad Laboratories Ltd, 
Hemel Hempstead, UK), at 10 volts/80mA for 70 minutes at room temperature.  
 
   Following transfer, membranes were blocked for 2 hours in a solution (10mM Tris, 
100mM NaCl, 0.2% Tween-20) containing 5% BSA and incubated overnight at room 
temperature with Phospho-p44/42 MAP Kinase antibody (Cell Signalling 
Technology Inc., Beverly, MA) diluted 1:3000 in the same solution but with 1% 
BSA. After primary antibody incubation, membranes were washed (5 times, 5 
minutes per wash) with Tris Buffered Saline (TBS).  Membranes were incubated 
with Horseradish Peroxidase (HRP)-conjugated anti-rabbit anti-immunoglobulin 
(1:10,000; Amersham Biosciences, Buckinghamshire, UK) for 1 hour at room 
temperature with gentle rotation. Membranes were then washed in Nonidet p-40-Tris 
Buffered Saline (N-TBS) for 10 minutes, placed in a new container and washed with 
TBS for 5 minutes. These wash steps were repeated once before immune complexes 
were visualised using Super Signal West Femto maximum sensitivity detection 
system (Pierce Chemical Inc., Rockford, IL) and imaged using Fluro-S Scanning 
System (Bio-Rad Laboratories Ltd, Hemel Hempstead, UK). Densitometry analyses 
were done using Quantity One Analysis Software (Bio-Rad). 
 
2.3.4 QPCR analyses of CYP11A1 and COX-2 
 
   Granulosa cells were plated in 12-well plates at a density of 500, 000 cells per well 
and allowed to settle for 24 hours. Cells were then incubated in duplicate wells with 
media alone, FSH (10ng/ml) or LH (100ng/ml), VEGF (1, 10 or 100 ng/ml) or with a 
combination of FSH (10ng/ml) or LH (10ng/ml) and VEGF (1ng/ml). In some 
experiments, granulosa cells were pre-incubated with VEGFR2 inhibitor 
(ZM323881) for 1 hour prior to addition of treatments.  
 
   After a 48 h-incubation, total RNA was extracted using RNeasy Mini Kit (Quiagen, 
Sussex, UK). Cells were lysed by addition of 350µl of buffer RLT (containing â-
Mercaptoethanol, 1%) and homogenised by passage through a 20-gauge needle 10 
times. In brief, the RNA purification procedure is based on silica-gel membrane 
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technology where total RNA is adsorbed to the silica gel membrane in the presence 
of chaotropic salts which remove water from hydrated molecules in solution. 
Polysaccharides and proteins are not adsorbed and are removed. After washing, RNA 
is eluted in small volumes under low salt conditions. RNA concentration and quality 
were checked using a NanoDrop (ND-1000) spectrophotometer (NanoDrop 
Technologies Inc, Wilmington, DE, USA). Total RNA was stored at -80OC until 
cDNA synthesis.  
 
   First strand cDNA synthesis was conducted by incubating 500ng of Random 
Primers (Promega, Madison, WI, USA), 10mM dNTP mixture (Bioline, London, 
UK), and 0.5 µg of RNA at 65OC for 5min and then adding 5X First-Strand Buffer, 
0.1mM DTT, 40 units RNaseOUT Recombinant RNase Inhibitor (Invitrogen Corp., 
Carlsbad, CA) and 400 units SuperScript III Reverse Transcriptase (Invitrogen Corp., 
Carlsbad, CA). This mixture was incubated at 25OC for 5 minutes and then at 50OC 
for 60 minutes.  The reaction was inactivated by heating at 70OC for 15 minutes. 
Complementary DNA was stored at -20OC until required for PCR. To exclude the 
presence of contaminating genomic DNA, all reverse transcription reactions included 
a control that lacked the Superscript III enzyme. Water was used as a negative 
control.  
 
   Quantitation of CYP11A1 and COX-2 mRNA levels were carried out using Real-
Time PCR (RT-PCR). Oligonucleotide primers for 18S (ribosomal housekeeping 
gene), CYP11A1 and COX-2 were designed using LightCycler Probe Design 
software from bovine-specific sequences obtained from a gene database 
(http://www.ncbi.nlm.nih.gov). Primers were obtained from Eurogentec Ltd. 
(Hampshire, UK) and are shown in table 1. Primers were first validated to ensure 
amplification of a single fragment of the expected size. This was done using fresh 
granulosa cell samples by semi-quantitative PCR as described below 
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Table 2.1.  Primers used to amplify specific bovine transcripts 
 
   Amplification of each bovine transcript was done using Quantace SensiMix dT kit 
(Quantace, London, UK). PCR reactions were performed in a total volume of 12.5µl, 
containing 1µl of cDNA and 11.5µl of SYBR® Green mastermix and specific 
primers (final concentration 200nM) using a quantitative PCR machine, Statagene 
Mx3000p. A set of standards were created using 3µl of cDNA from a pool of fresh 
granulosa cell samples and included the following dilutions: 1:2, 1:4, 1:8, 1:16, 1:32, 
1:64 and 1:128. Each sample was run in duplicate at a 1:20 dilution for quantification 
of 18S and a 1:4 dilution for quantification of CYP11A1 and COX-2. Also included in 
the PCR reaction were duplicate samples without cDNA template (non-template 
controls) and duplicate reverse transcriptase controls. PCR cycles consisted of 10 
minutes at 95OC, followed by 40 cycles of 15s at 95OC, 60OC for 30s and 72OC for 
30s.  
 
   RT-PCR results were analysed using Mx3000p software. Copy numbers from each 
sample were obtained from the corresponding Ct values (the first reaction cycle at 
which an increase in template amplification can be detected) by extrapolation from a 
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values were normalised to the 18S value for each sample. Within each experiment, 
CYP11A1 and COX-2 expression were calculated relative to the value in untreated 
controls which was taken as 1. 
 
2.3.5 Semi-quantitative PCR of VEGFR1 and VEGFR2  
 
Semi-Quantitative PCR was done on three pools of fresh granulosa cells and one 
pool of follicle wall cells from follicles of various sizes (4 to 14mm). Semi 
Quantitative PCR conditions were: 4 min 30 sec at 95OC, followed by 15 cycles 
(18S) or 30 cycles (VEGFR1 and VEGFR2) of 30 sec at 95OC, 30 sec at 55OC and 30 
sec at 72OC. A final inactivation step at 72OC for 4 minutes and 30 sec was also 
carried out. PCR products were run on a 2.5% agarose gel.  
 
2.4 Statistical Analyses 
 
For cell proliferation data, percentage increases over untreated controls were 
calculated in each experiment and used for statistical analyses. For any other 
endpoints, responses to treatments were expressed as fold-increase over values in 
untreated controls. Dixons test was used to identify suspected outlier values within 
data sets. These values were then excluded from subsequent analyses.  The 
Kolmogorov-Smirnov normality test was applied to each data set (P < 0.01). Data 
that were not normally distributed were log transformed. Data were then analysed by 
General Linear Model procedure using Minitab 15 statistical software package 
(Minitab Ltd. Coventry, UK) to determine main effect of treatment using each 
individual experiment as a block. If the main effect was significant (P < 0.05) or 
tended to be significant (P < 0.1), pair-wise multiple comparisons of the means were 
performed using Tukeys test to establish differences among groups. Comparisons 
involving only two treatment groups were done by unpaired T test. Significance was 
considered at P < 0.05 whereas values between P = 0.1 and P = 0.05 were considered 
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2.5 Results 
 
2.5.1 VEGFR expression in bovine granulosa cells   
 
   As detected by semi-quantitative PCR (figure 2.1), fresh bovine granulosa cell 
pools showed expression of both VEGFR1 and VEGFR2.  Transcript levels for the 
two receptors were lower in granulosa cells than in follicle wall lysates.  
 
 
Figure 2.1. Specific PCR products for VEGFR1, VEGFR2 and 18S in pools of freshly collected walls 
and granulosa cells from bovine follicles 4 to 14 mm (n = 12 follicles). 
 
 
2.5.2 Effects of VEGF on granulosa cell proliferation 
 
A dose-dependent effect of VEGF treatment on granulosa cell proliferation was 
observed (Figure 2.2). On average, granulosa cell proliferation was significantly 
induced by 1 ng/ml VEGF dose (24% over untreated controls; P = 0.024) but there 
were no detectable responses to 10 or 100 ng/ml VEGF (P > 0.1). As expected, FSH 
(10ng/ml) induced a significant proliferative response (40%; P < 0.0001) whereas 
LH did not (P > 0.1). Co-administration of FSH (10ng/ml) and VEGF (1ng/ml) 
resulted in a cell proliferation response that was 2.4-fold that elicited by FSH alone 
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Figure 2.2. Proliferation response (mean % ± SEM; n = 3 to 12 experiments) of bovine granulosa 
cells collected from 4-8mm follicles to different VEGF doses (1, 10 and 100 ng/ml), FSH (10 ng/ml), 
a combination of FSH (10 ng/ml) and VEGF (1 ng/ml), and LH (10 ng/ml). There was an overall 
effect of treatment, P < 0.0001. A star denotes a significant difference from untreated control (P < 
0.05). Means with different letters (a, b) are different (P < 0.05) 
 
2.5.3 ERK1/2 phosphorylation in response to VEGF 
 
   Exposure of cultured bovine granulosa cells to 0, 1, 10 or 100 ng/ml VEGF 
resulted in a dose-dependent increase in p-ERK 1/2 (p < 0.002), with the highest 
response being induced by the 100 ng/ml dose (3.2-fold over untreated controls; 
Figure 2.3). On average, this response was about 65 % the response induced by 100 
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Figure 2.3 Representative immunoblot and mean (± S.E) band intensities of p-ERK 1/2 after 
treatment of bovine granulosa cells collected from follicles 4 to 8 mm with different doses of VEGF 
(1, 10 and 100 ng/ml; n = 3 to 9 experiments).  EGF, 100 ng/ml treatment was included as a positive 
control. Statistical analyses was done of data from groups treated with VEGF (0 to 100 ng/ml) and 
indicated a significant effect of treatment (P<0.002). A star on a mean responses to VEGF treatment 
denotes a significant difference from untreated controls (P < 0.03). 
 
 
2.5.4 Effects of VEGF on expression of CYP11A1 and COX-2  
 
Expression of CYP11A1 in cultured bovine granulosa cells collected from follicles 4 
to 8 mm did not change in response to VEGF concentrations of 1, 10 or 100 ng/ml (P 
> 0.1) (figure 2.4). In contrast, FSH (10 ng/ml; P < 0.001), but not LH (P > 0.1) 
significantly increased the expression of CYP11A1. The response to FSH (about 2.8-
fold relative to controls) was not significantly affected by co-stimulation with VEGF 
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Figure 2.4. Fold-increase in CYP11A1 expression (mean ± SEM; n = 4 to 13 experiments) in response 
to different doses of VEGF (1, 10 and 100 ng/ml), FSH (10 ng/ml), LH (10 ng/ml) or a combination 
of FSH (10 ng/ml) and VEGF (1 ng/ml) in cultured granulosa cells from bovine follicles 4 to 8 mm. 
There was an effect of treatment (P < 0.00001), A star denotes a significant difference from untreated 
controls (P < 0.0001). 
 
   Treatment of granulosa cells collected from 9 to 14 mm follicles with 1 ng/ml of 
VEGF induced a significant increase in COX-2 expression (approximately 1.8 fold) 
compared to untreated control (P = 0.003) (figure 2.5). Neither of the 10 or 100 
ng/ml VEGF doses had a significant effect on COX-2 expression (P > 0.1). The 
response to 1 ng/ml VEGF was similar to that induced by LH (100 ng/ml). However, 
co-stimulation of cells with LH (10 ng/ml) and VEGF (1 ng/ml) resulted in a 
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Figure 2.5. Fold-increase in COX-2 expression (mean ± SEM; n = 3 to 8 experiments) in response to 
different doses of VEGF (1, 10 and 100 ng/ml), LH (10 ng/ml) or a combination of LH (10 ng/ml) and 
VEGF (1 ng/ml) in cultured bovine granulosa cells collected from 9-14mm follicles. There was a 
significant effect of treatment (P < 0.0001) A star denotes a significant difference from untreated 
control (P < 0.004).  Means with different letters (a, b) are significantly different (P <0.002). 
 
2.5.5 Effect of ZM323881 on LH-induced ERK1/2 phosphorylation  
 
   Levels of p-ERK in granulosa cells from 9 to 14 mm follicles increased relative to 
controls in response to LH treatment (P = 0.003) but did not increase in LH-treated 
cells that were pre-incubated with the VEGFR2 inhibitor, ZM323881 (50µM; P = 
0.27 Figure 2.6, A). Exposure of granulosa cells to ZM323881 alone did not alter p-
ERK levels (P > 0.9). As expected, an increase in p-ERK in response to VEGF 
occurred in the absence (P = 0.0001) but not in the presence (P = 0.2694) of 
ZM323881 (Figure 2.6, B). In contrast, EGF stimulated p-ERK both in the absence 































































Figure 2.6. Representative Immunoblots and mean (± SEM, n = 3 to 5 assays) band intensities of p-
ERK in cultured bovine granulosa cells collected from 9-14mm follicles and  exposed to LH (100 
ng/ml, A), VEGF (100 ng/ml, B) and EGF (100 ng/ml, C) in the presence or absence of ZM323881 
(50µM). Within each graph, levels of p-ERK for each treatment group are shown relative to treatment 
with VEGF, LH or EGF. There was an overall effect of treatment on p-ERK levels in all cases (A: P = 
< 0.0001, B: P = 0.001, C: <0.0001). Means with different letters (a, b) within a graph are 
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2.5.6 Effect of ZM323881 on LH-induced COX-2  
 
   There was a significant increase in COX-2 in response to LH stimulation of 
granulosa cells from 9 to 14mm follicles (100 ng/ml: P = 0.0007) that was abolished 
by pre-incubating cells with ZM323881 (50µM, P = 0.017) (figure 2.7). Treatment of 





















Figure 2.7. Fold increase in COX-2 mRNA (mean ± SEM; n = 3 experiments) in cultured bovine 
granulosa cells collected from 9-14 mm follicles and exposed to LH (100 ng/ml) and/or ZM323881 
(50µM). There was an overall effect of treatment (P = 0.001) on COX-2 expression. Means with 




























































   Treatment of primates with VEGF antagonists has demonstrated that VEGF is an 
absolute requirement for the completion of follicle development (Hazzard, Xu, & 
Stouffer 2002) (Fraser, Wilson, Rudge et al. 2005). It has been observed that 1) the 
avascular granulosa cell layer is a major site of VEGF production within the follicle 
(Geva & Jaffe 2000; Grasselli, Basini, Bussolati et al. 2002), 2) these cells express 
VEGF receptors (Greenaway, Connor, Pedersen et al. 2004), an observation that we 
have confirmed in the present study and 3) the expression of both VEGF and VEGF 
receptors in granulosa cells markedly increase in selected (dominant) follicles 
(Ginther, Gastal, Gastal et al. 2004b; Greenaway, Connor, Pedersen et al. 2004). 
These observations led us to more precisely investigate in vitro the direct effects that 
physiological doses of VEGF, alone or in combination with gonadotrophins, may 
have in specific responses of granulosa cells during development and ovulation of 
the dominant follicle. Proliferative and steroidogenic responses to the follicle 
selection-associated increase in VEGF levels were investigated in vitro using 
granulosa cells from follicles 4 to 8 mm in diameter, corresponding to diameters just 
before selection of the dominant follicle, whereas potential effects of VEGF on the 
peri-ovulatory increase in COX2 expression were assessed in cells collected from 
follicles with a diameter close to that before ovulation (9 to 14 mm).    
 
   VEGF concentrations in bovine follicular fluid were reported to be about 1 ng/ml 
in follicles 5-7 mm and concentrations increased  to 5 ng/ml in follicles 12-14 mm 
(Einspanier, Schonfelder, Muller et al. 2002). In another study (Grazul-Bilska, 
Navanukraw, Johnson et al. 2007) mean intrafollicular VEGF concentrations in 
oestrogen-active follicles with a mean diameter of 8.6 mm (corresponding to the 
beginning of dominance) were 1.2 ng/ml, whereas oestrogen-inactive follicles (mean 
diameter, 11.3 mm) had a mean VEGF concentration of 0.5 ng/ml. In comparison, 
VEGF levels in follicular fluid from preovulatory follicles have been reported to 
range between 0.7 and 7 ng/ml in primates (Asimakopoulos, Nikolettos, Papachristou 
et al. 2005; Anasti, Kalantaridou, Kimzey et al. 1998; Hazzard, Molskness, Chaffin 
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et al. 1999) and between 3 and 10 ng/ml in pigs (Barboni, Turriani, Galeati et al. 
2000); (Galeati, Spinaci, Govoni et al. 2003). Thus, the doses of VEGF used in this 
study (1, 10 and 100 ng/ml) were chosen to encompass the expected range of 
concentrations found within the developing bovine dominant follicle.   
 
   To our knowledge, this study showed for the first time that VEGF dose-
dependently induces proliferation of bovine granulosa cells. This is consistent with 
results with porcine granulosa cells (Grasselli, Basini, Bussolati et al. 2002) and with 
a variety of other non-endothelial cell types (Zhu, Jin, Mao et al 2003; Gaudio, 
Barbaro, Alvaro et al. 2006; Wilgus, Matthies, Radek et al. 2005; Chen, Qian, Wu et 
al. 2007). A concentration of VEGF of 1 ng/ml resulted in a significant proliferative 
response of granulosa cells whereas higher VEGF concentrations (10 and 100 ng/ml) 
abolished all proliferative effects. In a previous study, Greenaway et al (2004) found 
that VEGF increased the survival of granulosa cells but had no effect on cell 
proliferation. We speculate that the concentrations of VEGF used in the Greenaway 
study (50 and 100 ng/ml) were above the range of concentrations expected to 
stimulate cell proliferation.  
 
   In the present study, co-administration of FSH (10 ng/ml) and VEGF (1 ng/ml) 
resulted in a 2.4 fold increase in cell proliferation relative to FSH treatment alone, 
thus indicating that VEGF potentiates the effects of FSH. Consistent with this result, 
co-treatment of bovine cumulus-oocyte complexes with FSH and VEGF in vitro 
resulted in enhanced blastocyst formation compared to FSH alone (Einspanier, 
Schonfelder, Muller et al. 2002). The results on induction of cell proliferation by 
VEGF in the present study suggest that the differential increases in VEGF and VEGF 
receptor expression in granulosa cells during follicle selection (Einspanier, 
Schonfelder, Muller et al. 2002; Ginther, Gastal, Gastal et al. 2004b) act in 
combination with FSH to enhance cell proliferation thus promoting the continuous 
growth of the dominant follicle in a similar manner to what has been shown for other 
growth factors such as IGF-I (Gutierrez, Campbell, & Webb 1997b). Presumably, 
once VEGF concentrations (and VEGF receptor expression in granulosa cells) reach 
their highest levels in preovulatory follicles, a stimulatory effect on cell proliferation 
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may no longer occur, a suggestion that is in keeping with the cease in cell 
proliferation associated with the terminal differentiation of follicular cells during 
ovulation (Richards 1980).  
 
   Since VEGF stimulates proliferation of endothelial cells via VEGFR2 activation of 
ERK 1/2 (Byrne, Bouchier-Hayes, & Harmey 2005) we investigated whether VEGF 
induced ERK activation in granulosa cells. VEGF treatment did result in a dose-
dependant increase in phosphorylation of ERK 1/2 with a maximal effect induced by 
the 100 ng/ml dose of VEGF. The apparent dissociation between ERK 1/2 activation 
and proliferative responses at the higher VEGF doses (10 and 100 ng/ml) may be 
explained by the role of ERK 1/2 signalling in both proliferation and differentiation 
responses of cells (Vaudry, Stork, Lazarovici et al. 2002), including granulosa cells 
in which an increase in ERK1/2 activity in preovulatory follicles mediates cell cycle 
arrest and terminal cell differentiation (Su, Nyegaard, Overgaard et al. 2006). 
 
We then examined the potential involvement of VEGF in another granulosa cell 
response in selected follicles, P450scc expression. A predominant feature of the 
selection process is a pronounced increase in steroid production by the dominant 
follicle (Reviewed by Beg & Ginther 2006). In cattle, this increase is largely 
accounted for by an increase in mRNA for P450scc in granulosa and theca cells 
(Tian, Berndtson, & Fortune 1995). In the present study, in contrast to FSH, VEGF 
did not induce CYP11A1 expression at any concentration used. In a study with 
porcine granulosa cells, however, VEGF induced an increase in oestradiol production 
by granulosa cells (Grasselli, Basini, Bussolati et al. 2002). Whether induction of 
oestradiol production by VEGF involved an increase in P450scc was not analysed in 
that study. The precise role of VEGF in follicular cell steroidogenesis and whether 
such a role varies in different species warrants further investigation. 
 
   We also examined the effects of VEGF on a hallmark granulosa cell response 
associated with ovulation, COX2 expression. COX2 acts as a key rate-limiting step 
in the production of prostaglandins which are critical for the rupture of the 
preovulatory follicle in response to the ovulatory LH surge (Reviewed by Espey & 
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Richards 2006). COX2 is a component of the temporal inflammatory response 
associated with ovulation and as such is only transiently induced in the ovulatory 
follicle in response to the ovulatory gonadotrophin surge, and this occurs both in 
vivo and in vitro (Hedin, Gaddy-Kurten, Kurten et al. 1987; Duffy & Stouffer 2001; 
Joyce, Pendola, O'Brien et al. 2001; Richards 1997; Sirois 1994; Sirois & Dore 1997; 
Sirois & Richards 1992; Wong & Richards 1991). In bovine ovulatory follicles the 
induction of COX2 occurs some 28-30 hours post-hCG treatment (Sirois, Sayasith, 
Brown et al. 2004). VEGF has been shown to be involved in upregulation of COX2 
in endothelial (Tamura, Sebastian, Gurates et al. 2002) and non-endothelial cells 
(Wijayagunawardane, Kodithuwakku, Yamamoto et al. 2005).  Treatment of bovine 
oviductal cells, with 1 ng/ml VEGF induced a significant increase in COX2 as well 
as stimulating the synthesis and release of prostaglandins E2 and F2á and 
Endothelin-1, leading to the conclusion that VEGF may enable proper oviduct 
contraction and transport of gametes in the oviduct (Wijayagunawardane, 
Kodithuwakku, Yamamoto et al. 2005). In the present study we found that treatment 
of cultured granulosa cells from bovine pre-ovulatory size follicles (9-14 mm in 
diameter) with 1 ng/ml VEGF stimulated a significant increase in COX2 (about 1.8-
fold relative to controls). This increase was similar to that induced by treatment with 
LH (10 ng/ml), suggesting that VEGF, in addition to LH, may regulate the peri-
ovulatory increase in follicular COX2. The reason for the absence of a COX2 
response to stimulation of granulosa cells simultaneously with VEGF and LH in the 
present study is not known, although it is conceivable that a stimulation threshold 
exists above which VEGF is no longer induced. This possibility would be consistent 
with the need for fine-tuned intracellular mechanisms that ensure that the peri-
ovulatory increase in COX2 expression is only transient. 
 
   The results on COX2 induction in the present study raised the possibility of a 
potential interplay between VEGF and LH in preovulatory follicles similar to that 
described between LH and the EGF system (Conti, Hsieh, Park et al. 2006). In 
particular, the EGF receptor has been shown to mediate the LH induction of specific 
ovulatory-associated responses, among them COX2 induction. To address this, we 
evaluated the effects of specific VEGFR2 inhibition with ZM323881 on LH 
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responses in granulosa cells from pre-ovulatory size follicles (9 to 14mm), namely 
phosphorylation of ERK1/2 and induction of COX2.  The induction of p-ERK1/2 by 
100 ng/ml LH was consistent with previous results on granulosa cells from 
preovulatory follicles (Salvador, Maizels, Hales et al. 2002) and with the reported 
role of ERK1/2 activation in mediating LH-induced differentiation of granulosa cells 
(Su, Nyegaard, Overgaard et al. 2006). Inhibition of VEGFR2 severely restricted the 
ability of LH to stimulate ERK phosphorylation in granulosa cells (approximately 
1.67-fold) compared to LH alone (2.5-fold). The observed effect was presumably 
specific to VEGFR2 because the same inhibitor also abolished ERK1/2 activation by 
VEGF but not by a different RTK, (EGFR). Previous studies showed that inhibition 
of the EGFR has similar effects on gonadotrophin-induced ERK1/2 activation in 
granulosa cells (Andric & Ascoli 2006). The effects of VEGFR inhibition on 
immediate cell signalling responses (p-ERK1/2) to LH was associated with similar 
effects on a longer-term response, namely COX2 induction, as inhibition of VEGFR2 
completely abolished the ability of LH to stimulate COX2 mRNA.  These findings 
are consistent with an involvement of ERK1/2 activation on COX2 induction in 
cumulus granulosa cells (Hsieh & Conti 2005). 
 
   The mechanism(s) by which VEGFR may mediate the effects of LH in these cells 
needs to be examined. In relation to the EGFR, a model has been proposed whereby 
LH stimulation of granulosa cells in the pre-ovulatory follicle induces the expression 
of EGF-like growth factors which then act in a paracrine or juxtacrine manner to 
activate the EGFR (Conti, Hsieh, Park et al. 2006). It has been shown that for LH to 
elicit maturation of the mouse oocyte EGFR must be phosphorylated (Park, Su, 
Ariga et al. 2004). An additional mechanism by which EGF seems to mediate some 
of the actions of LH in follicles is LH-induced shedding of cell membrane-bound 
EGF-like growth factors that could then act on target cells (Andric & Ascoli 2006). 
Such release or shedding of growth factors from the extracellular matrix (ECM) is 
believed to involve specific membrane-bound matrix metalloproteinases that induce 
proteolytic cleavage of growth factor molecules at the cell surface (Ashkenazi, Cao, 
Motola et al. 2005; Hsieh & Conti 2005; Prenzel, Zwick, Daub et al. 1999; Roelle, 
Grosse, Aigner et al. 2003). 
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Based on previous results, any or both of the two mechanisms outlined above, i.e., 
induction of growth factor expression in follicular cells and stimulation of growth 
factor release from follicular cell membrane stores, may explain the effects of 
VEGFR on LH-induced COX2 observed in this study. In particular, LH is known to 
stimulate VEGF synthesis from granulosa cells both in vivo and in vitro (Christenson 
& Stouffer 1997; Schams, Kosmann, Berisha et al. 2001). In addition, as in the case 
of EGF-like growth factors, large molecular weight isoforms of VEGF are bound to 
the ECM whereas small (bioactive) isoform are freely diffusible (Park, Keller, & 
Ferrara 1993). In this way, the ECM can sequester and act as a reservoir for VEGF 
(Houck, Leung, Rowland et al. 1992). Cleavage of VEGF from the ECM has been 
reported to involve the action of matrix metalloproteinases (Bergers, Brekken, 
McMahon et al. 2000; Lee, Jilani, Nikolova et al. 2005; Rodriguez-Manzaneque, 
Lane, Ortega et al. 2001). Although the specific MMPs involved in ligand-shedding 
depends on the cell type (Hsieh & Conti 2005), one interesting observation is that 
MMP9 seems to be commonly involved in cleavage of both EGF and VEGF 
(Bergers, Brekken, McMahon et al. 2000; Lee, Jilani, Nikolova 2005; Rodriguez-
Manzaneque, Lane et al. 2001; Roelle, Grosse, Aigner et al. 2003). It would therefore 
be of interest to further investigate the involvement of MMP9 in VEGFR 
transactivation using specific MMP inhibitors. In other studies, matrix 
metalloproteinase activity has been shown to be required for LH-mediated EGFR 
stimulation (Ashkenazi, Cao, Motola et al 2005; Panigone, Hsieh, Fu et al. 2008; 
Woods & Johnson 2007) where inhibition of MMP activity abolished or severely 
reduced the LH-induced phosphorylation of EGFR. Therefore, based on the findings 
above, it can be hypothesized that the LH preovulatory surge acts to increase VEGF 
expression by granulosa cells and at the same time stimulates the release of pre-
existing VEGF from ECM stores. This increases the availability of bioactive VEGF 
to induce some of the responses associated with ovulation. Further studies will be 
needed to test this hypothesis.  
 
   In contrast to the effects on COX2 expression, the effects of VEGFR inhibition on 
LH-induced p-ERK1/2 in granulosa cells were exerted within a very short period of  
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time (<20 mins) and therefore may not be explained by stimulation of de novo-
production of VEGF by LH. In a previous study, an MMP inhibitor abolished an 
immediate increase (within 20 min) in p-ERK1/2 in response to LH (Andric & 
Ascoli 2006) suggesting that release of growth factor ligand from ECM stores is 
involved in this response. An additional mechanism that may explain the role of 
VEGFR on the immediate activation of p-ERK1/2 by LH involves Src tyrosine 
kinases. Numerous examples have been described of Src tyrosine kinases playing a 
role in transactivation of RTKs by GPCRs (Luttrell & Luttrell 2004), and it is known 
that Src TKs can be activated by gonadotrophins in granulosa cells (Wayne, Fan, 
Cheng et al. 2007).  The involvement of Src tyrosine kinases in transactivation of 
RTKs by the LH surge in granulosa cells should be explored further.   
 
   In summary, a concentration of VEGF (1 ng/ml) equivalent to levels found 
physiologically in bovine dominant follicles acted to induce proliferation of bovine 
granulosa cells from 4 to 8 mm follicles and did not increase the expression of the 
steroidogenic enzyme, P450scc. The effect of VEGF on proliferation was associated 
with an increase in ERK1/2 activation in those cells. Treatment of granulosa cells 
from dominant-size follicles (9 to 14 mm in diameter) with the same dose of VEGF 
up-regulated the expression of COX2. In addition, pre-treatment of these cells with a 
selective VEGFR2 inhibitor (ZM323881) resulted in a significant reduction in the 
ability of LH to induce ERK phosphorylation and a complete block on the ability of 
LH to stimulate COX2 expression. The results of this study clearly demonstrate 
potentially important roles of VEGF, independent of its angiogenic effects, at 
different stages during the development of the dominant follicle, and particularly 
suggest a role of VEGFR2 in mediating ovulatory responses induced by the 
gonadotrophin surge similar to what has been described for EGFR. 
   
 









Expression of Gá subunits and PLCâ isoforms in bovine 
granulosa cells throughout antral follicle development. 
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3.1 Abstract 
 
   Previous reports suggest that VEGF exerts its effects through not only Receptor 
Tyrosine Kinases (RTKs) but also via interactions with specific heterotrimeric G-
proteins and PLCâ isoforms. To investigate whether such intracellular cross-talk may 
mediate some of the effects of VEGF shown in Chapter 2, we first examined the 
expression of heterotrimeric G-protein á subunits (GNAS, GNAQ, GNA11, and 
GNAI1, 2 and 3) and PLCâ isoforms 1 to 4 in bovine granulosa cells throughout 
follicle development. Results showed that GNAS, GNA11 and GNAI2 were all 
expressed at significantly (P < 0.05) higher levels in granulosa cells of large follicles 
(10.0 to 13.9 mm) than in cells from small (2.0 to 5.9 mm) and medium (6.0 to 9.9 
mm) size follicles. In addition, all PLCB isoforms except PLCB2 were expressed in 
bovine granulosa cells with PLCB3 being more abundant than PLCB 1 and 4.  Levels 
of PLCB3 in granulosa cells from large follicles were very high (>16-fold; P < 
0.005) compared to medium or small follicles. Immunocytochemical analysis 
revealed that PLCB3 was located primarily in the cytoplasm, whereas PLCB1 was 
distributed primarily in the nucleus. In conclusion, this study identified GNAS, 
GNA11 and GNAI2 and PLCB3 as potentially involved in cross-talk between VEGF 
and G protein signalling pathways during the development of the dominant follicle. 
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3.2 Introduction 
 
   The studies described in Chapter 2 indicated that, in addition to directly stimulating 
bovine granulosa cell responses, VEGF modulates the effects of gonadotrophins on 
these cells. Specifically, when granulosa cells were co-stimulated with VEGF and 
gonadotrophins, VEGF enhanced the proliferative effects of FSH and inhibited LH-
induced expression of COX2. These results prompted the investigation of potential 
cross-talking between VEGF and gonadotrophin signalling pathways in these cells, 
as described in the present chapter and Chapter 4.  
 
   The receptors for FSH (FSHR) and LH (LHR) belong to the G-protein-coupled 
receptor (GPCR) superfamily and signal primarily through adenylate cyclase 
activation by the heterotrimeric G protein type, Gs, and possibly through an 
additional pathway involving Gi/Gq activation of Phospholipase Câ (PLCâ) 
(Herrlich, Kuhn, Grosse et al. 1996; Kuhn & Gudermann 1999; Rajagopalan-Gupta, 
Lamm, Mukherjee et al. 1998). VEGF is recognised to elicit its effects via two 
receptor tyrosine kinases (VEGFR1 and VEGFR2), which signal through activation 
of Phospholipase Cã (PLCã) and Raf-MEK-MAP pathways (Petrova, Makinen, & 
Alitalo 1999). Cross-talk between GPCR and RTK signalling pathways is well 
characterised in relation to GPCR transactivation of RTKs (Reviewed by Luttrell, 
Daaka, & Lefkowitz 1999). This includes LH transactivation of EGF receptor, a 
phenomenon that has been shown to be involved in granulosa differentiation and 
oocyte activation during the peri-ovulatory period (Reviewed by Conti, Hsieh, Park, 
& Su 2006). 
 
   Accumulating evidence indicates that cross-talk between GPCR and RTKs may 
also occur in the other direction, that is, through activation of specific hetrotrimeric 
G proteins by different RTKs (Reviewed in Patel 2004)). In the case of VEGFR, 
Mukhopadhyay and associates  provided evidence that in endothelial cell lines, 
VEGF induced cell proliferation and migration via VEGFR2 interactions with  
Gáq/11 and PLC-â (rather than via the classical RTK-activated PLC-ã pathway) 
(Mukhopadhyay, Zeng, & Bhattacharya 2004). In the same study, it was shown that 
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the Gi inhibitor, pertussis toxin (PTX), abolished VEGFR1 mediated MAPK 
phosphorylation but had no effect on VEGFR2 mediated MAPK phosphorylation. 
Those results indicated that Gq/11 proteins are involved in VEGFR2-mediated 
responses, whilst PTX-sensitive Gi/o proteins are involved in responses mediated by 
VEGFR1. In another study, a requirement for another heterotrimeric G-protein, 
Gá13, during VEGF stimulated endothelial cell migration was reported (Shan, Chen, 
Wang, Tan, Gu, & Huang 2006). Overall, these observations are important because 
they indicate signalling roles for heterotrimeric G proteins in addition to their known 
involvement in GPCR pathways. Whether VEGFR activation of heterotrimeric G-
proteins is a more general signalling mechanism involved in the physiological effects 
of VEGF in other cell types has not been reported to date. In that regard, granulosa 
cells provide a suitable primary culture model to study such interactions.   
 
   Human granulosa cells (Lopez Bernal, Bellinger, Marshall et al. 1995; Saltarelli 
1999) and porcine follicular membranes (Rajagopalan-Gupta, Lamm, Mukherjee et 
al. 1998) were shown to express the G protein types, Gás, Gái1, Gái2, Gái3, Gáq 
and Gá11, whereas in addition, bovine luteal membranes were found to express, 
Gá12 and Gá13 (Herrlich, Kuhn, Grosse et al. 1996). Expression of Gáo was found 
in some of these studies (Saltarelli 1999) but not in others (Herrlich, Kuhn, Grosse et 
al. 1996; Lopez Bernal, Bellinger, Marshall et al. 1995). All known isoforms of 
PLCâ (PLCâ1 through 4), which are activated by G proteins, were reportedly 
identified in porcine granulosa cells (Lieberherr, Grosse, & Machelon 1999).  
 
   Any of these G protein types and PLCâ isoforms may be involved in mediating the 
actions of VEGF on granulosa cells during the development of the dominant follicle. 
To address this question more precisely, temporal expression patterns of Gá subunits 
and PLCâ isoforms in bovine granulosa cells during follicle development need to be 
characterised and to our knowledge this has not been done. The aims of this study 
were therefore to 1) establish which G protein á subunits and PLCâ isoforms are 
expressed by bovine granulosa cells and 2) determine changes in expression of these 
signalling molecules throughout the development of the dominant follicle.  
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 3.3 Materials and Methods 
 
3.3.1 Collection of fresh granulosa cell samples for gene expression 
 
   Granulosa cells were obtained from bovine ovaries as described in Chapter 2 and 
kept on ice throughout to prevent protein and RNA degradation. Granulosa cells 
were isolated from follicles of different size categories as small (2.0 to 5.9 mm), 
medium (6.0 to 9.9 mm) and large (10.0 to 13.9 mm). The largest follicle of a wave 
becomes dominant when it reaches 8.0 to 9.0 mm (Ginther 2000), therefore, the 
chosen diameter ranges corresponded to before the emergence of the dominant 
follicle (small follicles), beginning of dominance (medium follicles), and established 
dominance or preovulatory stage (large follicles). Fourteen different sets of samples 
including the three diameter categories were obtained from different ovarian 
collections on different days. Within each set, separate granulosa cell pools were 
obtained from small follicles (5 to 27 follicles per pool) and medium follicles (4 to 
20 follicles per pool), whereas large follicles were processed individually. This was 
done to increase the number of cells collected from small and medium follicles to 
numbers comparable to those from large follicles. Half of the cells obtained from 
each diameter range were processed for RNA extraction and the other half were used 
for isolation of protein. 
 
3.3.2 QPCR analysis of Gá subunits and PLCB isoforms 
 
   RNA extraction, cDNA synthesis, primer validation and QPCR were carried out 
according to the methodologies described in chapter 2. Primers (Table 3.1) were 
obtained from Eurogentec Ltd. (Hampshire, UK). Messenger RNA levels for Gás, 
Gáq, Gá11, Gái1, Gái2 and Gái3 were analysed because these specific Gá subunits 
have been previously identified in follicular cells from human and pig (Lopez Bernal, 
Bellinger, Marshall, Phaneuf, Europe-Finner, Asboth, & Barlow 1995) (Rajagopalan-
Gupta, Lamm, Mukherjee, Rasenick, & Hunzicker-Dunn 1998). The four PLCâ 
isoforms were also analysed. LHR was quantified because is a hallmark of healthy, 
growing dominant follicles (Bao & Garverick 1998;Bao, Garverick, Smith et al. 
1997). Data from large follicles that had LHR expression levels less than 3-fold 
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higher the levels in medium follicles from the same collection were discarded. This 
criterion was based on results from previous studies on LHR expression during 
follicular waves (Beg & Ginther 2006). 
 













































































































Within each sample set, before statistical analyses expression data for each follicle 
size were normalised to the corresponding value for small follicles which was taken 
as 1.  
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3.3.3 Western Blotting Analysis of Gá subunits and PLBâ3 
 
   Protein lysates were processed and western blotting procedure was carried out 
using the methodologies previously described in chapter 2 with the following 
modifications. Cell lysis was carried out in the absence of phosphatase inhibitors. 
Protein lysates were run on separate 7.5% and 12% SDS-Polyacrylamide gels for 
subsequent immunoblotting with PLCâ3 and Gá antibodies, respectively (table 3.2). 
Following blocking, membranes were incubated overnight at room temperature with 
the appropriate antibody (see table 2). Prior to this incubation, membranes derived 
from 7.5% gels were cut horizontally into two portions for separate detection of 
PLCB3 (150kDa) and â-Tubulin (55kDa).  Following antibody incubations, 
membranes were washed, imaged and analysed as described in chapter 2. 
Membranes derived from 12% gels were stripped and re-blotted to allow sequential 
detection of Gás, Gáq/11, Gái and â-Tubulin. Stripping was done by rinsing 
membranes twice for 5 minutes in TBS and then washing for 2 hours with constant 
agitation in stripping solution (0.2M Glycine pH 2.0, 0.1% SDS, 0.1% Tween-20). 
Membranes were then washed twice in TBS for 10 minutes before they were 
incubated in 3% blocking buffer for 2 hours and subsequently re-probed with the 
appropriate primary antibody.  
 
3.3.4 Immunocytochemical Analysis of PLCB1 and 3. 
 
   Immunocytochemistry was performed to investigate the sub-cellular localisation of 
PLCâ1 and 3. Bovine granulosa cells from large follicles were plated in glass Lab-
Tek chamber slides (Nunc Inc., Rochester, NY, USA) that had been pre-coated with 
fibronectin (Sigma) at a density of 0.2 million cells per chamber. Following 24 hours 
in culture, cells were washed with Phosphate Buffered Saline (PBS) and fixed with 
500µl 4% Paraformaldehyde (PFA) for 20 minutes at room temperature. Cells were 
again washed with PBS and permeabilised with 500µl 100% ethanol for 5 minutes at 
room temperature. Cells were washed twice with PBS. Five hundred µl blocking 
buffer (10% Normal Goat Serum (NGS), 0.1% Tween in PBS) were then added to 
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each chamber and incubated at room temperature for 1 hour. After aspiration of 
blocking buffer, anti-PLCâ1 (1:50 diluted in blocking buffer solution, anti-rabbit, 
Santa Cruz) or anti-PLCâ3 (1:200 diluted in blocking buffer solution, anti-rabbit, 
Santa Cruz) antibody was added to each chamber (table3.2). Chamber slides were 
incubated at 4OC overnight with gentle agitation. The following day, cells were 
washed twice with PBS for 5 minutes. One hundred µl of secondary antibody was 
added (1:80 diluted in PBS, Anti-Rabbit IgG Fluorescein Isothiocyanate (FITC) 
conjugate, Sigma) to each chamber and incubated in the dark at room temperature for 
1 hour. In each slide, one control chamber was included containing PBS instead of 
primary antibody. Following incubation, cells were washed twice with PBS for 10 
minutes. Chamber walls were removed and 25µl of VECTASHIELD with DAPI, 4, 
6  diamidino-2-phenylindole (Vector Laboratories Inc, Bulingame, CA, USA) were 
dispensed onto each slide and a cover slide was applied prior to viewing using a 
Nikon EC1 inverted microscope (Nikon, Melville, N.Y, USA). Images were 
processed using Nikon EZ-C1 software. 
 











â-Tubulin 55 1:1000 Rabbit Cell Signalling Technology Inc 
Gás 43-45 & 48-52 1:1000 Rabbit Millipore/Upstate 
Gáq/11 42 1:500 Rabbit Santa Cruz Biotechnology 
Gái 1/2 40 1:1000 Rabbit Millipore/Upstate 
PLCâ1 150 1:50 Rabbit Santa Cruz Biotechnology 
PLCâ3 150 1:200 Rabbit Santa Cruz Biotechnology 
 
3.4 Statistical Analysis 
 
   Dixons test was used to identify suspected outlier values within data sets (P < 
0.01). These values were then excluded from subsequent analyses. The Kolmogorov-
Smirnov normality test was applied to each data set to asses whether data were 
normally distributed. Data not normally distributed (P < 0.01) were log transformed. 
Data were then analysed by General Linear Model using Minitab 15 statistical 
software package (Minitab Ltd. Coventry, UK) to determine the main effect of 
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follicle size in each case and using sample set as a block. If follicle size effect was 
significant (P < 0.05) or tended to be significant (P < 0.1), pairwise comparisons of 




3.5.1 Gá subunit and LH Receptor mRNA levels during follicle development  
  
3.5.1.1 LHR and GNAS  
 
   A total of 9 large follicle samples were discarded because of their reduced LHR 
expression, according to criteria indicated above. In the remaining samples, an 
overall mean increase in LHR expression in fresh bovine granulosa cells during 
follicle development was observed (P < 0.001; Figure 3.1A). Granulosa cells from 
small follicles expressed only residual levels of LHR, while granulosa cells from 
large follicles expressed LHR at levels that were approximately 250 fold greater than 
found in granulosa cells of medium follicles (P < 0.001).  There was an overall effect 
of follicle size on GNAS expression in granulosa cells (P = 0.04; Figure 3.1B) with 
approximately 1.4-fold higher GNAS expression in large than in small or medium 
















Figure 3.1.  LHR (A) and GNAS (B) levels (mean ± SEM) in fresh bovine granulosa cells from small, 
medium and large follicles (n = 5 to 13 pools per diameter category).  Within each sample set, 
expression levels for each diameter category were calculated relative to the value in small follicles, 
which was taken as 1. There was an effect of follicle size on LHR (P < 0.001) and GNAS (P = 0.04). 
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3.5.1.2 GNAQ and GNA11  
 
   There was no overall effect of follicle size on GNAQ expression (P = 0.2; Fig 
3.2A), although mean levels were approximately 1.6 fold higher in granulosa cells 
from large compared with small follicles. There was an effect for GNA11 (P = 0.027; 
Fig 3.2B) with approximately 1.5fold higher levels of GNA11 in granulosa cells of 













Figure 3.2. GNAQ (A) and GNA11 (B) levels (mean ±) in fresh bovine granulosa cells from small, 
medium and large follicles (n = 5 to 13 pools per diameter category). Within each sample set, 
expression levels for each diameter category were calculated relative to the value in small follicles, 
which was taken as 1. Levels of each gene are shown relative to the value in small follicles. There was 
an overall effect on GNA11 (P = 0.027). Within each graph, means with different letters (a, b) are 
significantly different (P < 0.05). 
 
 
3.5.1.3 GNAI 1, 2 and 3  
 
There was no effect (P > 0.5) of follicle size on GNAI1 (Figure 3.3 A) or GNAI3 
(Figure 3.3 C) expression in granulosa cells. There was however an overall effect of 
follicle size on GNAI2 expression (P = 0.03; Figure 3.3 B,) with approximately 1.6-
fold higher levels of GNAI2 expression in granulosa cells from large than small or 
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Figure 3.3. GNAI1 (A), GNAI2 (B) and GNAI3 
(C) expression (mean ± SEM) in fresh bovine 
granulosa cells from small, medium and large 
follicles  (n= 5 to 13 pools per diameter 
category). Within each sample set, expression 
levels for each diameter category were 
calculated relative to the value in small 
follicles, which was taken as 1.  Levels of each 
gene are shown relative to the value in small 
follicles. There was an overall effect of follicle 
size on GNAI2 (P = 0.028). Within each graph, 
means with different letters (a, b) are 
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3.5.2 Gá subunit protein levels during follicle development 
 
Representative blots for GNAS (short form and long forms, Figure 3.4A), 
GNAQ/GNA11 (Figure 3.4B) and GNAI1/GNAI2 (Figure 3.4C) are shown together 
with the corresponding â-Tubulin bands (loading control).  
There was an overall effect of follicle size for both GNAS (P < 0.0001) and 
GNAQ/GNA11 (P = 0.03) levels but not for GNAI1/GNAI2 levels (P = 0.28). 
Granulosa cells from large follicles contained approximately 2-fold higher GNAS 
than cells from small or medium follicles (P < 0.05). Similarly, GNAQ/GNA11 
levels were approximately 2-fold higher for large than for small or medium follicles 
(P =0.003), whereas GNAI1/GNAI2 levels were 1.6 fold higher (non-significant) in 




















































































Figure 3.4. GNAS (A), GNAQ/GNA11 (B) 
and GNAI1/GNAI2 (C) levels (mean ± 
SEM) in fresh bovine granulosa cells from 
small, medium and large follicles (n = 5 to 13 
pools per diameter category). Within each 
sample set, expression levels for each 
diameter category were calculated relative to 
the value in small follicles, which was taken 
as 1. There was an overall effect of follicle 
size on GNAS (P= < 0.001) and 
GNAQ/GNA11 (P = 0.003) respectively. 
Means with different letters (a, b) are 
significantly different (P < 0.05). 
Representative immunoblots are shown 
above corresponding charts with â-Tubulin 
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3.5.3 PLCB mRNA levels during follicle development 
 
   Semi-Quantitative PCR analyses of fresh bovine granulosa cells showed expression 
of PLCB1, 3 and 4 but not PLCB2 (Figure 3.5). PLCB3 was expressed at similar 
levels in granulosa cells and in positive controls (bovine brain and liver); whereas 
PLCB1 and PLCB4 were expressed at relatively lower levels in granulosa cells. 
Levels of PLCB4 were particularly low as they could only be detected at the highest 























Figure 3.6 shows changes in expression of PLCB1 (A) and PLCB3 (B) during follicle 
development. There was no overall change (P > 0.5) in expression of PLCB1 in 
granulosa cells during follicle growth whereas PLCB3 expression increased during 
follicle growth (P = 0.012) with approximately 1.6-fold higher levels of PLCB3 










PLCB1 (133 bp) 
 PLCB2 (256 bp) 
 PLCB3 (181 bp) 
PLCB4 (219 bp) 
Figure 3.5. Semi-quantitative PCR of PLCB isoforms. Lane 1 = PCR Markers, 
2 = Bovine Liver, 3 = Liver RT-, 4 = Bovine Brain, 5 = Brain RT-, 6 = Fresh  
Bovine Granulosa Cell pool (4-8mm follicles, n = 14), 7 = Fresh Bovine 















Figure 3.6. PLCB1 (A), and PLCB3 (B) expression (mean ± SEM) in fresh bovine granulosa cells 
from small, medium and large follicles (n = 5 to 13 pools per diameter category). Within each sample 
set, expression levels for each diameter category were calculated relative to the value in small 
follicles, which was taken as 1.  Levels of each gene are shown relative to the value in small follicles.   
There was an overall effect of follicle size on PLCB3 expression (P = 0.012). Within each graph, 
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3.5.4 PLCB3 protein levels during follicle development 
 
   Figure 3.7 shows representative blots of PLCB3 in granulosa cells from follicles of 
different diameters. There was an overall effect of follicle size on PLCB3 levels (P = 
0.004) with much higher (P < 0.05) levels of PLCB3 in granulosa cells from large 























Figure 3.7. PLCB3 levels (means ± SEM) in fresh bovine granulosa cells from small, medium and 
large follicles (n = 5 to 13 pools per diameter category). Within each sample set, expression levels for 
each diameter category were calculated relative to the value in small follicles, which was taken as 1. 
Levels of PLCB3 are shown relative to the value in small follicles. There was an overall effect of 
follicle size on PLCB3 levels (P = 0.004). Means with different letters (a, b) are significantly different 
(P < 0.05). Representative Immunoblot is shown above chart. 
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3.5.5 Immunocytochemical Analysis of PLCB3 and PLCB1 
 
Immunocytochemistry analysis of bovine granulosa cells showed predominant 
cytosolic localisation of PLCB3 (Figure 3.8, A-C). In contrast PLCB1 staining was 
relatively more abundant in the nucleus than in the cytoplasm of bovine granulosa 


















Figure 3.8. Immunofluorescence staining of PLCB3 (A to C) and PLCB1 (D to F) in cultured 
bovine granulosa cells (x40).  Representative pictures show secondary antibody-bound FITC 
(green) without (A, D) or with DAPI staining (blue; B, E) and DAPI-stained negative controls 
(C, F).  
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3.6 Discussion 
 
   This is to our knowledge, the first study to characterise the expression of 
heterotrimeric Gá subunits and PLCâ subunits during follicle development in any 
species. The dramatic increase in mean levels of LHR in large follicles confirmed 
that visual assessment of stage of development and health of follicles was adequate. 
Further, there was good agreement between changes in mRNA levels and protein 
levels for each specific gene during follicle development. The presence of Gás, Gáq, 
Gá11, and Gái1-3 in bovine granulosa cells is consistent with a previous report on 
human granulosa cells (Lopez Bernal, Bellinger, Marshall et al. 1995) and also 
agrees with results from studies with porcine follicular membranes (Rajagopalan-
Gupta, Lamm, Mukherjee et al. 1998) and bovine luteal membranes (Herrlich, Kuhn, 
Grosse et al. 1996).   
 
   The increase in the levels of both mRNA and protein for Gás in granulosa cells of 
large follicles was in agreement with the demonstrated involvement of cAMP 
signalling in ovulation and luteinisation of preovulatory follicles (Conti 2002; 
Richards, Fitzpatrick, Clemens et al. 1995). Because these processes presumably 
involve a transient but massive increase in AC activity mediated by Gás in granulosa 
cells in response to the elevated gonadotrophin levels of the preovulatory LH surge, 
an increase in levels of Gás in preovulatory follicles would be expected.  
 
   In addition to Gás, mRNA and protein levels of members of the Gáq/11 and Gái 
families also increased in large follicles, and this was associated with a very large 
increase in protein levels of PLCâ3. This result is consistent with abundant 
experimental data suggesting that exposure of preovulatory follicles to the elevated 
LH concentrations of the gonadotrophin surge results in the activation of not only the 
Gs-AC pathway but also the Gq/Gi-PLCâ pathway.  The ability to simultaneously 
activate different G proteins has been described for other GPCRs (Eason, Kurose, 
Holt et al. 1992; Laugwitz, Allgeier, Offermanns et al. 1996; Munshi, Pang, 
Sternweis et al. 1991). Specifically for the LHR, in vitro stimulation of rodent and 
pig granulosa cells with high doses of LH (100 ng/ml) resulted in a differential 
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increase in phosphoinositide production (Davis, Farese, & Clark 1983; Davis, 
Weakland, West et al. 1986) or intracellular calcium concentrations (Veldhuis & 
Klase 1982a; Veldhuis & Klase 1982b), both of which are products of PLCâ.  In 
addition, in the follicle, LH receptor has been shown to couple physically and 
functionally not only to Gás but also to Gáq/11, Gá13 and Gái in porcine ovarian 
follicular membranes (Rajagopalan-Gupta, Lamm, Mukherjee et al. 1998; 
Rajagopalan-Gupta, Rasenick, & Hunzicker-Dunn 1997) and to Gás  and Gái in 
luteal cells and LH-transfected cell lines (Herrlich, Kuhn, Grosse et al. 1996) . In 
addition it was recently shown that constitutive activation of Gáq produced 
granulosa cell differentiation responses similar to those induced by LH (Donadeu & 
Ascoli 2005).  Abundant evidence also indicates that PKC, an effector of PLCâ, is 
involved in LH-induced granulosa cell differentiation (Donadeu & Ascoli 2005; 
Flores & Veldhuis 1993; Morris & Richards 1993; Morris & Richards 1995; 
Richards, Fitzpatrick, Clemens et al. 1995; Sen, Choudhary, Inskeep et al. 2005). 
 
   The relative contribution of Gáq and Gá11 to the observed increase in protein 
levels detected by the Gáq/11 antibody is not known. Although there was an overall 
significant effect of follicle size on Gá11 but not on Gáq mRNA levels, the mean 
increase in mRNA levels was similar for each subunit (1.5- and 1.6fold, 
respectively), suggesting that both subunits may contribute similarly to the increase 
in Gáq/11 protein levels. In HeLa cells, Gá11 was 10 times more abundant than 
Gáq, however, both subunits contributed similarly to histamine-stimulated PLCâ 
activity (Krumins & Gilman 2006).  
 
   The present results indicated an increase in Gái2 levels but not in the levels of 
other Gái subunits in large follicles. In contrast to mRNA, only a minor (non-
significant) increase in Gái protein was detected because an isoform-specific 
antibody was not available and an antibody recognising both Gái subtypes 1 and 2 
was used. Immunocytochemistry studies in NIH 3T3 cells demonstrated that Gái2 
was located primarily at the cell surface membrane whereas Gái3 was concentrated 
around intracellular membranes (Golgi apparatus in particular) and was only found 
on the plasma membrane when over-expressed (Hermouet, de, Spiegel et al. 1992). 
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In another study, it was concluded that Gái2 was the principal mediator of the 
inhibition of AC in adipose cells, based on a relatively much lower efficiency of 
Gái1 and Gái3 to inhibit AC (Rudolph, Spicher, & Birnbaumer 1996). These results 
together with those of the current study suggest an important role of Gái2 relative to 
the other two Gái subtypes in signalling at the cell membrane level. 
 
   PLCâ isoforms are normally activated by á-subunits released upon Gq/11 
activation or âã subunits which are often derived from activation of Gi (Reviewed in 
Morris & Malbon 1999). Gáq/11 and Gâã reportedly have specific affinities for 
different PLCâ isoforms (Reviewed by Rebecchi & Pentyala 2000), specifically, 
Gáq/11 may preferentially activate PLCâ1, 3 and 4. All members of the Gáq/11 
family (Gáq, -11, -14 and -15/16) were shown to stimulate PLCâ1 whereas only 
Gá16 could activate PLCâ2 (Lee, Park, Wu et al. 1992; Park, Jhon, Kriz et al. 1992).  
PLCâ2 (but not PLCâ1) was also shown to be strongly activated by âã subunits 
(Boyer, Waldo, & Harden 1992; Camps, Carozzi, Schnabel et al. 1992; Katz, Wu, & 
Simon 1992). The specificity of such G-protein activation of PLCâ isoforms 
remained unclear since Gáq and Gá11 were later found to stimulate PLCâ2 whilst âã 
subunits were found to activate PLCâ1 (Hepler, Kozasa, Smrcka et al.  1993;Smrcka 
& Sternweis 1993). Although PLCâ isoforms are differentially sensitive to particular 
Gáq related proteins, this sensitivity is not specific and Gáq related proteins can have 
promiscuous associations with PLCâ isoforms (Rebecchi & Pentyala 2000; Xu, 
Croy, Zeng et al. 1998). It is apparent that G protein-PLCâ coupling specificities 
depend on the cell context. In addition, consideration should be given to the fact that 
the aforementioned studies were carried out in cell lines and that the observations of 
PLC enzymatic activities in vivo or in primary cell culture systems may be different.  
 
   In the current study, PLCâ isoforms 1 and 3 and, at very low levels, PLCâ 4, were 
found to be expressed in bovine granulosa cells. This is in contrast with the findings 
of (Lieberherr, Grosse, & Machelon 1999) who found that all four PLCâ isoforms, 
including PLCâ2, were expressed in porcine granulosa cells. In support of our 
findings, PLCâ1 and 3 isoforms are known to be widely expressed in body tissues 
whereas PLCB4 is less widely expressed, with highest concentrations being found in 
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the brain and retina (Reviewed by Rebecchi & Pentyala 2000). In contrast, PLCâ2 
expression has previously been shown to be restricted to cells of hematopoetic origin 
(Lee, Rao, Lee et al. 1996; Li, Jiang, Xie et al. 2000). The present results are also 
consistent with the report by Zhong et al (2005) who found that PLCâ3 is the 
predominant PLCâ isoform in rat myometrial tissue (Zhong, Ku, & Sanborn 2005). 
Taken together these results suggest important functions of PLCâ3 in the female 
reproductive tract. There was no increase in PLCâ1 mRNA levels during follicle 
growth. In contrast, PLCâ3 expression increased during follicle growth with very 
high levels of PLCâ3 protein in granulosa cells of large compared to small or 
medium follicles.  
 
   Some PLCâ isoforms can be distinctly expressed in the cell membrane or nuclear 
compartments. Specifically, two alternatively spliced variants of PLCâ1, PLCB1a 
and PLCB1b, have been described in human, and they are preferentially expressed in 
the cytoplasm and nucleus respectively (Bahk, Song, Baek et al. 1998). Nuclear 
PLCâ1b seems to have an important role in cell differentiation processes (Faenza, 
Bregoli, Ramazzotti et al. 2008). Therefore, we investigated the subcellular 
localisation of the increase in PLCâ3 in granulosa cells by immunocytochemistry. In 
contrast to PLCâ1, most PLCâ3 staining was localised to the cytoplasm of granulosa 
cells in large follicles, consistent with an involvement of the high PLCâ3 levels in 
plasma membrane receptor-mediated cell differentiation. Overall, the present results 
on PLCâ suggest an important role of PLCâ3 in ovulation and/or luteinisation.     
 
   In summary, the results described in the current study characterise for the first 
time, the expression of heterotrimeric G-protein alpha subunits and PLCâ isoforms 
during follicle development. Results demonstrate that the granulosa cell expression 
of Gás, Gá11, Gái2 and, especially, PLCâ3 increase in dominant follicles providing 
support for a physiological role of the heterotrimeric G-protein/PLCâ cascade(s) in 
the final development and/or subsequent differentiation of dominant follicles. Further 
studies described in Chapter 4 investigate whether this cascade is functionally 
involved in the actions of VEGF in dominant follicles. 
 









Cross-Talk between VEGF and heterotrimeric G-protein 
signalling pathways in bovine granulosa cells.  
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4.1 Abstract  
 
Results in chapter 3 demonstrated an increase in the levels of Gái, Gáq/11 and 
PLCB3 in bovine granulosa cells of dominant-size follicles (9-14 mm) compared to 
smaller follicles. The aim of this study was to investigate the potential involvement 
of these signalling molecules on VEGF-induced responses in granulosa cells from 9-
14 mm follicles. Results showed that VEGF induced a 1.6fold mean increase in p-
ERK (P < 0.0001). Inhibition of Gi with PTX (pertussis toxin) completely abolished 
VEGF-induced p-ERK to levels that were not different from those in untreated cells 
(P > 0.8). Inhibition of Gq/11 with YM-25489 (specific Gq/11 inhibitor) partially 
abolished the VEGF-induced p-ERK response (1.6-fold mean increase relative to 
untreated controls; P = 0.039). LH induced a 1.6fold increase in p-ERK1/2 (P < 
0.02) and this response was prevented by pre-incubation with PTX (P > 0.4) or YM-
25489 (P > 0.5). In contrast, similar EGF-induced phosphorylation of ERK (about 5-
fold relative to controls) occurred in the absence (P < 0.003) or presence of PTX (P < 
0.003) or YM-25489 (P < 0.003).  Transfection of granulosa cells with a combination 
of 3 siRNA targeting PLCB3 resulted after 48 h in approximately 40% reduction (P < 
0.005) in levels of PLCB3 protein as determined by western blotting and 
immunocytochemistry. However, transfection with PLCB3 siRNAs did not have an 
effect (P = > 0.7) on phosphorylation of ERK in response to VEGF, LH or EGF in 
granulosa cells.  In conclusion, the results of this study suggest a functional role of 
Gi and Gq/11 in VEGF stimulation of the ERK1/2 in bovine granulosa cells 
indicating that the stimulatory effects of VEGF on follicle development may be 
mediated, at least in part, by heterotrimeric G proteins.
 




   Results in Chapter 2 indicated novel and potentially important non-angiogenic 
roles of VEGF during the selection and ovulation of the dominant follicle. However, 
very little is known about the intracellular signals induced by VEGF in non-
endothelial cell types. The biological activities of VEGF are mediated through its 
two receptor tyrosine kinases, VEGFR1 and VEGFR2. Ligand binding results in 
receptor phosphorylation and subsequent activation of intracellular effector pathways 
including Phospholipase C ã (PLC ã), Phosphatidyl-inositol 3-kinase (PI-3K) and 
P38 pathways (Reviewed by Cross, Dixelius, Matsumoto et al. 2003; Takahashi & 
Shibuya 2005). 
 
   In addition to the classical model for RTK signalling, evidence has accumulated 
that a number of RTKs can act through activation of heterotrimeric G-protein 
pathways (reviewed by Patel 2004). For example the phosphorylated epidermal 
growth factor receptor (EGFR) has been shown to activate the Gi/o (Johnson & 
Garrison 1987; Rashed & Patel 1991) and Gs (Sun, Chen, Poppleton et al. 1997; Sun, 
Seyer, & Patel 1995) families. Similarly, platelet derived growth factor receptor 
(PDGFR) signalling in smooth muscle cells seems to involve Gi, as treatment of cells 
with the Gi/o-specific inhibitor, pertussi toxin (PTX) results in a 40% reduction in 
the ability of PDGF to activate ERK (Conway, Rakhit, Pyne et al. 1999).  
 
   Zeng and associates (2003) demonstrated an involvement of G11 and Gâã in 
VEGF-stimulated migration of human umbilical vein endothelial cells (HUVEC) 
mediated through activation of VEGFR2/RhoA (Zeng, Zhao, & Mukhopadhyay 
2002a). An interaction between G11 and VEGFR2 was also found to regulate both 
phosphorylation of VEGFR2 and subsequent VEGF-stimulated proliferation and 
ERK1/2 activation in HUVEC (Zeng, Zhao, Yang et al. 2003). In contrast, VEGFR1 
was found to inhibit HUVEC proliferation and this effect was mediated by a receptor 
interaction with Gi (Zeng, Dvorak, & Mukhopadhyay 2001a). It was concluded from 
these studies that signalling by VEGFR1 and VEGFR2 involves activation of Gi/o 
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and Gq/11, respectively. Other studies have found that Gi is involved in VEGFR1-
mediated migration of macrophages (Barleon, Sozzani, Zhou et al. 1996) or basic 
fibroblast growth factor (bFGF)-stimulated chemotaxis in bovine aortic cells (Sa & 
Fox 1994).  In light of present evidence, clarification of the precise roles of the 
Gq/11 and Gi families in VEGF signalling is clearly needed.  
 
   Not only heterotrimeric G-proteins but also its effectors have been suggested to be 
involved in VEGFR signalling. Specifically, there is evidence to suggest that, in 
addition to canonically activating PLCã, VEGF can also interact with and activate 
PLCâ isoforms. Evidence of this was provided by a study using HUVEC in which 
stimulation with VEGF led to an increase in intracellular calcium within 40 seconds 
(Mukhopadhyay, Zeng, & Bhattacharya 2004). However, PLCã phosphorylation was 
not reportedly detected until approximately 5 minutes after VEGF stimulation, 
therefore, the activities of other enzymes, namely PLCâ isoforms were tested in 
VEGF- stimulated endothelial cells. Results indicated no significant changes in the 
catalytic activities of PLCâ1, PLCâ2 or PLCã, but an increase in the catalytic 
activity of PLCB3 within 20 seconds of VEGF stimulation with a peak in activity 
after approximately 60 seconds (Mukhopadhyay, Zeng, & Bhattacharya 2004). These 
findings suggested a role for PLCB3, rather than PLCã, in VEGF-stimulated 
intracellular calcium release in these cells.  
 
   As indicated, evidence for a role of G proteins/PLCâ isoforms in VEGFR 
signalling has been obtained in studies using immortalised cell systems. In that 
regard, primary granulosa cell cultures provide a valuable model system that may be 
more physiologically relevant. Results in Chapter 3 demonstrated an increase in the 
expression of Gáq/11, Gái2 and PLCB3 in pre-ovulatory size follicles in which the 
expression of VEGF and VEGF receptors is also highest (Kaczmarek, Schams, & 
Ziecik 2005; Greenaway, Connor, Pedersen et al. 2004). The temporal association 
between these proteins in preovulatory follicles is consistent with the functional 
interactions between the two signalling systems described in HUVEC. The objective 
of the present study was to functionally test the actual involvement of Gq/11, Gi and 
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PLCB3 on VEGF responses of granulosa cells by assessing the effect of specific 
inhibitors of Gáq/11, Gái2 or PLCB3 on VEGF-induced phosphorylation of ERK. 
 
4.3 Materials and Methods 
 
4.3.1 Culture and transfection of Granulosa Cells 
 
   Granulosa cells from 9-14 mm follicles were collected and cultured as described in 
chapter 2. Twenty four hours after plating granulosa cells were starved overnight and 
then treated with VEGF (100 ng/ml), LH (100 ng/ml), EGF (100 ng/ml) or media 
only for 20 minutes at 37OC in the presence or absence of Gi inhibitor (Pertussis 
Toxin, PTX, 100 ng/ml, Sigma) or a selective Gáq/11 inhibitor, YM-254890 (final 
concentration 100µM, gifted by Professor Robert Millar, MRC, Human 
Reproductive Sciences Unit, Edinburgh). PTX and YM-254890 were added to cells 
24 h and 1 h before administration of treatments, respectively.  After incubation cells 
were lysed, and protein collected for western blotting as described in chapter 2. 
 
   In another set of experiments, 500, 000 cells per well were cultured in McCoys 
media (Sigma, Dorset, UK) in 12 well plates (Nuclon, Nunc, Roskilde, Denmark). 
One day later, culture media was replaced and HiPerFect reagent (Qiagen, Sussex, 
UK) was used to transfect cells with 30nM of each of the three PLCB3 siRNAs 
(Eurofins MWG Operon, London, UK) or 90nM of scrambled oligonulceotide 
(Allstars, Qiagen) according to manufacturers protocol. Media was replaced 24 
hours post transfection and plates were incubated for either 48 or 72 h before cells 
were lysed for protein collection or processed for immunocytochemistry. The three 
siRNA sequences were designed using a web based design tool, BLOCK iT RNAi 
designer (Invitrogen Corp, CA, USA) to target different regions of PLCB3 (table 4.1) 
that had no homology with other PLCÂ isoforms   
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Sequence of Nucleotide 
siRNA 1 Sense 5-GGAACACCUUCUUGCGCAA-3 
siRNA 1 Antisense 5-UUGCGCAAGAAGGUGUUCC-3 
siRNA 2 Sense 5-GCAGCUCAUGGAUUUCAUU-3 
siRNA 2 Antisense 5-AAUGAAAUCCAUGAGCUGC-3 
siRNA 3 Sense 5-GCAUCCUGGUGAAGAACAA-3 
siRNA 3 Antisense 5-UUGUUCUUCACCAGGAUGC-3 
 
4.3.2 Western blotting Analysis of ERK 1/2 and PLCB3  
 
   Western blotting of p-ERK/1, PLCB3 and â-Tubulin was done using procedures 
and reagents described in Chapter 2 and 3. For detection of total ERK, similar 
procedures were followed using a primary antibody (Cell Signalling Inc, Beverly, 
MA) at a dilution of 1:1000 and a secondary Horseradish Peroxidase (HRP)-
conjugated anti-rabbit anti-immunoglobulin (Amersham Biosciences, 
Buckinghamshire, UK) at a dilution of. 1:10,000. The proportion of phosphorylated 
ERK within a protein sample was calculated by dividing the numerical value for 
band intensity of phosphorylated ERK by that of Total ERK.  
 
4.3.3 Immunocytochemical Analysis of PLCB3 
 
Immunofluorescence of cells transfected with scrambled oligonucleotide or PLCB3 
siRNA for 48 hours was carried out as described in chapter 3.  
 
4.4 Statistical Analysis 
 
   Dixons test was used to identify suspected outlier values within data sets (P<0.01). 
These values were then excluded from subsequent analyses. The Kolmogorov-
Smirnov normality test was applied to each data set to asses whether data were 
normally distributed. Data not normally distributed (P<0.01) were log transformed. 
Data were analysed using General Linear Model (Minitab Ltd. Coventry, UK) to 
determine the main effect of treatment considering each replicate as a block. For 
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analysis of siRNA data, the interaction of treatment by siRNA was also determined. 
If main effect(s) or an interaction were significant (P<0.05) or tended to be 
significant (P<0.1), pair-wise comparisons of means were performed using Tukeys 





4.5.1 Effect of PTX and YM-254890 on VEGF stimulation of p-ERK 
 
   Exposure of cultured bovine granulosa cells to VEGF (100 ng/ml) induced an 
increase in p-ERK relative to untreated granulosa cells (P < 0.0001 Figure 4.1, A). 
PTX (100 ng/ml) completely abolished the effect of VEGF treatment on p-ERK, 
resulting in p-ERK levels similar to those in untreated granulosa cells (P > 0.8). In 
the presence of YM-254890 (100µM), VEGF induced a 1.6 fold increase in p-ERK 
(P = 0.039), which was on average lower (P = 0.06) to that induced by VEGF alone 
(2.3-fold). Treatment with PTX or YM-254890 alone had no significant effects on p-
ERK (P > 0.5). 
 
   Treatment with LH (100 ng/ml) induced an increase in p-ERK levels (2.5-fold; P = 
0.0115) similar to that induced by VEGF alone (Figure 4.1, B). In contrast, LH failed 
to induced phosphorylation of ERK in the presence of either PTX (P >0.4) or YM-
254890 (P > 0.5). 
 
   EGF treatment induced a 5.0-fold increase in p-ERK (P = 0.0029, Figure 4.1, C), 
similar to the increase induced by EGF in the presence of PTX (P < 0.003) or YM-
























































Figure 4.1. Representative immunoblots and mean (± SEM, n = 3 to 7 assays) band intensities of p-
ERK in bovine granulosa cells exposed to VEGF (100 ng/ml, A), LH (100 ng/ml, B) and EGF (100 
ng/ml, C) in the presence or absence of PTX (100 ng/ml) or YM-254890 (100µM). In each 
experiment, values for p-ERK were calculated relative to the value in cells treated with VEGF (A), 
LH (B) or EGF (C) alone. There was an overall effect of treatment on p-ERK levels in all cases (A: 
P = < 0.0001, B: P = 0.025 C: P = 0.001). *, ** or *** denotes statistical significance compared to 
untreated (P < 0.02, < 0.003 and < 0.0001, respectively). The same amount of protein was loaded 
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4.5.2 Effects of PLCB3 siRNA on PLCB3 expression 
 
As shown in Figure 4.2, PLCB3 levels were lower in PLCB3 siRNA- than 
scrambled oligonucleotide-transfected cells by 48 hours (mean, 0.41 % decrease; P = 













































Figure 4.2. PLCB3 band intensities (Mean ± SEM) in bovine granulosa cells 48 h and 72 h 
after transfection with PLCB3 siRNA or scrambled oligonucleotide (90 nM, n = 4 
experiments).  *denotes a significant difference (P < 0.005) between treatments within a time 
point. PLCâ3 band intensities were calculated relative to â-Tubulin 
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Immunofluorescence analysis of PLCB3 48 h after transfection of granulosa cells 
with PLCB3 siRNA revealed a marked decrease in PLCB3 staining relative to cells 




















4.5.3 Effect of PLCB3 siRNA on VEGF stimulation of ERK 
 
Treatment of granulosa cells with VEGF (P = 0.0009) or EGF (P < 0.0001), but 
not LH (P > 0.9), resulted in a significant increase in p-ERK. In all cases, p-ERK 
responses were not different (P>0.7) between scrambled oligonucleotide- and 





Figure 4.3. Immunodetection of PLCB3 in cultured bovine granulosa cells 48h after 
transfection with PLCâ3 siRNA (90nM; A, B) or scrambled oligonucleotide (C, D, E). 
Representative micrographs (x40) of cells incubated with PLCB3 antibody and FITC-bound 
secondary antibody without (A, C) or with DAPI (B, D) are shown, as well as negative 
control cells incubated with FITC-bound secondary antibody and stained with DAPI (E). 
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   The signalling mechanisms of VEGF are complex and as yet have not been fully 
elucidated, in particular in non-endothelial cell types. To our knowledge this study 
provides the first evidence of a link between the VEGF and the heterotrimeric G-
protein signalling systems in the developing follicle. In the present study, p-ERK 
activation was used as a functional endpoint because it is a robust indicator of 
VEGFR activity in granulosa cells (as shown in Chapter 2), as in other cells (Kilic, 
Kilic, Jarve et al. 2006; Xu, Liu, Jiang et al. 2008; Gupta, Kshirsagar, Li et al. 1999) 
and because p-ERK plays an important role during the development of dominant 
follicles, most notably in mediating cell differentiation in the preovulatory follicle 
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Figure 4.4. p-ERK band intensities corrected for total ERK (mean ± SEM; n =3 to 4 
experiments) in bovine granulosa cells transfected with scrambled oligonucleotides, 90 
nM (grey shading) or PLCÂ3 siRNA, 90 nM (black shading) for 48h and treated with 
VEGF (100 ng/ml), LH (100 ng/ml) or EGF (100 ng/ml) for 20 minutes. There was a 
main effect of treatment (P < 0.0001) but no effect of transfection (P > 0.2) or an 
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   The results of the current study indicate for the first time that inhibition of either Gi 
or Gq/11 has a profound effect on the ability of VEGF to stimulate ERK 
phosphorylation in granulosa cells. Pre-incubation with the Gi inhibitor, PTX, 
completely abolished the response to VEGF, thus indicating that Gi is a requirement 
for effective VEGF activation of the ERK pathway in these cells. Although the 
Gq/11 inhibitor, YM-254890, also markedly reduced ERK phosphorylation in 
response to VEGF, it did not completely abolish the p-ERK response (1.6-fold 
increase compared to 2.3fold increase in VEGF alone-treated cells). These results 
may indicate a stricter requirement of Gi than Gq/11 for VEGF induction of p-
ERK1/2 in granulosa cells, however, the possibility that these differences may result 
from different abilities of the two inhibitors to effectively block the function of their 
targets should also be considered. Nevertheless, these findings are consistent with the 
results of Zeng et al (2003) who showed that RNAi-mediated G11 silencing resulted 
in inhibition of ERK1/2 phosphorylation by VEGF through VEGFR2 in HUVEC 
(Zeng, Zhao, Yang et al. 2003). In contrast, Gi was shown to be involved in down-
regulation of HUVEC proliferation although not via VEGFR2 but via VEGFR1 
(Zeng, Dvorak, & Mukhopadhyay 2001a). In other studies, EGF was shown to 
activate ERK in theca cells in a PTX sensitive manner (Budnik, Brunswig-
Spickenheier, & Mukhopadhyay 2003), whereas the insulin receptor has been 
reported to associate with both Gi (Ciaraldi & Maisel 1989; Krupinski, Rajaram, 
Lakonishok et al. 1988; O'Brien, Houslay, Milligan et al. 1987; Rothenberg & Kahn 
1988) and Gq/11 (Imamura, Vollenweider, Egawa et al. 1999; Kanzaki, Watson, 
Artemyev et al. 2000) to mediate the actions of insulin.  
 
   To determine the specificity of inhibition of Gq/11 and Gi on VEGF responses, the 
effects on LH and EGF-induced p-ERK were also analysed. LH and EGF are known 
to induce robust p-ERK responses in granulosa cells (Keel & Davis 1999; Salvador, 
Maizels, Hales et al. 2002; Woods & Johnson 2007) and this was confirmed in 
chapter 2 of this thesis. It has been suggested that in addition to Gs, Gi (Herrlich, 
Kuhn, Grosse et al. 1996; Kuhn & Gudermann 1999; Rajagopalan-Gupta, Lamm, 
Mukherjee et al. 1998) and Gq/11 (Rajagopalan-Gupta, Lamm, Mukherjee, et al. 
1998) are involved in LH signalling. The results of the current study are in agreement 
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with those suggestions as LH failed to stimulate ERK phosphorylation in the 
presence of PTX or YM-254890., 
   EGFR has been shown to couple to different heterotrimeric G-proteins depending 
on the type of tissue in which it is expressed. For example, in the heart EGFR has 
been shown to couple to Gs (Nair, Parikh, Milligan et al. 1990; Nair, Rashed, & Patel 
1993), whereas in the liver this receptor is known to couple to the Gi/o family 
(Johnson & Garrison 1987; Liang & Garrison 1991; Rashed & Patel 1991). In the 
current study, neither Gi nor Gq/11 were found to be involved in EGF stimulation of 
p-ERK, however the possible involvement of other G-proteins can not be ruled out. 
Taken together, the present and previous results are consistent with a tissue-specific 
involvement of different G proteins in EGF signalling. 
 
   Both Gq (through Gá) and Gi (through Gâã) are putative intracellular activators of 
PLCâ isoforms (Rhee 2001) and since PLCB3 is the predominant PLCâ isoform in 
granulosa cells of dominant-sized follicles (as demonstrated by results in chapter 3), 
it is reasonable to assume that interactions of VEGF with Gq and/or Gi may activate 
PLCB3 in these cells. Results by Mukhopadhyay et al (2004) suggested that in 
HUVEC, VEGF signalling was mediated via PLCB3. In the current study we tested 
the hypothesis that VEGF signalling in bovine granulosa cells was also mediated by 
PLCB3.  
 
   Although the three siRNA sequences targeting PLCB3 in this study did not 
completely abolish the levels of target protein after transfection (40% 
downregulation), in another recent study, transfection of myometrial cells with a 
PLCB3 shRNA reduced PLCB3 expression by only 40 to 50% and this was 
sufficient for functional silencing as shown by approximately 40% attenuation of an 
oxytocin-stimulated increase in intracellular calcium levels (Zhong, Murtazina, 
Phillips et al. 2008). In spite of those findings, in the present study there was no 
effect of PLCB3 silencing on phosphorylation of ERK induced by VEGF, as well as 
by LH or EGF. This initially suggested that the mechanisms of VEGF signalling in 
granulosa and HUVEC may differ. Unexpectedly, LH stimulation of scrambled 
oligonucleotide-transfected granulosa cells also did not induce any significant 
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response in p-ERK. In addition, it should be noted that although the response of 
granulosa cells to VEGF in this experiment was similar to that in earlier experiments 
(approximately 2-fold increase in p-ERK compared to untreated controls), the 
increase in p-ERK in response to EGF was substantially lower (approximately 1.7-
fold relative to untreated cells) than typically observed previously (5-fold; Figures 
4.1(A) and 4.1(C)). Because of the apparently low responses of cells to LH and EGF, 
the results of this experiment should be interpreted with caution. 
 
   The reason(s) for the reduced cell responses in the present experiment is not 
known. During the studies described in this thesis, ovaries collected at the abattoir 
usually provided not only granulosa cells but also cumulus-oocyte complexes 
(COCs) that were used in simultaneous studies in another laboratory. Interestingly, in 
this particular case, the collected COCs were reported to be of unusually poor quality 
and did not respond well to IVM treatments (Allison Ainslie, SAC, personal 
communication). These observations together with the poor responses of granulosa 
cells suggest that the ovaries collected for these specific experiments were, for 
unknown reasons, of unprecedented and unexpected poor quality, and indicate the 
need to repeat these tests to clarify the present results.  
 
   Although the present results did not allow any conclusions on the precise 
involvement of PLCB3 in VEGF signalling in granulosa cells, they did provide 
strong evidence that Gái and Gáq/11 are required for VEGF-induced 
phosphorylation of ERK in these cells. The nature of the potential interaction 
between VEGFR and G proteins needs clarification. For other RTKs including EGF 
and IGF/IGF-I receptors a mechanism has been described whereby binding of ligand 
to the receptor causes membrane-associated heterotrimeric G-proteins to dissociate 
into á and âã subunits and subsequent activation of downstream effector targets, 
similar to the mechanism, involved in GPCR signalling (Reviewed by Patel 2004). In 
the case of VEGFR2, it was reported that receptor activation of G11 is required for 
and precedes receptor tyrosine kinase activity (Zeng, Zhao, Yang et al. 2003). In 
support of a GPCR-like mechanism of G protein activation by RTKs, sequencing 
data has revealed that both EGFR and â-adrenergic receptor contains short amino 
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acid sequences that are consensus for Gs binding (Okamoto, Murayama, Hayashi et 
al. 1991; Sun, Chen, Poppleton et al. 1997). It will be essential to determine whether 
any Gi or Gq/11 recognition consensus sequences exist in the VEGFR2 sequence.  
 
   In addition to PLCB, several targets of Gq/11 or Gi may have a role in mediating 
the effects of VEGF on ERK1/2. These effects may occur though activity of either 
Gá or Gâã. In HUVEC, transfection with a Gâã-sequestering peptide did not inhibit 
VEGFR2 phosphorylation but did inhibit intracellular calcium mobilisation and 
MAPK phosphorylation which are required for HUVEC cell proliferation (Zeng, 
Sanyal, & Mukhopadhyay 2001). It has been proposed that VEGFR2 activation and 
Gâã subunits are required for VEGF-induced stimulation of PLCã in HUVEC cells. 
Further support of the involvement of Gâã in VEGF signalling was provided by a 
study in zebrafish that found that silencing of Gã2 resulted in inhibition of 
PLCã/AKT-mediated angiogenic sprouting (Leung, Chen, Stauffer et al. 2006). A 
role of Gâã in IGF-I-induced p-ERK has also been shown (Kuemmerle & Murthy 
2001). Since Gi proteins have been described as a major source of intracellular Gâã 
(Birnbaumer 2007), the dramatic effect of PTX on VEGF-induced p-ERK in the 
present study may be explained by a similar role of Gâã in granulosa cells. In 
addition to Gâã, Gá subunits (particularly Gáq/11) may also account for some of the 
effects of the G-protein inhibitors on VEGF-induced p-ERK since these two types of 
Gá subunit have been shown to activate directly or indirectly ERK1/2. For example, 
in several cell types Gáq has been shown to stimulate the ERK pathway not only 
through PLCâ but also via Brutons tyrosine kinase (Btk)/PLCã (Anger, Klintworth, 
Stumpf et al. 2007;Cramer, Schmenger, Heinrich et al. 2001;Lopez De, Zalduegui, 
Ruiz, I et al. 2006;Qiu & Kung 2000;Sanborn, Ku, Shlykov et al. 2005). Also Gái 
can induce ERK1/2 signalling through Rap (Weissman, Ma, Essex, Gao, & Burstein 
2004) and both Gáq and Gái can activate PYK2 and Src which subsequently activate 
ERK1/2 (Dikic, Tokiwa, Lev et al. 1996; Igishi & Gutkind 1998; la Rocca, van, 
Daaka et al. 1997).  
   
   In summary, results of the current study indicate that Gi and Gq/11 mediate VEGF-
induced activation of ERK1/2 in bovine granulosa cells. However, whether PLCB3 is 
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involved in VEGF signalling in these cells could not be clarified. Because ERK1/2 
signalling has important roles in both proliferation and differentiation of granulosa 
cells, it can be concluded from the present results that Gi and Gq/11 likely mediate 
some of the functions of VEGF in follicles described in Chapter 2. In addition, such 
interactions between VEGF and heterotrimeric proteins may underlie potential cross-
talk between VEGF and gonadotrophin signals in the follicles. 
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Discussion and Conclusions 
 
   The studies detailed within this thesis investigated the effects and signalling 
mechanisms of VEGF in granulosa cells using an established bovine primary cell 
culture system (Gutierrez, Campbell, & Webb 1997b). The bovine has been 
described as a suitable model for the study of follicle development in the human as 
both species have similar patterns of antral follicle growth and bovine follicles are 
easily accessible experimentally both in vivo and ex vivo (Adams & Pierson 1995). 
The initial aim was to gain insight into the contribution of non-angiogenic effects of 
VEGF to the development of the dominant follicle. The effects of VEGF on 
granulosa cell proliferation, steroidogenesis and ERK1/2 activation were determined 
using a commercially available proliferation assay, real time PCR analysis of 
P450scc and western blotting, respectively, in cells from follicles of a diameter (4.0 
to 8.0 mm) corresponding to the natural diameter of follicles just before they become 
dominant. Granulosa cells from dominant-size follicles (9.0 to 14.0 mm) were used 
to investigate the effects of VEGF on the periovulatory increase in COX2 (Espey & 
Richards 2006) using real time PCR. Although actual identities of the follicles 
collected in these studies were unknown, visual assessment was used to determine 
whether follicles were healthy (growing follicles) or atretic, as previously described 
(Yang & Rajamahendran 2000). The validity of this approach was confirmed by the 
observed increase in mean expression levels of LHR in granulosa cells from 
dominant-size follicles (9-14 mm; Chapter 3) consistent with these being non-atretic 
follicles (Bao, Garverick, Smith et al. 1997; Conti 2002). Based on previous 
evidence in other cell types (Mukhopadhyay, Zeng, & Bhattacharya 2004; Zeng, 
Dvorak, & Mukhopadhyay 2001a; Zeng, Zhao, & Mukhopadhyay 2002a), we then 
sought to determine the involvement of heterotrimeric G-proteins and PLCâ isoforms 
on the effects of VEGF in granulosa cells. Expression of heterotrimeric G-protein á 
subunits and PLCâ isoforms were characterised in freshly collected granulosa cells 
throughout antral follicle development using real-time PCR and western blotting. 
The specific roles of Gáq/11 and Gái2 as well as PLCâ3 on VEGF activation of 
ERK1/2, a pathway that is known to mediate cell proliferative and COX2 responses 
(Kim, Na, Pak et al. 2008; Rodriguez-Barbero, Dorado, Velasco et al. 2006; Shaul & 
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Seger 2007; Souza, Shewmake, Pearson et al. 2004; Yoon & Seger 2006) were tested 
in granulosa cell from dominant-size follicles using specific chemical inhibitors and 
RNAi approaches.  
 
   The role of VEGF in follicle development has been well characterised with respect 
to its angiogenic effects resulting in the development of vascular networks 
particularly in the dominant follicle (Fraser 2006; Kaczmarek, Schams, & Ziecik 
2005). Dominant follicles acquire an enriched blood supply thus receiving 
preferential delivery of nutrients and factors required for growth, and in this way 
VEGF indirectly promotes follicle selection. In recent years there has been 
accumulating evidence of direct effects of VEGF on proliferation, survival and 
migration of a wide range of non-vascular cell types (Gaudio, Barbaro, Alvaro et al. 
2006; Oosthuyse, Moons, Storkebaum et al. 2001 ;Wilgus, Matthies, Radek et al. 
2005; Zhu, Jin, Mao et al. 2003; Barleon, Sozzani, Zhou et al 1996; Sondell, 
Lundborg, & Kanje 1999c). The effects of VEGF on the development of antral 
follicle independent of its classical angiogenic effects have not been fully described, 
although limited studies have shown that VEGF can stimulate granulosa cell survival 
and proliferation (Grasselli, Basini, Bussolati et al. 2002; Greenaway, Connor, 
Pedersen et al. 2004). Particularly high levels of VEGF and VEGF receptors are 
found in granulosa cells of dominant follicles (Kaczmarek, Schams, & Ziecik 2005), 
suggesting potentially important non-endothelial roles of VEGF during the latest 
stages of follicle development. 
 
   Whilst in vivo models have undoubtedly the highest physiological relevance, 
separating the effects of VEGF that are due to the stimulation of blood flow in the 
follicle wall from those that occur through direct interaction of VEGF with non-
endothelial follicular cells, such as granulosa cells, would be quite challenging and 
may only be reliably achieved by creating rodent models with cell-specific knockouts 
of the VEGF receptors. Alternatively, the use of cell culture models, with intrinsic 
lower complexity, offers some advantages. In that regard, the cell culture system 
used in the current study allowed investigation of granulosa cell responses to VEGF 
stimulation independently of follicular angiogenic effects.  
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   The results of the current study suggest that VEGF is an important direct regulator 
of granulosa cell functions, including proliferation and periovulatory responses such 
as COX2 synthesis. We were interested in studying in vitro the effects of the follicle 
selection-associated increase in VEGF and VEGF receptors (Greenaway, Connor, 
Pedersen et al. 2004) on granulosa cells and for that reason we used cells from 
follicles with diameters encompassing those of a dominant follicle. However, VEGF 
may also regulate earlier stages of follicle development as evidence exists of positive 
effects of VEGF in pre-antral follicles in vitro. For example, Yang and Fortune 
(2007) recently reported that VEGF treatment of bovine cortical pieces resulted in an 
increased number of secondary follicles (Yang & Fortune 2007). The exact 
mechanisms of such stimulatory effects by VEGF in early stages of follicle growth 
remain unknown.  
 
   Our results (chapter 2) indicated that VEGF functionally interacts with 
gonadotrophins in follicles as shown by the synergistic effects of FSH and VEGF on 
granulosa cell proliferation and the VEGF-mediation of LH effects. The latter was 
indicated by the observation that inhibition of VEGFR2 using a specific inhibitor 
(ZM323881) significantly reduced the ability of LH to stimulate phosphorylation of 
ERK and completely abolished the LH-stimulated increase in COX2. This finding 
demonstrates for the first time that VEGF may have a primary role in mediating 
ovulation.  Transactivation of VEGFR2 by GPCRs other than LHR has been shown.  
For example, stimulation of Gq/11-coupled bradykinin receptor induces tyrosine 
phosphorylation of VEGFR2 in cardiac endothelial cells to increase the activity of 
nitric oxide synthase activity (Thuringer, Maulon, & Frelin 2002). Another study 
showed that binding of sphingosine-1 phosphate to its Gi-coupled receptor stimulates 
phosphorylation of VEGFR2 (Tanimoto, Jin, & Berk 2002). In addition to VEGFR, 
LH has been shown to transactivate EGFR. This effect is mediated through induction 
of MMPs that cleave membrane bound-EGF-like growth factors which then act to 
rely the LH signal to COCs (Conti, Hsieh, Park et al. 2006; Park, Su, Ariga et al. 
2004). Here we propose that EGF may not be the only growth factor responsible for 
mediation of the LH signal. Membrane-bound VEGF variants (i.e. VEGF145, 
VEGF189 and VEGF206) may be released in response to LH surge and act in an 
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autocrine and/or paracrine manner to amplify the LH signal within the follicle. 
Interestingly, not only LH but also EGF has been shown to up-regulate the 
expression of VEGF (Frank, Hubner, Breier et al. 1995; Goldman, Kim, Wong et al. 
1993; Ravindranath, Wion, Brachet et al. 2001). Based on results from previous 
studies, LHR may transactivate VEGFR2 by stimulating the synthesis of VEGF in 
granulosa cells (Christenson & Stouffer 1997). Alternatively, LHR activation may 
stimulate the activity of intracellular ligands such as c-Src, as has shown to occur in 
EGFR activation (Stover, Becker, Liebetanz et al. 1995; Zwick, Hackel, Prenzel et 
al. 1999). Further studies are required to elucidate the precise mechanism involved in 
this effect. 
 
   A rational, sequential experimental approach was taken to elucidate potential roles 
of heterotrimeric G-proteins in these studies involving the identification of Gá 
subunits and PLCâ isoforms that may be functionally relevant in dominant follicles 
followed by actual testing of the requirement of these molecules for VEGFR 
signalling. This approach allowed focus on specific molecules that were likely to be 
physiologically relevant. The finding that Gás, Gáq/11, Gái and PLCâ3 were present 
at significantly higher levels in granulosa cells of dominant-size compared to smaller 
follicles indicated that these molecules may be important in relying the LH-surge 
signal. This conclusion is in agreement with other studies that reported that LHR in 
granulosa cells physically and functionally couples not only to Gs-AC but also to 
Gi(Gq/11)-PLCâ (Donadeu & Ascoli 2005; Herrlich, Kuhn, Grosse et al. 1996; 
Rajagopalan-Gupta, Rasenick, & Hunzicker-Dunn 1997; Rajagopalan-Gupta, Lamm, 
Mukherjee et al. 1998). The observed increase in PLCâ3 in granulosa cells of 
dominant-size follicles is also in agreement with results that this also was the 
predominant PLCâ isoform in myometrial tissue, suggesting a particularly relevant 
role of PLCâ3 in female reproductive tissues (Zhong, Murtazina, Phillips et al. 
2008).  
 
   Results in several cell types have shown that, in addition to stimulating classical 
RTK-associated signalling pathways, VEGFR, as other RTKs, can mediate its effects 
via heterotrimeric G-protein cascades (Patel 2004; Zeng, Zhao, & Mukhopadhyay 
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2002a; Zeng, Zhao, & Mukhopadhyay 2002b; Zeng, Zhao, Yang et al. 2003b). We 
provide evidence for the first time that VEGF signal transduction can occur via Gi 
(most likely Gi2) and Gq/11 in granulosa cells.  
 
   Consensus binding sequences for the activation of numerous Gá subunits have 
been located on various RTKs, including Gás activation sequences on the EGF 
receptor (Sun, Chen, Poppleton et al 1997; Sun, Seyer, & Patel 1995) and sites in 
insulin, â-adrenergic, muscarinic cholinergic, IGFR type 2 and á2-adrenergic 
receptors that are required for the activation of Gs and Gi/o (Ikezu, Okamoto, Ogata 
et al. 1992; Okamoto, Murayama, Hayashi, Inagaki et al. 1991; Okamoto & 
Nishimoto 1992). The use of bioinformatics approaches to investigate the presence 
of consensus sequences for binding of Gái2 and Gáq/11 in the VEGFR2 could 
provide confirmation for the findings in the current studies. The identification of 
such sequences would in addition provide an opportunity to use site-directed 
mutagenesis approaches to provide a more accurate determination of the relative 
involvement of Gq/11 and Gi in VEGF signalling. 
 
   Our experimental approach did not enable us to distinguish whether the G protein 
effects on VEGF induction of p-ERK were due to Gá or Gâã. In addition, we do not 
know the stoichiometric concentrations of each of the subunits in these cells. To 
elucidate the relative involvement of Gá and Gâã, transfection of granulosa cells 
with constructs coding for âARK, which acts to bind and sequester Gâã, or dominant 
negative forms of specific Gá subunits could be used. RNAi technology to target 
specific Gá subunits would also be useful. 
 
   At the present time we can speculate that the majority of Gâã-mediated effects 
would be derived from Gi as this has been shown to be the most abundant source of 
Gâã complexes in many cell types (Rebecchi & Pentyala 2000) and Gâã is a putative 
intracellular activator of p-ERK, for example through PLCâ (Rhee 2001). As Gáq/11 
is known to stimulate all PLCâ isoforms and according to some studies (Jhon, Lee, 
Park et al. 1993; Mukhopadhyay, Zeng, & Bhattacharya 2004) has a high affinity for 
PLCâ3, it is possible that VEGF stimulation of phosphorylation of ERK1/2 in 
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granulosa cells occurs in part through Gáq/11 activation of PLCâ3. Although we 
were unable to demonstrate an involvement of PLCâ3 in VEGF signalling 
mechanisms in granulosa cells, PLCâ3 levels were very high in granulosa cells of the 
dominant follicle and this together with evidence that VEGF Gq/11 signalling in 
HUVEC cells occurred via PLCâ3 further supports the argument that PLCâ3 could 
be involved in VEGF signalling in granulosa cells. Further work is required to 
elucidate the findings of the current study. One of the primary actions of Gái2 is to 
reduce cAMP levels; however this subunit can activate ERK1/2 phosphorylation 
through pathways that include Src and Rap (Weissman, Ma, Essex et al. 2004). 
Although not investigated, the role of other Gá subunits such as Gás, Gái1, Gái3 and 
Gá12/13 in mediating VEGF signals can not be ruled out. For example, Gá13 has 
previously been shown to be required for VEGF-induced migration of endothelial 
cells (Shan, Chen, Wang et al. 2006).  
 
A working model on the intracellular mechanisms involved in VEGF-induced 
ERK-mediated responses in granulosa cells based on the results described in this 
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Figure 5.1. Model for VEGF-induced responses in granulosa cells from dominant follicles. The high 
levels of VEGF produced by granulosa cells of dominant follicles act in an autocrine/paracrine 
manner to stimulate cell proliferation and/or COX2 expression, depending on the stage of follicle 
development, two responses that involve activation of Classical pathways involved in VEGF-induced 
ERK activation include PLCã and possibly the SHC/Grb2/Sos complex. Here we propose that 
heterotrimeric G-proteins, specifically Gi2 and Gq/11, are also required for VEGF-activation of ERK 
in these cells and the subsequent stimulation of cell proliferation and/or COX2 expression. This 
mechanism provides a functional link between VEGF and classical heterotrimeric G protein-linked 
trophic factors, such as gonadotrophins, in granulosa cells. Whether the effects of Gq/11 and Gi on 
VEGF-induced ERK are mediated by PLCâ3 remains unclear. In addition, the VEGFR also acts to 
mediate gonadotrophin responses in granulosa cells (such as COX2 expression) through 
transactivation of VEGFR by LHR (and maybe also FSHR), perhaps through a similar mechanism to 
that described for LHR transactivation of EGFR in ovulatory follicles, thus providing an additional 
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Abstract 
Despite critical roles of the ovarian surface epithelium (OSE) in ovulation and 
post-ovulatory wound repair, little is known about the physiological mechanism 
regulating OSE proliferation. A role of follicles and corpora lutea in locally 
regulating the proliferative activity of OSE has been suggested. In this study, the 
effects of follicular and luteal products on proliferation of cultured OSE cells were 
tested using cells obtained from seasonally anoestrous ewes. Follicular fluid but not 
luteal extracts induced OSE cell proliferation (2.5-fold relative to untreated controls; 
P<0.0001). The response of OSE cells was not affected by follicle size or previous 
charcoal-extraction of follicular fluid (P>0.1). Treatment with IGF-I (2.2 fold; 
P<0.01), EGF (1.9 fold; P<0.01) and, to a lesser extent, FSH (P<0.05) also induced 
OSE cell proliferation. In contrast, oestradiol or progesterone did not induce cell 
proliferation or enhance the effects of FSH on proliferation (P>0.1). It was concluded 
that follicular fluid can directly stimulate ovine OSE cell proliferation and that this 
effect is attributable to non-steroidal mitogens. 
 




The ovarian surface epithelium (OSE) is composed of a single layer of flat to 
cuboidal simple epithelial cells that surround the ovary and are separated from 
underlying stroma by a basement membrane and a dense connective tissue layer, the 
tunica albuginea (Auersperg et al., 2001).  The OSE transports material to and from 
the peritoneal cavity and plays an important role during ovulation and postovulatory 
wound repair (reviewed in Auersperg et al., 2001).  Most interest on OSE biology 
has derived from its involvement in ovarian cancer in women. OSE-derived cancers 
constitute over 90% of all ovarian cancers and are the most aggressive of all 
gynaecological malignancies (Auersperg et al., 2001).  
Despite the extensive literature on the biology of neoplasic OSE (reviewed in 
Auersperg et al., 2001; Leung and Choi, 2006), relatively little is known on the 
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physiological mechanisms regulating the proliferation of normal OSE in humans or 
animals. During normal ovarian cycles the OSE undergoes periodic proliferative 
changes associated with follicular growth and luteal development (Gaytan et al., 
2005).  Although regulation of OSE function by systemic factors (e.g., 
gonadotrophins) in vivo is well established (Stewart et al., 2004; Burdette et al., 
2006) recent studies encompassing the entire oestrous cycle in rodents have provided 
compelling evidence of the importance of local ovarian mechanisms in the regulation 
of OSE proliferation. Specifically, it was found that cyclic proliferative activity in rat 
and mouse OSE is localised to areas overlying growing follicles and corpora lutea 
(Gaytan et al., 2005; Burdette et al., 2006) and this activity is enhanced by 
gonadotrophins (Davies et al., 1999; Stewart et al., 2004; Burdette et al., 2006). 
In addition to gonadotrophins, oestrogens and androgens can stimulate OSE 
proliferation in vitro (Syed et al., 2001; Murdoch and Van Kirk, 2002; Gubbay et al., 
2004), although this has not been confirmed in other studies (Karlan et al., 1995; 
Wright et al., 2002). Instead, progesterone has been reported to block OSE 
proliferation in vitro in some studies (Syed et al., 2001; Murdoch and Van Kirk, 
2002) and this is consistent with a correlation between high levels of progesterone 
and a reduced risk of ovarian cancer in humans (Auersperg et al., 2001). Several 
peptide growth factors produced locally in the ovary can also modulate OSE 
proliferation (Wong and Leung, 2007). Overall, these findings suggest important 
roles for follicle- and/or luteal-derived products in the regulation of OSE function 
and perhaps also tumourogenesis.  
Rodent models have previously been used to study the biology of normal OSE 
(Tan and Fleming, 2004; Gaytan et al., 2005; Burdette et al., 2006), however, 
ruminant models with reproductive cycles more closely resembling humans may be 
preferable (Parrott et al., 2001; Murdoch and McDonnel, 2002). In addition, ovine 
OSE have been shown to be an adequate model for in vitro studies on human OSE 
(Gubbay et al., 2004).  
The aim of the present study was to clarify the role of local ovarian regulation of 
OSE proliferation by determining the effects of follicular and luteal products on the 
proliferation of ovine OSE cells in culture. The identities of specific follicular/luteal 
components responsible for such effects were then investigated.  
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Material and Methods 
Cell culture 
 Pools of surface epithelial cells were obtained from four seasonally anestrous 
sheep immediatedly after sacrifice. OSE from such animals is expected to be 
relatively quiescent as it is not subjected to proliferative stimuli associated with 
periodic postovulatory wound repair and therefore provides an optimum model for 
testing the effects of substances on OSE cell proliferation.  The ovarian surface was 
gently scraped with the blunt end of a sterile scalpel blade and then rinsed into 
culture media consisting of M199/MCDB 105 medium (1:1) containing 1 mM L-
glutamine, 100UI/ml Penicillin, 100ug/ml Streptomycin and 10% fetal calf serum 
(FCS), as described (Gubbay et al., 2006). The presence of OSE flakes in the 
scrapings was confirmed by phase-contrast microscopy. OSE cells from each animal 
were transferred to separate culture flasks that had been pre-coated with FCS and 
were incubated in culture media at 37º C in a humidified atmosphere of 5% CO2. 
Media was replaced every 7 days until cultures reached confluence (normally after 3 
to 4 weeks). Highly pure ovine OSE cultures are consistently obtained using these 
procedures (Gubbay et al., 2006). Cells were passaged once and used for 
proliferation assays when they reached confluence.  
  
Cell proliferation assay 
Cell cultures derived from different animals were pooled and cells were incubated 
with culture media in 96-well plates at a density of 5000 cells/well for 24 h. Media 
was then replaced with media without serum for a further 24 h after which treatments 
were applied to triplicate wells. These consisted of follicular fluid (final 
concentration in culture media, 10%) from follicles of different sizes (indicated 
below) that was either pure or had been charcoal-extracted previously, extracts from 
mature corpora lutea (final concentration, 10%), recombinant human IGF-I (100 
ng/ml; NHPP, Torrance, California), recombinant human EGF (100 ng/ml; Sigma-
Aldrich, Dorset, UK),  progesterone (3, 30 and 300 ng/ml; Sigma-Aldrich), 17â-
oestradiol (3, 30 and 300 ng/ml, Sigma-Aldrich), ovine FSH (100 ng/ml; NHPP), 
FCS (as supplied by manufacturer, final concentration, 10%, Sigma-Aldrich) or 
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combinations of these treatments. Cell proliferation was measured with the Cell Titer 
96® Aqueous One Solution Proliferation Assay (Promega, Southampton, UK ) 
following instructions by the manufacturer after a 3-day incubation with treatments.  
According to the manufacturer, this procedure is based on the reduction of an MTS 
tetrazolium compound into a coloured formazan product by metabolically active 
cells and the quantity of formazan product as measured by the absorbance at 490 nm 
is directly proportional to the number of living cells in culture. Proper validation of 
this method in ovine OSE cells was performed over a range of cell densities (2700 to 
135000 cells/well of 96-well plates).  Over this range, a linear relationship was found 
between cell density and optical density (OD) of the samples according to the 
equation, OD = (cell density/105) + 0.0343. ODs for all experimental samples fell 
well within this linear range. 
Follicular fluid used to treat OSE cells was prepared by pooling aspirates from 
small (2-4 mm), medium (6-8 mm) and large (10-12 mm) follicles taken from six 
bovine ovaries collected at an abattoir. Preliminary data (not shown) demonstrated 
that OSE had similar proliferative responses to bovine and ovine follicular fluid. A 
fraction from each bovine follicular fluid pool was charcoal-extracted to remove 
steroids and other lipids as described (van Tol and Bevers, 2001). Follicular fluid 
was filter-sterilised and frozen at -20C for later use. Oestradiol concentrations in 
follicular fluid were measured by RIA (England et al., 1981) and they were found to 
be, before charcoal-extraction, 8.9, 69.9 and 594.3 ng/ml in fluid from small, 
medium and large follicles, respectively. Oestradiol levels were reduced by charcoal-
extraction to 1.3, 0.8 and 8.2 ng/ml in the three types of fluid, respectively.  Luteal 
extracts were obtained by grinding four freshly collected, mature corpora lutea from 
bovine ovaries followed by filtration, centrifugation, collection of supernatants into 
OSE culture media and filter-sterilisation before storage at -20C.  
 
Statistical analyses 
In each case, the mean values from triplicate wells were used for statistical 
analyses. Data were analyzed by one-way ANOVA using the General Linear Model 
(Minitab 15).  When a main effect was significant or approached significance, 
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Tukeys test was used to locate differences between means. Main effects and 
differences between means were considered to be significant when P≤ 0.05.  
Results  
Incubation of cultured ovine OSE cells with follicular fluid resulted in a 2.5-fold 
increase in cell proliferation relative to untreated controls (P<0.0001), which was 
approximately 40% the proliferative response induced by FCS (Figure 1A). There 
were no effects (P>0.1) of follicle size or previous charcoal extraction in the 
proliferative responses to follicular fluid. Luteal extracts, in contrast, did not 
stimulate cell proliferation (P>0.1).  IGF-I or EGF induced proliferation of OSE cells 
(means of 2.2- and 1.9-fold over untreated controls, respectively; P<0.01; Figure 
1B). In contrast, progesterone or oestradiol had no effects on cell proliferation at any 
of the doses used (P>0.1). FSH had a small but significant effect on cell proliferation 
(mean, 1.2-fold; P<0.05). Proliferative responses to FSH in the presence of oestradiol 
or progesterone were not significantly different (P>0.1) to those of control cells or 




Cyclic proliferative activity in OSE has been reported to be localised to areas 
overlying growing follicles and corpora lutea (Gaytan et al., 2005; Burdette et al., 
2006), suggesting a stimulatory effect (direct or indirect) of follicular and/or luteal 
products on OSE proliferation. The effects of some of these products, particularly 
steroids, on OSE cell proliferation in culture have been studied, although results have 
been inconclusive (Karlan et al., 1995; Syed et al., 2001; Murdoch and Van Kirk, 
2002; Wright et al., 2002; Stewart et al., 2004). Therefore, we decided to test the 
direct effects of whole follicular fluid and luteal extracts on OSE cell proliferation 
and then investigate individual components that may account for any observed 
effects. Our results show for the first time that follicular fluid but not luteal extracts 
stimulate proliferation of ovine OSE in culture.  The observed effects of follicular 
fluid on OSE proliferation and the smaller response of OSE to follicular fluid than to 
serum were not surprising since follicular fluid is partially an exudate of serum and 
therefore it is expected to contain at least some of the mitogenic factors found in 
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serum (Murray et al., 1998). In addition, the levels of some of these mitogens, such 
as IGF-I, are higher in serum than in follicular fluid (Kirby et al., 1993).  Follicular 
fluid has been shown to induce the proliferation of other non-follicular cell types 
such as endometrial and endothelial cells (Bahtiyar et al., 1998; von Otte et al., 
2006). 
The absence of an effect of charcoal extraction on the proliferative responses of 
OSE cells to follicular fluid and the inability of oestradiol or progesterone, at any of 
the three doses chosen to encompass physiological levels in ovine follicular fluid 
(Spicer et al., 1995; Evans et al., 2000), to induce significant cell proliferation or to 
modify the response of OSE cells to FSH excludes a steroidal component being 
responsible for the mitogenic effects of follicular fluid on OSE cells. Several non-
steroidal growth factors have been shown to stimulate OSE proliferation in vitro, 
including members of the IGF and EGF families and gonadotrophins (Gubbay et al., 
2004; Wong and Leung, 2007), specific receptors for which are expressed in OSE 
(Auersperg et al., 2001). In the present study, IGF-I and EGF induced, on average, 
2.2- and 1.9-fold increases in OSE proliferation, respectively, which are similar to 
the responses induced by follicular fluid (combined average for all follicle sizes, 2.3-
fold increase). The dose of IGF-I used in this study was within the range of 
concentrations reported in follicular fluid (Kirby et al., 1993; Artini et al., 1994).  In 
contrast, the dose of EGF in follicular fluid has been reported to be substantially 
lower to that of IGF-I (Artini et al., 1994). Therefore, although the two growth 
factors had similar effects on OSE proliferation in this study, their relative roles in 
vivo may be different.  The effect of FSH on proliferation, albeit relatively low, was 
consistent with previous results in vitro (Gubbay et al., 2006) and in vivo (Stewart et 
al., 2004; Burdette et al., 2006). Taken together, these findings suggest that the 
mitogenic effects of follicular fluid on OSE derive, to a considerable extent, from 
IGF-I and EGF, and possibly other mitogenic peptides (Khan et al., 1997; Wong and 
Leung, 2007), rather than from direct effects of follicular steroids. This finding 
should be confirmed in future studies by assessing the effects of follicular fluid 
depletion of IGF-I and EGF on proliferative responses of OSE. 
The present findings imply potentially important role(s) of follicular fluid in OSE 
remodelling during the oestrous/menstrual cycle. Such role(s) would most readily 
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take place after the release of the follicular contents into the abdominal cavity and 
over the ovarian surface during ovulation as this may provide a strong stimulus for 
OSE proliferation thus contributing to initiate the re-epithelisation of the ovulatory 
wound. Proliferative responses in this study resulted from a 3-day exposure of 
cultured OSE to follicular fluid.  OSE responses to follicular fluid after ovulation in 
vivo would presumably follow different kinetics, due for example to relative shorter 
exposure of OSE cells to mitogenic stimuli, and therefore the magnitude of such 
response would be different from that observed in vitro. Further studies will be 
needed to address this.  
In contrast to the direct effects on the ovulatory wound, a mitogenic effect of 
follicular fluid on the OSE overlying developing follicles would depend on the 
ability of mitogenic products to diffuse from the follicular fluid compartment to the 
OSE compartment. Such an influence of follicular fluid may readily occur during the 
latest stages of maturation of the ovulatory follicle when considerable thinning of the 
follicle wall and adjacent tunica albuginea occur in preparation for ovulation 
(Murdoch and McDonnel, 2002), but may have a less important role during earlier 
stages of follicular growth.  
In this study, in contrast to follicular fluid, CL extracts did not induce significant 
proliferative activity. Results from a preliminary study (not showed) demonstrated 
that these differences were not due to differences in protein content between 
follicular fluid and CL extract. A possible explanation for the present result is that 
mitogenic substances produced in the highly vascularised corpus luteum may not 
accumulate locally since they would be continually cleared into the circulation. 
Luteal stimuli, therefore, may not play a significant role in the re-epithelisation of the 
ovulatory wound. Instead, this process may largely involve stimulatory signals 
generated locally at the borders of the ovulatory wound and adjacent stroma in 
response to ovulation-induced inflammation and rupture of OSE integrity, similar to 
the mechanisms involved in regeneration of other body epithelia (Grinnell, 1992). 
This conclusion is consistent with responses to experimentally induced OSE injury 
(Stewart et al., 2004; Wright et al., 2007). An alternative explanation for the lack of 
effects of CL extracts on proliferation is that these extracts as obtained in the present 
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study may not contain the full mitogenic potential of the CL, a possibility that cannot 
be ruled out.  
In summary, follicular fluid but not luteal extracts stimulated proliferation of 
cultured ovine OSE cells. The effects of follicular fluid were not dependent on 
follicle size and were attributed, at least partially, to IGF-I and EGF but not to 
follicular steroids.  Follicular fluid from ovulatory follicles may have an important 
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Figure legends 
Figure 1. Proliferative responses (mean ± SEM; n=4 experiments) of cultured ovine 
OSE cells to (A) FCS, follicular fluid and luteal extracts and (B) IGF-I, EGF, 
oestradiol, progesterone and FSH (alone or in combination with oestradiol or 
progesterone). Follicular fluid was separately pooled from small (2-4 mm), medium 
(6-8 mm) or large (10-12 mm) bovine follicles and a fraction from each pool was 
charcoal-extracted. Values for each treatment are expressed relative to the value in 
untreated cells which was taken as 1.  In each case, stars indicate treatment means 
that are different from the mean value in untreated controls (P<0.05).  
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